| 12846289 | CV376554 | single nucleotide variant | NM_030662.4(MAP2K2):c.*2A>T | not specified [RCV000441365] | likely benign | 19 | 4090596 | 4090596 | Human | | name |
| 12835047 | CV377543 | single nucleotide variant | NM_030662.4(MAP2K2):c.-9G>A | not provided [RCV000421011]|not specified [RCV004701478] | likely benign|uncertain significance | 19 | 4123884 | 4123884 | Human | | name |
| 13527540 | CV506841 | single nucleotide variant | NM_030662.4(MAP2K2):c.-4C>G | Cardiovascular phenotype [RCV004025003]|not provided [RCV001719091]|not specified [RCV003987621] | likely benign|uncertain significance | 19 | 4123879 | 4123879 | Human | | name |
| 8609081 | CV55387 | single nucleotide variant | NM_030662.3(MAP2K2):c.*8C>T | Noonan syndrome and Noonan-related syndrome [RCV001813363]|RASopathy [RCV000523941]|not specified [RCV000039466] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4090590 | 4090590 | Human | 1 | name |
| 8609082 | CV55389 | single nucleotide variant | NM_030662.4(MAP2K2):c.*9G>A | not specified [RCV000039467] | likely benign | 19 | 4090589 | 4090589 | Human | | name |
| 150450425 | CV1215245 | single nucleotide variant | NM_030662.4(MAP2K2):c.*24C>G | not provided [RCV001611835] | benign | 19 | 4090574 | 4090574 | Human | | name |
| 8691901 | CV141867 | single nucleotide variant | NM_030662.3(MAP2K2):c.*19C>T | not provided [RCV001723694]|not specified [RCV000126682] | benign|likely benign | 19 | 4090579 | 4090579 | Human | | name |
| 155741371 | CV1779973 | single nucleotide variant | NM_030662.4(MAP2K2):c.-16G>A | not specified [RCV002302577] | uncertain significance | 19 | 4123891 | 4123891 | Human | | name |
| 11637876 | CV264853 | single nucleotide variant | NM_030662.4(MAP2K2):c.-42C>T | not provided [RCV000293798] | likely benign|uncertain significance | 19 | 4123917 | 4123917 | Human | | name |
| 12834714 | CV377714 | single nucleotide variant | NM_030662.4(MAP2K2):c.-23C>A | not provided [RCV000420421] | likely benign | 19 | 4123898 | 4123898 | Human | | name |
| 12835337 | CV377716 | single nucleotide variant | NM_030662.4(MAP2K2):c.-47A>G | not provided [RCV000421494] | likely benign | 19 | 4123922 | 4123922 | Human | | name |
| 12833891 | CV379588 | single nucleotide variant | NM_030662.4(MAP2K2):c.*20G>A | not provided [RCV001704470]|not specified [RCV000419366] | benign|likely benign | 19 | 4090578 | 4090578 | Human | | name |
| 12837593 | CV379589 | single nucleotide variant | NM_030662.4(MAP2K2):c.*14C>T | not specified [RCV000425437] | likely benign | 19 | 4090584 | 4090584 | Human | | name |
| 11542335 | CV49318 | single nucleotide variant | NM_030662.4(MAP2K2):c.*24C>T | not provided [RCV001636616]|not specified [RCV000248903] | benign | 19 | 4090574 | 4090574 | Human | | name |
| 13526102 | CV507414 | single nucleotide variant | NM_030662.4(MAP2K2):c.-50C>A | not specified [RCV000603670] | likely benign | 19 | 4123925 | 4123925 | Human | | name |
| 151352088 | CV1325066 | single nucleotide variant | NM_030662.4(MAP2K2):c.-243C>T | Noonan syndrome and Noonan-related syndrome [RCV001813621] | benign | 19 | 4124118 | 4124118 | Human | | name |
| 152063609 | CV1587855 | single nucleotide variant | NM_030662.4(MAP2K2):c.93-4G>T | RASopathy [RCV002090571] | likely benign | 19 | 4117633 | 4117633 | Human | 1 | name |
| 9690498 | CV176033 | single nucleotide variant | NM_030662.4(MAP2K2):c.93-6C>T | Noonan syndrome and Noonan-related syndrome [RCV001813405]|RASopathy [RCV000465734]|not provided [RCV001711316]|not specified [RCV000156178] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4117635 | 4117635 | Human | 1 | name |
| 156006500 | CV1902735 | single nucleotide variant | NM_030662.4(MAP2K2):c.93-8C>T | RASopathy [RCV003099055] | likely benign | 19 | 4117637 | 4117637 | Human | 1 | name |
| 597893586 | CV3857104 | single nucleotide variant | NM_030662.4(MAP2K2):c.92+8G>A | RASopathy [RCV005200967] | likely benign | 19 | 4123776 | 4123776 | Human | 1 | name |
| 150502609 | CV49319 | single nucleotide variant | NM_030662.4(MAP2K2):c.*174C>A | not provided [RCV001595149] | benign | 19 | 4090424 | 4090424 | Human | 4 | name |
| 13796619 | CV553046 | single nucleotide variant | NM_030662.4(MAP2K2):c.-206G>T | not provided [RCV000680668] | benign | 19 | 4124081 | 4124081 | Human | | name |
| 13796560 | CV553047 | single nucleotide variant | NM_030662.3(MAP2K2):c.-269G>A | not provided [RCV000680647] | benign | 19 | 4124144 | 4124144 | Human | | name |
| 13796618 | CV553048 | single nucleotide variant | NM_030662.3(MAP2K2):c.-285G>T | not provided [RCV000680667] | benign | 19 | 4124160 | 4124160 | Human | | name |
| 13796731 | CV553049 | single nucleotide variant | NM_030662.3(MAP2K2):c.-366G>A | not provided [RCV000680725] | benign | 19 | 4124241 | 4124241 | Human | | name |
| 13797739 | CV553050 | single nucleotide variant | NM_030662.3(MAP2K2):c.-406C>A | not provided [RCV000681396] | likely benign | 19 | 4124281 | 4124281 | Human | | name |
| 13797738 | CV553051 | single nucleotide variant | NM_030662.3(MAP2K2):c.-419C>A | not provided [RCV000681395] | likely benign | 19 | 4124294 | 4124294 | Human | | name |
| 127245463 | CV1106528 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+7C>T | RASopathy [RCV001424323] | likely benign | 19 | 4102369 | 4102369 | Human | 1 | name |
| 127290813 | CV1127904 | single nucleotide variant | NM_030662.4(MAP2K2):c.984+8C>T | RASopathy [RCV001475872] | likely benign | 19 | 4097271 | 4097271 | Human | 1 | name |
| 127294515 | CV1158549 | duplication | NM_030662.4(MAP2K2):c.93-15dup | Noonan syndrome and Noonan-related syndrome [RCV001813600]|RASopathy [RCV001511778] | benign|uncertain significance | 19 | 4117638 | 4117639 | Human | 1 | name |
| 150508667 | CV1214102 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-3C>T | RASopathy [RCV001866247]|not provided [RCV001596623] | likely benign|uncertain significance | 19 | 4101146 | 4101146 | Human | 1 | name |
| 150479624 | CV1239417 | single nucleotide variant | NM_030662.4(MAP2K2):c.92+27C>G | not provided [RCV001652580] | benign | 19 | 4123757 | 4123757 | Human | | name |
| 150503090 | CV1241723 | single nucleotide variant | NM_030662.4(MAP2K2):c.93-31A>G | not provided [RCV001657314] | benign | 19 | 4117660 | 4117660 | Human | | name |
| 150492440 | CV1281110 | single nucleotide variant | NM_030662.4(MAP2K2):c.93-78A>G | not provided [RCV001716813] | benign | 19 | 4117707 | 4117707 | Human | | name |
| 151795253 | CV1338537 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-2A>C | RASopathy [RCV001898553] | uncertain significance | 19 | 4101282 | 4101282 | Human | 1 | name |
| 151800014 | CV1365727 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+2T>C | RASopathy [RCV001917630] | uncertain significance | 19 | 4101017 | 4101017 | Human | 1 | name |
| 151710472 | CV1376960 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+6T>C | RASopathy [RCV001889269] | uncertain significance | 19 | 4102370 | 4102370 | Human | 1 | name |
| 8691902 | CV141868 | single nucleotide variant | NM_030662.4(MAP2K2):c.93-20A>C | Cardiofaciocutaneous syndrome 4 [RCV005229950]|RASopathy [RCV002055668]|not provided [RCV004717044]|not specified [RCV000126683] | benign | 19 | 4117649 | 4117649 | Human | 2 | name |
| 152083884 | CV1533357 | single nucleotide variant | NM_030662.4(MAP2K2):c.920-6G>A | MAP2K2-related disorder [RCV003968850]|RASopathy [RCV002093211] | likely benign | 19 | 4097349 | 4097349 | Human | 2 | name , trait , alternate_id |
| 152171496 | CV1552770 | single nucleotide variant | NM_030662.4(MAP2K2):c.93-11G>T | RASopathy [RCV002143466] | likely benign | 19 | 4117640 | 4117640 | Human | 1 | name |
| 152142108 | CV1583636 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+8C>G | RASopathy [RCV002120514] | likely benign | 19 | 4101011 | 4101011 | Human | 1 | name |
| 152150836 | CV1605450 | single nucleotide variant | NM_030662.4(MAP2K2):c.92+12G>T | RASopathy [RCV002102205] | likely benign | 19 | 4123772 | 4123772 | Human | 1 | name |
| 152083720 | CV1647933 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+9G>T | RASopathy [RCV002076711] | likely benign | 19 | 4110500 | 4110500 | Human | 1 | name |
| 9689189 | CV176032 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+8C>G | MAP2K2-related disorder [RCV003945213]|RASopathy [RCV000520093]|not provided [RCV000587724]|not specified [RCV000154642] | benign | 19 | 4117411 | 4117411 | Human | 2 | name , trait , alternate_id |
| 156346227 | CV1868340 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-2A>G | RASopathy [RCV003064534] | uncertain significance | 19 | 4101145 | 4101145 | Human | 1 | name |
| 156371480 | CV1923592 | single nucleotide variant | NM_030662.4(MAP2K2):c.580+5G>C | RASopathy [RCV002633424] | uncertain significance | 19 | 4101224 | 4101224 | Human | 1 | name |
| 156406292 | CV1963556 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-6C>G | RASopathy [RCV002585858] | likely benign|uncertain significance | 19 | 4102459 | 4102459 | Human | 1 | name |
| 156314322 | CV2031792 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-4C>G | RASopathy [RCV002716713] | likely benign | 19 | 4101147 | 4101147 | Human | 1 | name |
| 156015735 | CV2035076 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-8G>T | RASopathy [RCV002780393] | likely benign | 19 | 4101151 | 4101151 | Human | 1 | name |
| 156118172 | CV2035708 | single nucleotide variant | NM_030662.4(MAP2K2):c.580+8C>T | RASopathy [RCV002785679] | likely benign | 19 | 4101221 | 4101221 | Human | 1 | name |
| 156228267 | CV2088906 | single nucleotide variant | NM_030662.4(MAP2K2):c.93-10G>C | RASopathy [RCV002876136] | likely benign | 19 | 4117639 | 4117639 | Human | 1 | name |
| 156188680 | CV2098893 | single nucleotide variant | NM_030662.4(MAP2K2):c.985-5C>G | RASopathy [RCV002917375] | likely benign | 19 | 4095454 | 4095454 | Human | 1 | name |
| 156134414 | CV2109399 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-7C>G | RASopathy [RCV002914671] | uncertain significance | 19 | 4101287 | 4101287 | Human | 1 | name |
| 156028488 | CV2125303 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+9T>G | RASopathy [RCV002949119] | likely benign | 19 | 4099192 | 4099192 | Human | 1 | name |
| 156366305 | CV2130669 | single nucleotide variant | NM_030662.4(MAP2K2):c.93-10G>T | RASopathy [RCV002967333] | likely benign | 19 | 4117639 | 4117639 | Human | 1 | name |
| 156328653 | CV2216238 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+5G>A | Cardiovascular phenotype [RCV004097198]|RASopathy [RCV003539463] | uncertain significance | 19 | 4110504 | 4110504 | Human | 1 | name |
| 11090941 | CV231025 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-8G>A | Cardiofaciocutaneous syndrome 4 [RCV003741165]|RASopathy [RCV001442552]|not provided [RCV001722158]|not specified [RCV000216682] | benign|likely benign | 19 | 4101151 | 4101151 | Human | 2 | name |
| 11546944 | CV257129 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-5T>C | RASopathy [RCV001487659]|not specified [RCV000247121] | likely benign|uncertain significance | 19 | 4101285 | 4101285 | Human | 1 | name |
| 11642738 | CV265077 | single nucleotide variant | NM_030662.4(MAP2K2):c.580+5G>A | not provided [RCV000380904] | uncertain significance | 19 | 4101224 | 4101224 | Human | | name |
| 401908242 | CV2815195 | duplication | NM_030662.4(MAP2K2):c.528+1dup | not provided [RCV003423209] | uncertain significance | 19 | 4102374 | 4102375 | Human | | name |
| 405160065 | CV2868114 | deletion | NM_030662.4(MAP2K2):c.93-20del | RASopathy [RCV003539643] | likely benign | 19 | 4117649 | 4117649 | Human | 1 | name |
| 405162375 | CV2869201 | single nucleotide variant | NM_030662.4(MAP2K2):c.706-9C>G | RASopathy [RCV003539686] | likely benign | 19 | 4099423 | 4099423 | Human | 1 | name |
| 405159197 | CV2870384 | single nucleotide variant | NM_030662.4(MAP2K2):c.920-8C>G | RASopathy [RCV003539605] | likely benign | 19 | 4097351 | 4097351 | Human | 1 | name |
| 405161340 | CV2890764 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+6C>T | RASopathy [RCV003540141] | uncertain significance | 19 | 4117413 | 4117413 | Human | 1 | name |
| 405162602 | CV2896671 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+7C>T | RASopathy [RCV003540222] | likely benign | 19 | 4099194 | 4099194 | Human | 1 | name |
| 405163602 | CV2911998 | single nucleotide variant | NM_030662.4(MAP2K2):c.304-4G>A | RASopathy [RCV003540241] | likely benign | 19 | 4110659 | 4110659 | Human | 1 | name |
| 405054569 | CV2940480 | single nucleotide variant | NM_030662.4(MAP2K2):c.92+18A>T | RASopathy [RCV003655456] | likely benign | 19 | 4123766 | 4123766 | Human | 1 | name |
| 405058137 | CV2968898 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+8C>T | RASopathy [RCV003655679] | likely benign | 19 | 4110501 | 4110501 | Human | 1 | name |
| 405060024 | CV2981880 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-4C>T | RASopathy [RCV003655764] | likely benign | 19 | 4102457 | 4102457 | Human | 1 | name |
| 405041137 | CV3141119 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+3G>A | RASopathy [RCV003831412] | uncertain significance | 19 | 4110506 | 4110506 | Human | 1 | name |
| 405236313 | CV3169010 | single nucleotide variant | NM_030662.4(MAP2K2):c.92+15G>A | RASopathy [RCV003866289] | likely benign | 19 | 4123769 | 4123769 | Human | 1 | name |
| 408387281 | CV3518788 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+5G>T | not provided [RCV004761107] | uncertain significance | 19 | 4102371 | 4102371 | Human | | name |
| 597662542 | CV3709758 | single nucleotide variant | NM_030662.4(MAP2K2):c.304-3C>G | Cardiofaciocutaneous syndrome 4 [RCV005028651] | uncertain significance | 19 | 4110658 | 4110658 | Human | 1 | name |
| 597864332 | CV3742131 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+7C>G | RASopathy [RCV005067747] | likely benign | 19 | 4102369 | 4102369 | Human | 1 | name |
| 597956330 | CV3754609 | single nucleotide variant | NM_030662.4(MAP2K2):c.985-3C>T | RASopathy [RCV005080459] | uncertain significance | 19 | 4095452 | 4095452 | Human | 1 | name |
| 597953122 | CV3756661 | single nucleotide variant | NM_030662.4(MAP2K2):c.580+3A>G | RASopathy [RCV005079719] | uncertain significance | 19 | 4101226 | 4101226 | Human | 1 | name |
| 12833474 | CV379594 | single nucleotide variant | NM_030662.4(MAP2K2):c.304-7C>T | RASopathy [RCV001441223]|not provided [RCV000418571] | likely benign | 19 | 4110662 | 4110662 | Human | 1 | name |
| 597937626 | CV3807884 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+1G>A | RASopathy [RCV005158263] | uncertain significance | 19 | 4099200 | 4099200 | Human | 1 | name |
| 597880875 | CV3826445 | single nucleotide variant | NM_030662.4(MAP2K2):c.93-15G>T | RASopathy [RCV005178142] | likely benign | 19 | 4117644 | 4117644 | Human | 1 | name |
| 597895420 | CV3833676 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+9T>G | RASopathy [RCV005180368] | likely benign | 19 | 4117410 | 4117410 | Human | 1 | name |
| 597940933 | CV3836646 | single nucleotide variant | NM_030662.4(MAP2K2):c.93-12G>A | RASopathy [RCV005187667] | likely benign | 19 | 4117641 | 4117641 | Human | 1 | name |
| 597925898 | CV3855290 | single nucleotide variant | NM_030662.4(MAP2K2):c.92+11A>G | RASopathy [RCV005205889] | likely benign | 19 | 4123773 | 4123773 | Human | 1 | name |
| 598124989 | CV3883762 | single nucleotide variant | NM_030662.4(MAP2K2):c.984+5G>A | not provided [RCV005236117] | uncertain significance | 19 | 4097274 | 4097274 | Human | | name |
| 150454060 | CV49237 | single nucleotide variant | NM_030662.4(MAP2K2):c.92+42G>T | not provided [RCV001612302] | benign | 19 | 4123742 | 4123742 | Human | | name |
| 150442875 | CV49238 | single nucleotide variant | NM_030662.4(MAP2K2):c.92+46G>C | not provided [RCV001679490] | benign | 19 | 4123738 | 4123738 | Human | | name |
| 150476247 | CV49270 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-6C>T | RASopathy [RCV003539397]|not provided [RCV001672031] | benign|likely benign | 19 | 4102459 | 4102459 | Human | 1 | name |
| 8609103 | CV49278 | single nucleotide variant | NM_030662.4(MAP2K2):c.580+6G>A | Cardiofaciocutaneous syndrome 4 [RCV000625449]|MAP2K2-related disorder [RCV003891460]|Noonan syndrome and Noonan-related syndrome [RCV001813314]|RASopathy [RCV000229923]|not provided [RCV000443089]|not specified [RCV000039488] | benign|likely benign|conflicting interpretations of pathogenicity | 19 | 4101223 | 4101223 | Human | 2 | name , trait , alternate_id |
| 12845020 | CV49304 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+4C>T | Cardiofaciocutaneous syndrome 4 [RCV002496506]|RASopathy [RCV001030072]|not provided [RCV000588970]|not specified [RCV001797594] | benign|likely benign|conflicting interpretations of pathogenicity | 19 | 4099197 | 4099197 | Human | 2 | name |
| 13529756 | CV507041 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-9C>T | RASopathy [RCV001480416]|not specified [RCV000605856] | likely benign|conflicting interpretations of pathogenicity | 19 | 4101152 | 4101152 | Human | 1 | name |
| 13527557 | CV507049 | single nucleotide variant | NM_030662.4(MAP2K2):c.92+11A>C | RASopathy [RCV002529617]|not specified [RCV000599798] | likely benign | 19 | 4123773 | 4123773 | Human | 1 | name |
| 14690790 | CV621871 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-5T>C | RASopathy [RCV002067381]|not specified [RCV000781518] | likely benign|uncertain significance | 19 | 4101148 | 4101148 | Human | 1 | name |
| 15156156 | CV690216 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-7C>T | MAP2K2-related disorder [RCV003938284]|RASopathy [RCV002064575]|not provided [RCV000868178]|not specified [RCV002307638] | likely benign|uncertain significance | 19 | 4102460 | 4102460 | Human | 2 | name , trait , alternate_id |
| 15103906 | CV690217 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+9G>A | Noonan syndrome and Noonan-related syndrome [RCV001813559]|RASopathy [RCV001416539] | likely benign | 19 | 4110500 | 4110500 | Human | 1 | name |
| 34895753 | CV917555 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+5G>A | Cardio-facio-cutaneous syndrome [RCV005359914]|RASopathy [RCV005057073]|not specified [RCV001192910] | uncertain significance | 19 | 4099196 | 4099196 | Human | 2 | name |
| 34896165 | CV917556 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-9G>A | RASopathy [RCV005094025]|not specified [RCV001193486] | likely benign|uncertain significance | 19 | 4102462 | 4102462 | Human | 1 | name |
| 150336134 | CV1165126 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-27C>A | not provided [RCV001530705] | likely benign | 19 | 4101307 | 4101307 | Human | | name |
| 150421656 | CV1181764 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+29G>A | not provided [RCV001552117] | likely benign | 19 | 4117390 | 4117390 | Human | | name |
| 150424059 | CV1185487 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+22G>A | not provided [RCV001556159] | likely benign | 19 | 4110487 | 4110487 | Human | | name |
| 150428797 | CV1188779 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+26C>T | not provided [RCV001562741] | likely benign | 19 | 4102350 | 4102350 | Human | | name |
| 150407662 | CV1192169 | single nucleotide variant | NM_030662.4(MAP2K2):c.304-46G>A | not provided [RCV001565081] | likely benign | 19 | 4110701 | 4110701 | Human | | name |
| 150417656 | CV1195415 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+40C>T | not provided [RCV001568863] | likely benign | 19 | 4110469 | 4110469 | Human | | name |
| 150504895 | CV1222758 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+29C>T | not provided [RCV001621692] | benign | 19 | 4110480 | 4110480 | Human | | name |
| 150506857 | CV1242316 | single nucleotide variant | NM_030662.4(MAP2K2):c.93-242C>A | not provided [RCV001658671] | benign | 19 | 4117871 | 4117871 | Human | | name |
| 150455484 | CV1246922 | single nucleotide variant | NM_030662.4(MAP2K2):c.984+33C>T | not provided [RCV001668690] | benign | 19 | 4097246 | 4097246 | Human | | name |
| 150470500 | CV1258598 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+33C>T | not provided [RCV001684143] | benign | 19 | 4099168 | 4099168 | Human | | name |
| 150480766 | CV1258788 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+46C>G | not provided [RCV001685918] | benign | 19 | 4117373 | 4117373 | Human | | name |
| 150470015 | CV1259755 | single nucleotide variant | NM_030662.4(MAP2K2):c.304-18G>A | RASopathy [RCV001859431]|not provided [RCV001684056] | benign|likely benign | 19 | 4110673 | 4110673 | Human | 1 | name |
| 150446248 | CV1261337 | single nucleotide variant | NM_030662.4(MAP2K2):c.580+39G>T | not provided [RCV001680011] | benign | 19 | 4101190 | 4101190 | Human | | name |
| 150477596 | CV1262525 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-45G>A | not provided [RCV001685338] | benign | 19 | 4102498 | 4102498 | Human | | name |
| 150475885 | CV1271256 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-49C>G | not provided [RCV001696079] | benign | 19 | 4101329 | 4101329 | Human | | name |
| 150443950 | CV1277925 | single nucleotide variant | NM_030662.4(MAP2K2):c.92+168A>G | not provided [RCV001707068] | benign | 19 | 4123616 | 4123616 | Human | | name |
| 150472832 | CV1281296 | single nucleotide variant | NM_030662.4(MAP2K2):c.92+204G>A | not provided [RCV001713432] | benign | 19 | 4123580 | 4123580 | Human | | name |
| 150488239 | CV1283977 | single nucleotide variant | NM_030662.4(MAP2K2):c.580+31C>T | not provided [RCV001716070] | benign | 19 | 4101198 | 4101198 | Human | | name |
| 151759275 | CV1340655 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+15G>T | RASopathy [RCV001913788]|not specified [RCV002266059] | benign|likely benign|uncertain significance | 19 | 4117404 | 4117404 | Human | 1 | name |
| 8691893 | CV141860 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-12G>A | RASopathy [RCV002055665]|not specified [RCV000126672] | benign|likely benign|conflicting interpretations of pathogenicity | 19 | 4101292 | 4101292 | Human | 1 | name |
| 8691896 | CV141863 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+11G>C | Cardiofaciocutaneous syndrome 4 [RCV003741151]|RASopathy [RCV002055666]|not provided [RCV003415934]|not specified [RCV000154752] | benign | 19 | 4101008 | 4101008 | Human | 2 | name |
| 8691903 | CV141869 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+11C>T | RASopathy [RCV002055669]|not specified [RCV000126684] | benign | 19 | 4117408 | 4117408 | Human | 1 | name |
| 151866864 | CV1447538 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+19A>G | RASopathy [RCV001924712] | likely benign|uncertain significance | 19 | 4099182 | 4099182 | Human | 1 | name |
| 152092405 | CV1530894 | single nucleotide variant | NM_030662.4(MAP2K2):c.985-19C>A | Cardiofaciocutaneous syndrome 4 [RCV003120830]|RASopathy [RCV002114254]|not specified [RCV003226533] | likely benign|uncertain significance | 19 | 4095468 | 4095468 | Human | 2 | name |
| 152070644 | CV1535430 | single nucleotide variant | NM_030662.4(MAP2K2):c.1046+7G>A | RASopathy [RCV002111401] | likely benign | 19 | 4095381 | 4095381 | Human | 1 | name |
| 152122414 | CV1554928 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+17C>T | RASopathy [RCV002198235] | likely benign | 19 | 4117402 | 4117402 | Human | 1 | name |
| 152130666 | CV1567755 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+19C>T | RASopathy [RCV002218025] | likely benign | 19 | 4102357 | 4102357 | Human | 1 | name |
| 152054163 | CV1575143 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+15G>A | RASopathy [RCV002109336] | likely benign | 19 | 4117404 | 4117404 | Human | 1 | name |
| 152107453 | CV1577902 | single nucleotide variant | NM_030662.4(MAP2K2):c.985-14G>A | RASopathy [RCV002096371] | likely benign | 19 | 4095463 | 4095463 | Human | 1 | name |
| 152156027 | CV1589301 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-13C>T | RASopathy [RCV002122437] | likely benign | 19 | 4101293 | 4101293 | Human | 1 | name |
| 152026897 | CV1593602 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+17C>G | RASopathy [RCV002104711]|not specified [RCV003235672] | likely benign|uncertain significance | 19 | 4102359 | 4102359 | Human | 1 | name |
| 152172602 | CV1599192 | single nucleotide variant | NM_030662.4(MAP2K2):c.304-19C>T | RASopathy [RCV002143832] | likely benign | 19 | 4110674 | 4110674 | Human | 1 | name |
| 152045376 | CV1600123 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-14G>T | RASopathy [RCV002088490] | likely benign | 19 | 4101294 | 4101294 | Human | 1 | name |
| 152032540 | CV1614813 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-19C>A | RASopathy [RCV002086599] | likely benign | 19 | 4102472 | 4102472 | Human | 1 | name |
| 152042039 | CV1617985 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-13C>T | RASopathy [RCV002206472] | likely benign | 19 | 4101156 | 4101156 | Human | 1 | name |
| 152047371 | CV1627369 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-14T>C | RASopathy [RCV002108504] | likely benign | 19 | 4102467 | 4102467 | Human | 1 | name |
| 152131475 | CV1633019 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-18C>G | RASopathy [RCV002136976] | likely benign | 19 | 4101298 | 4101298 | Human | 1 | name |
| 152032962 | CV1643220 | single nucleotide variant | NM_030662.4(MAP2K2):c.304-15C>G | RASopathy [RCV002205080] | likely benign | 19 | 4110670 | 4110670 | Human | 1 | name |
| 152085382 | CV1646778 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+11A>T | RASopathy [RCV002149854] | benign | 19 | 4099190 | 4099190 | Human | 1 | name |
| 152080559 | CV1663661 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+19A>C | RASopathy [RCV002149254] | likely benign | 19 | 4099182 | 4099182 | Human | 1 | name |
| 9689992 | CV176172 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+13G>A | RASopathy [RCV002056094]|not specified [RCV000155636] | benign|likely benign | 19 | 4110496 | 4110496 | Human | 1 | name |
| 9832797 | CV179831 | microsatellite | NM_030662.4(MAP2K2):c.-27CCG[3] | RASopathy [RCV000158020] | benign | 19 | 4123891 | 4123893 | Human | | name |
| 156020653 | CV1903008 | single nucleotide variant | NM_030662.4(MAP2K2):c.985-19C>T | RASopathy [RCV003100178] | likely benign | 19 | 4095468 | 4095468 | Human | 1 | name |
| 156020946 | CV1909523 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+18C>G | RASopathy [RCV002619390] | likely benign | 19 | 4101001 | 4101001 | Human | 1 | name |
| 156278354 | CV1912014 | single nucleotide variant | NM_030662.4(MAP2K2):c.580+18C>T | RASopathy [RCV002628343] | likely benign | 19 | 4101211 | 4101211 | Human | 1 | name |
| 155941005 | CV1913820 | single nucleotide variant | NM_030662.4(MAP2K2):c.706-19C>T | RASopathy [RCV002615634] | likely benign | 19 | 4099433 | 4099433 | Human | 1 | name |
| 156318302 | CV2025140 | single nucleotide variant | NM_030662.4(MAP2K2):c.580+12C>T | RASopathy [RCV002716930] | likely benign | 19 | 4101217 | 4101217 | Human | 1 | name |
| 156209894 | CV2036805 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+16G>A | RASopathy [RCV002790204] | likely benign | 19 | 4099185 | 4099185 | Human | 1 | name |
| 156129406 | CV2037332 | single nucleotide variant | NM_030662.4(MAP2K2):c.920-19C>T | RASopathy [RCV002800553] | likely benign | 19 | 4097362 | 4097362 | Human | 1 | name |
| 155958516 | CV2040298 | single nucleotide variant | NM_030662.4(MAP2K2):c.920-14C>T | RASopathy [RCV002776144] | likely benign | 19 | 4097357 | 4097357 | Human | 1 | name |
| 156010859 | CV2042991 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+20C>G | RASopathy [RCV002756677] | likely benign | 19 | 4100999 | 4100999 | Human | 1 | name |
| 156042906 | CV2071719 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+12G>A | RASopathy [RCV002846168] | likely benign | 19 | 4102364 | 4102364 | Human | 1 | name |
| 156013488 | CV2123061 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+18A>G | RASopathy [RCV002975774] | likely benign | 19 | 4110491 | 4110491 | Human | 1 | name |
| 156159851 | CV2147275 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-11G>A | RASopathy [RCV003023153] | likely benign | 19 | 4102464 | 4102464 | Human | 1 | name |
| 11093343 | CV231024 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+11G>A | RASopathy [RCV002057113]|not specified [RCV000219657] | benign|likely benign | 19 | 4101008 | 4101008 | Human | 1 | name |
| 11544593 | CV257130 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-15C>T | RASopathy [RCV002058363]|not specified [RCV000243998] | benign|likely benign|conflicting interpretations of pathogenicity | 19 | 4101295 | 4101295 | Human | 1 | name |
| 11550465 | CV257131 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+46C>T | not provided [RCV001689921]|not specified [RCV000251790] | benign | 19 | 4102330 | 4102330 | Human | | name |
| 401964307 | CV2843619 | single nucleotide variant | NM_030662.4(MAP2K2):c.985-14G>C | RASopathy [RCV003539493]|not specified [RCV003479962] | likely benign | 19 | 4095463 | 4095463 | Human | 1 | name |
| 405158789 | CV2861483 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+19T>C | RASopathy [RCV003539531] | likely benign | 19 | 4101000 | 4101000 | Human | 1 | name |
| 405159728 | CV2874190 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+12G>T | RASopathy [RCV003539619] | likely benign | 19 | 4102364 | 4102364 | Human | 1 | name |
| 405159926 | CV2878425 | single nucleotide variant | NM_030662.4(MAP2K2):c.1092+7G>A | RASopathy [RCV003539634] | likely benign | 19 | 4094446 | 4094446 | Human | 1 | name |
| 405159939 | CV2878426 | single nucleotide variant | NM_030662.4(MAP2K2):c.985-16C>A | RASopathy [RCV003539635] | likely benign | 19 | 4095465 | 4095465 | Human | 1 | name |
| 405161240 | CV2884446 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+13G>T | RASopathy [RCV003539718] | likely benign | 19 | 4117406 | 4117406 | Human | 1 | name |
| 405162312 | CV2888635 | single nucleotide variant | NM_030662.4(MAP2K2):c.706-11C>T | RASopathy [RCV003540039] | likely benign | 19 | 4099425 | 4099425 | Human | 1 | name |
| 405162654 | CV2907146 | single nucleotide variant | NM_030662.4(MAP2K2):c.984+15C>A | RASopathy [RCV003540226] | likely benign | 19 | 4097264 | 4097264 | Human | 1 | name |
| 405163715 | CV2919244 | single nucleotide variant | NM_030662.4(MAP2K2):c.706-15C>G | RASopathy [RCV003540273] | likely benign | 19 | 4099429 | 4099429 | Human | 1 | name |
| 405165753 | CV2933404 | single nucleotide variant | NM_030662.4(MAP2K2):c.985-15T>C | RASopathy [RCV003540456] | likely benign | 19 | 4095464 | 4095464 | Human | 1 | name |
| 405050403 | CV3060281 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+20C>T | RASopathy [RCV003654691] | likely benign | 19 | 4099181 | 4099181 | Human | 1 | name |
| 405050790 | CV3068065 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+16C>G | RASopathy [RCV003654720] | likely benign | 19 | 4101003 | 4101003 | Human | 1 | name |
| 405053037 | CV3077703 | single nucleotide variant | NM_030662.4(MAP2K2):c.984+12A>T | RASopathy [RCV003654900] | likely benign | 19 | 4097267 | 4097267 | Human | 1 | name |
| 405088063 | CV3122152 | single nucleotide variant | NM_030662.4(MAP2K2):c.920-12C>T | RASopathy [RCV003810907] | likely benign | 19 | 4097355 | 4097355 | Human | 1 | name |
| 405164387 | CV3125278 | single nucleotide variant | NM_030662.4(MAP2K2):c.920-18A>G | RASopathy [RCV003818550] | likely benign | 19 | 4097361 | 4097361 | Human | 1 | name |
| 405201216 | CV3128886 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+11G>T | RASopathy [RCV003821929] | likely benign | 19 | 4101008 | 4101008 | Human | 1 | name |
| 405212499 | CV3142619 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+15G>A | RASopathy [RCV003845976] | likely benign | 19 | 4102361 | 4102361 | Human | 1 | name |
| 405202322 | CV3143557 | single nucleotide variant | NM_030662.4(MAP2K2):c.304-10C>A | RASopathy [RCV003844543] | likely benign | 19 | 4110665 | 4110665 | Human | 1 | name |
| 405187731 | CV3156549 | single nucleotide variant | NM_030662.4(MAP2K2):c.304-11T>C | RASopathy [RCV003859427] | likely benign | 19 | 4110666 | 4110666 | Human | 1 | name |
| 405254349 | CV3175030 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+12A>C | RASopathy [RCV003871482] | likely benign | 19 | 4099189 | 4099189 | Human | 1 | name |
| 402504218 | CV3181377 | single nucleotide variant | NM_030662.4(MAP2K2):c.985-18C>T | RASopathy [RCV003878210] | likely benign | 19 | 4095467 | 4095467 | Human | 1 | name |
| 596924388 | CV3531129 | deletion | NM_030662.3(MAP2K2):c.93_114del | not provided [RCV004779703] | uncertain significance | 19 | 4117608 | 4117629 | Human | | name |
| 12741208 | CV360422 | single nucleotide variant | NM_030662.4(MAP2K2):c.1047-3C>T | not specified [RCV000414419] | uncertain significance | 19 | 4094501 | 4094501 | Human | | name |
| 597881987 | CV3744978 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-11G>C | RASopathy [RCV005070003] | likely benign | 19 | 4102464 | 4102464 | Human | 1 | name |
| 597945924 | CV3755464 | single nucleotide variant | NM_030662.4(MAP2K2):c.580+10A>T | RASopathy [RCV005078473] | likely benign | 19 | 4101219 | 4101219 | Human | 1 | name |
| 597836607 | CV3757715 | single nucleotide variant | NM_030662.4(MAP2K2):c.920-16C>G | RASopathy [RCV005085729] | likely benign | 19 | 4097359 | 4097359 | Human | 1 | name |
| 597833761 | CV3760424 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+10C>T | RASopathy [RCV005085167] | likely benign | 19 | 4102366 | 4102366 | Human | 1 | name |
| 12841795 | CV376555 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-20C>T | not provided [RCV000433215] | likely benign | 19 | 4101163 | 4101163 | Human | | name |
| 12846323 | CV377526 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+10G>A | MAP2K2-related disorder [RCV003942338]|RASopathy [RCV001478102]|not provided [RCV000441432]|not specified [RCV001175517] | likely benign|uncertain significance | 19 | 4099191 | 4099191 | Human | 2 | name , trait , alternate_id |
| 12839211 | CV377528 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-19C>T | RASopathy [RCV002059822]|not provided [RCV000428394]|not specified [RCV005239005] | benign|likely benign | 19 | 4101162 | 4101162 | Human | 1 | name |
| 12841014 | CV377530 | single nucleotide variant | NM_030662.4(MAP2K2):c.580+15G>A | RASopathy [RCV002061589]|not provided [RCV000431819]|not specified [RCV001251291] | benign|likely benign | 19 | 4101214 | 4101214 | Human | 1 | name |
| 12842639 | CV377684 | single nucleotide variant | NM_030662.4(MAP2K2):c.920-17T>A | RASopathy [RCV003539889]|not provided [RCV000434784] | likely benign | 19 | 4097360 | 4097360 | Human | 1 | name |
| 12840038 | CV377688 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-14G>A | RASopathy [RCV002061579]|not provided [RCV000429940] | likely benign | 19 | 4101294 | 4101294 | Human | 1 | name |
| 12834685 | CV377704 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+11C>T | RASopathy [RCV002061429]|not provided [RCV000420380]|not specified [RCV001778958] | benign|likely benign | 19 | 4102365 | 4102365 | Human | 1 | name |
| 12838407 | CV377707 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+12C>T | RASopathy [RCV002061427]|not provided [RCV000426906] | likely benign | 19 | 4110497 | 4110497 | Human | 1 | name |
| 12839345 | CV379590 | single nucleotide variant | NM_030662.4(MAP2K2):c.706-17C>T | RASopathy [RCV002521780]|not provided [RCV000428646] | likely benign | 19 | 4099431 | 4099431 | Human | 1 | name |
| 12844421 | CV379591 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-18G>A | RASopathy [RCV002061430]|not specified [RCV000437961] | benign | 19 | 4101161 | 4101161 | Human | 1 | name |
| 12845582 | CV379592 | single nucleotide variant | NM_030662.4(MAP2K2):c.580+14C>T | RASopathy [RCV002061587]|not provided [RCV000440079] | likely benign | 19 | 4101215 | 4101215 | Human | 1 | name |
| 12843949 | CV379593 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+17C>T | Cardiofaciocutaneous syndrome 4 [RCV002502475]|RASopathy [RCV002061428]|not provided [RCV000437136]|not specified [RCV001251389] | benign|likely benign | 19 | 4110492 | 4110492 | Human | 2 | name |
| 597971465 | CV3802492 | single nucleotide variant | NM_030662.4(MAP2K2):c.580+13C>T | RASopathy [RCV005142090] | likely benign | 19 | 4101216 | 4101216 | Human | 1 | name |
| 597908480 | CV3806127 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-19C>A | RASopathy [RCV005153885] | likely benign | 19 | 4101162 | 4101162 | Human | 1 | name |
| 597971236 | CV3832771 | single nucleotide variant | NM_030662.4(MAP2K2):c.706-20C>T | RASopathy [RCV005166850] | likely benign | 19 | 4099434 | 4099434 | Human | 1 | name |
| 597882754 | CV3834083 | single nucleotide variant | NM_030662.4(MAP2K2):c.985-14G>T | RASopathy [RCV005178402] | likely benign | 19 | 4095463 | 4095463 | Human | 1 | name |
| 597902307 | CV3845467 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+14G>A | RASopathy [RCV005181277] | likely benign | 19 | 4101005 | 4101005 | Human | 1 | name |
| 597903308 | CV3845924 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+19C>G | RASopathy [RCV005181546] | likely benign | 19 | 4102357 | 4102357 | Human | 1 | name |
| 597856638 | CV3849748 | single nucleotide variant | NM_030662.4(MAP2K2):c.304-18G>T | RASopathy [RCV005195257] | likely benign | 19 | 4110673 | 4110673 | Human | 1 | name |
| 597938373 | CV3852710 | single nucleotide variant | NM_030662.4(MAP2K2):c.1093-8C>T | RASopathy [RCV005187109] | likely benign | 19 | 4090716 | 4090716 | Human | 1 | name |
| 12899631 | CV410612 | duplication | NM_030662.4(MAP2K2):c.1047-2dup | not provided [RCV000480641] | likely benign|uncertain significance | 19 | 4094499 | 4094500 | Human | | name |
| 12901626 | CV410618 | deletion | NM_030662.4(MAP2K2):c.303+15del | RASopathy [RCV002526626]|not provided [RCV000485158] | benign|likely benign | 19 | 4117404 | 4117404 | Human | 1 | name |
| 11542368 | CV49259 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+18G>A | Cardiofaciocutaneous syndrome 4 [RCV001001924]|RASopathy [RCV002054548]|not provided [RCV001675588]|not specified [RCV000251005] | benign | 19 | 4117401 | 4117401 | Human | 2 | name |
| 8609098 | CV49264 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+15G>T | RASopathy [RCV002054549]|not provided [RCV001642534]|not specified [RCV000039483] | benign | 19 | 4110494 | 4110494 | Human | 1 | name |
| 150491153 | CV49266 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-79C>T | not provided [RCV001618771] | benign | 19 | 4102532 | 4102532 | Human | | name |
| 150439356 | CV49267 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-69G>C | not provided [RCV001609991] | benign | 19 | 4102522 | 4102522 | Human | | name |
| 150514080 | CV49268 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-44G>A | not provided [RCV001598890] | benign | 19 | 4102497 | 4102497 | Human | | name |
| 150462328 | CV49269 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-15T>G | not provided [RCV001710009] | benign | 19 | 4102468 | 4102468 | Human | | name |
| 11542312 | CV49274 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+20A>G | RASopathy [RCV002054550]|not provided [RCV001711144]|not specified [RCV000246991] | benign | 19 | 4102356 | 4102356 | Human | 1 | name |
| 150471737 | CV49275 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-26G>A | not provided [RCV001713247] | benign | 19 | 4101306 | 4101306 | Human | | name |
| 150472780 | CV49276 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-11C>A | not provided [RCV001671501] | benign | 19 | 4101291 | 4101291 | Human | | name |
| 150434387 | CV49279 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-29G>A | not provided [RCV001643722] | benign | 19 | 4101172 | 4101172 | Human | | name |
| 150488938 | CV49289 | single nucleotide variant | NM_030662.4(MAP2K2):c.706-81G>A | not provided [RCV001674421] | benign | 19 | 4099495 | 4099495 | Human | | name |
| 150446362 | CV49290 | single nucleotide variant | NM_030662.4(MAP2K2):c.706-72C>T | not provided [RCV001667160] | benign | 19 | 4099486 | 4099486 | Human | | name |
| 150492572 | CV49291 | single nucleotide variant | NM_030662.4(MAP2K2):c.706-38C>T | not provided [RCV001619016] | benign | 19 | 4099452 | 4099452 | Human | | name |
| 150471745 | CV49292 | single nucleotide variant | NM_030662.4(MAP2K2):c.706-35C>G | not provided [RCV001713248] | benign | 19 | 4099449 | 4099449 | Human | | name |
| 8609112 | CV49305 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+12A>G | Cardiofaciocutaneous syndrome 4 [RCV000603060]|RASopathy [RCV002054551]|not provided [RCV000509309]|not specified [RCV000039497] | benign|not provided | 19 | 4099189 | 4099189 | Human | 2 | name |
| 150445224 | CV49306 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+31G>C | not provided [RCV001691088] | benign | 19 | 4099170 | 4099170 | Human | | name |
| 150510452 | CV49307 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+37C>T | not provided [RCV001597588] | benign | 19 | 4099164 | 4099164 | Human | | name |
| 150471747 | CV49308 | single nucleotide variant | NM_030662.4(MAP2K2):c.920-24A>G | not provided [RCV001713249] | benign | 19 | 4097367 | 4097367 | Human | | name |
| 13536870 | CV497520 | single nucleotide variant | NM_030662.4(MAP2K2):c.1046+4G>A | RASopathy [RCV005091590]|not specified [RCV000609600] | uncertain significance | 19 | 4095384 | 4095384 | Human | 1 | name |
| 13526999 | CV507044 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+20G>A | RASopathy [RCV002065204]|not specified [RCV000604871] | likely benign | 19 | 4110489 | 4110489 | Human | 1 | name |
| 13536656 | CV507386 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-11G>A | not specified [RCV000609314] | likely benign | 19 | 4101154 | 4101154 | Human | | name |
| 13533643 | CV507388 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-10T>C | not specified [RCV000607156] | likely benign|conflicting interpretations of pathogenicity | 19 | 4101290 | 4101290 | Human | | name |
| 13796612 | CV553041 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+99A>G | not provided [RCV000680664] | benign | 19 | 4110410 | 4110410 | Human | | name |
| 13797606 | CV553044 | single nucleotide variant | NM_030662.4(MAP2K2):c.92+266G>A | not provided [RCV000681336] | likely benign | 19 | 4123518 | 4123518 | Human | | name |
| 8609083 | CV55390 | microsatellite | NM_030662.4(MAP2K2):c.-27CCG[6] | not specified [RCV000039468] | benign|likely benign|conflicting interpretations of pathogenicity | 19 | 4123890 | 4123891 | Human | | name |
| 8609086 | CV55393 | single nucleotide variant | NM_030662.4(MAP2K2):c.1093-6T>C | Cardiofaciocutaneous syndrome 4 [RCV003741149]|RASopathy [RCV000463260]|not provided [RCV000590120]|not specified [RCV000039471] | benign|likely benign | 19 | 4090714 | 4090714 | Human | 2 | name |
| 8609093 | CV55398 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+12G>A | RASopathy [RCV002054765]|not specified [RCV000039478] | benign|likely benign|conflicting interpretations of pathogenicity | 19 | 4117407 | 4117407 | Human | 1 | name |
| 8609097 | CV55401 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+14G>A | RASopathy [RCV002054766]|not specified [RCV000039482] | likely benign|conflicting interpretations of pathogenicity | 19 | 4110495 | 4110495 | Human | 1 | name |
| 8609107 | CV55406 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+10C>T | RASopathy [RCV002054767]|not provided [RCV000680363]|not specified [RCV000039492] | likely benign | 19 | 4101009 | 4101009 | Human | 1 | name |
| 15131693 | CV685459 | single nucleotide variant | NM_030662.4(MAP2K2):c.581-10C>T | RASopathy [RCV001421050] | likely benign | 19 | 4101153 | 4101153 | Human | 1 | name |
| 38598306 | CV963305 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+15G>A | not specified [RCV001251319] | uncertain significance | 19 | 4101004 | 4101004 | Human | | name |
| 40903243 | CV975839 | single nucleotide variant | NM_030662.4(MAP2K2):c.1047-6C>A | not specified [RCV001269160] | uncertain significance | 19 | 4094504 | 4094504 | Human | | name |
| 150421397 | CV1199129 | single nucleotide variant | NM_030662.4(MAP2K2):c.1047-31G>A | not provided [RCV001578020] | likely benign | 19 | 4094529 | 4094529 | Human | | name |
| 150506500 | CV1212222 | single nucleotide variant | NM_030662.4(MAP2K2):c.304-127G>A | not provided [RCV001596053] | likely benign | 19 | 4110782 | 4110782 | Human | | name |
| 150462943 | CV1214716 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+118A>G | not provided [RCV001613709] | benign | 19 | 4102258 | 4102258 | Human | | name |
| 150472659 | CV1235095 | deletion | NM_030662.4(MAP2K2):c.984+251del | not provided [RCV001651464] | benign | 19 | 4097028 | 4097028 | Human | | name |
| 150473094 | CV1235169 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-172A>G | not provided [RCV001651538] | benign | 19 | 4102625 | 4102625 | Human | | name |
| 150464542 | CV1241316 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+189C>G | not provided [RCV001649827] | benign | 19 | 4110320 | 4110320 | Human | | name |
| 150468576 | CV1259517 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+118C>G | not provided [RCV001683817] | benign | 19 | 4117301 | 4117301 | Human | | name |
| 150451404 | CV1260254 | duplication | NM_030662.4(MAP2K2):c.984+235dup | not provided [RCV001680744] | benign | 19 | 4097027 | 4097028 | Human | | name |
| 150440907 | CV1265476 | single nucleotide variant | NM_030662.4(MAP2K2):c.984+307C>T | not provided [RCV001679179] | benign | 19 | 4096972 | 4096972 | Human | | name |
| 151750940 | CV1415847 | single nucleotide variant | NM_030662.4(MAP2K2):c.1092+15C>T | RASopathy [RCV001927513] | likely benign|uncertain significance | 19 | 4094438 | 4094438 | Human | 1 | name |
| 8691899 | CV141866 | single nucleotide variant | NM_030662.4(MAP2K2):c.1046+13G>A | RASopathy [RCV002055667]|not specified [RCV000126680] | benign|likely benign | 19 | 4095375 | 4095375 | Human | 1 | name |
| 151844611 | CV1457861 | single nucleotide variant | NM_030662.4(MAP2K2):c.1093-19G>A | RASopathy [RCV001936537] | likely benign|uncertain significance | 19 | 4090727 | 4090727 | Human | 1 | name |
| 152107862 | CV1579626 | single nucleotide variant | NM_030662.4(MAP2K2):c.1092+16G>A | RASopathy [RCV002173954] | likely benign | 19 | 4094437 | 4094437 | Human | 1 | name |
| 152034629 | CV1634967 | single nucleotide variant | NM_030662.4(MAP2K2):c.1093-19G>T | RASopathy [RCV002087003] | likely benign | 19 | 4090727 | 4090727 | Human | 1 | name |
| 152129662 | CV1650621 | single nucleotide variant | NM_030662.4(MAP2K2):c.1092+14G>T | RASopathy [RCV002118912] | likely benign | 19 | 4094439 | 4094439 | Human | 1 | name |
| 155954370 | CV1936251 | single nucleotide variant | NM_030662.4(MAP2K2):c.706-350C>T | not provided [RCV002511912] | benign|likely benign | 19 | 4099764 | 4099764 | Human | | name |
| 156115617 | CV2084919 | single nucleotide variant | NM_030662.4(MAP2K2):c.1093-16T>C | RASopathy [RCV002889358] | likely benign | 19 | 4090724 | 4090724 | Human | 1 | name |
| 405050243 | CV3053939 | single nucleotide variant | NM_030662.4(MAP2K2):c.1046+12C>T | RASopathy [RCV003654598] | likely benign | 19 | 4095376 | 4095376 | Human | 1 | name |
| 405249633 | CV3170037 | single nucleotide variant | NM_030662.4(MAP2K2):c.1047-20C>T | RASopathy [RCV003869666] | likely benign | 19 | 4094518 | 4094518 | Human | 1 | name |
| 597913301 | CV3806660 | single nucleotide variant | NM_030662.4(MAP2K2):c.1046+14G>C | RASopathy [RCV005154227] | likely benign | 19 | 4095374 | 4095374 | Human | 1 | name |
| 597915380 | CV3833813 | single nucleotide variant | NM_030662.4(MAP2K2):c.1093-13C>T | RASopathy [RCV005183172] | likely benign | 19 | 4090721 | 4090721 | Human | 1 | name |
| 597929870 | CV3837466 | single nucleotide variant | NM_030662.4(MAP2K2):c.1046+10G>A | RASopathy [RCV005185624] | likely benign | 19 | 4095378 | 4095378 | Human | 1 | name |
| 597905651 | CV3846581 | single nucleotide variant | NM_030662.4(MAP2K2):c.1093-20C>T | RASopathy [RCV005182008] | likely benign | 19 | 4090728 | 4090728 | Human | 1 | name |
| 150438719 | CV49265 | single nucleotide variant | NM_030662.4(MAP2K2):c.451-135C>T | not provided [RCV001665984] | benign | 19 | 4102588 | 4102588 | Human | | name |
| 13525012 | CV507825 | single nucleotide variant | NM_030662.4(MAP2K2):c.1046+16C>A | RASopathy [RCV002062865]|not specified [RCV000602572] | likely benign | 19 | 4095372 | 4095372 | Human | 1 | name |
| 13796773 | CV553032 | single nucleotide variant | NM_030662.4(MAP2K2):c.985-150C>G | not provided [RCV000680746] | benign | 19 | 4095599 | 4095599 | Human | | name |
| 13797475 | CV553033 | single nucleotide variant | NM_030662.4(MAP2K2):c.919+252C>T | not provided [RCV000681247] | benign | 19 | 4098949 | 4098949 | Human | | name |
| 13796748 | CV553034 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+179T>C | not provided [RCV000680733] | benign | 19 | 4100840 | 4100840 | Human | | name |
| 13796642 | CV553035 | single nucleotide variant | NM_030662.4(MAP2K2):c.705+128C>T | not provided [RCV000680679] | likely benign | 19 | 4100891 | 4100891 | Human | | name |
| 13796745 | CV553037 | single nucleotide variant | NM_030662.4(MAP2K2):c.529-138G>A | not provided [RCV000680731] | benign | 19 | 4101418 | 4101418 | Human | | name |
| 13796889 | CV553038 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+242T>G | not provided [RCV000680864] | benign | 19 | 4102134 | 4102134 | Human | | name |
| 13797094 | CV553039 | single nucleotide variant | NM_030662.4(MAP2K2):c.528+237T>C | not provided [RCV000680960] | benign | 19 | 4102139 | 4102139 | Human | | name |
| 13797599 | CV553040 | single nucleotide variant | NM_030662.4(MAP2K2):c.450+307C>A | not provided [RCV000681334] | likely benign | 19 | 4110202 | 4110202 | Human | | name |
| 13796567 | CV553042 | single nucleotide variant | NM_030662.4(MAP2K2):c.303+127A>G | not provided [RCV000680656] | benign | 19 | 4117292 | 4117292 | Human | | name |
| 150425174 | CV1185486 | single nucleotide variant | NM_030662.4(MAP2K2):c.1093-128G>A | not provided [RCV001557658] | likely benign | 19 | 4090836 | 4090836 | Human | | name |
| 150426303 | CV1188777 | single nucleotide variant | NM_030662.4(MAP2K2):c.1092+127G>A | not provided [RCV001559399] | likely benign | 19 | 4094326 | 4094326 | Human | | name |
| 152107365 | CV1605264 | single nucleotide variant | NM_030662.4(MAP2K2):c.1092+341C>A | RASopathy [RCV002196328] | benign | 19 | 4094112 | 4094112 | Human | 1 | name |
| 155641627 | CV1709875 | single nucleotide variant | NM_030662.4(MAP2K2):c.1047-391C>T | not provided [RCV002292975] | benign|likely benign | 19 | 4094889 | 4094889 | Human | | name |
| 401908241 | CV2815194 | single nucleotide variant | NM_030662.4(MAP2K2):c.1047-366G>T | not provided [RCV003423208] | benign | 19 | 4094864 | 4094864 | Human | | name |
| 405161018 | CV2883322 | microsatellite | NM_030662.4(MAP2K2):c.920-17TC[3] | RASopathy [RCV003540115] | likely benign | 19 | 4097353 | 4097354 | Human | | name |
| 13797747 | CV553025 | single nucleotide variant | NM_030662.4(MAP2K2):c.1093-273C>T | not provided [RCV000681401] | likely benign | 19 | 4090981 | 4090981 | Human | | name |
| 13796767 | CV553027 | single nucleotide variant | NM_030662.4(MAP2K2):c.1047-212G>A | not provided [RCV000680742] | likely benign | 19 | 4094710 | 4094710 | Human | | name |
| 13797477 | CV553028 | single nucleotide variant | NM_030662.4(MAP2K2):c.1047-279C>T | not provided [RCV000681248] | benign | 19 | 4094777 | 4094777 | Human | | name |
| 13797697 | CV553029 | deletion | NM_030662.4(MAP2K2):c.1046+303del | not provided [RCV000681375] | likely benign | 19 | 4095085 | 4095085 | Human | | name |
| 13796785 | CV553030 | single nucleotide variant | NM_030662.4(MAP2K2):c.1046+200C>T | not provided [RCV000680753] | likely benign | 19 | 4095188 | 4095188 | Human | | name |
| 156108925 | CV2108145 | deletion | NM_030662.4(MAP2K2):c.578_580+9del | RASopathy [RCV002927340] | uncertain significance | 19 | 4101220 | 4101231 | Human | 1 | name |
| 156371758 | CV1993532 | single nucleotide variant | NM_030662.4(MAP2K2):c.4C>T (p.Leu2=) | RASopathy [RCV002652956] | likely benign | 19 | 4123872 | 4123872 | Human | 1 | name |
| 15122316 | CV695823 | microsatellite | NM_030662.4(MAP2K2):c.985-7_985-5del | RASopathy [RCV000874392]|not specified [RCV001824901] | likely benign|uncertain significance | 19 | 4095454 | 4095456 | Human | | name |
| 405164002 | CV2921008 | single nucleotide variant | NM_030662.4(MAP2K2):c.21G>A (p.Pro7=) | RASopathy [RCV003540333] | likely benign | 19 | 4123855 | 4123855 | Human | 1 | name |
| 597905913 | CV3846631 | single nucleotide variant | NM_030662.4(MAP2K2):c.12G>A (p.Arg4=) | RASopathy [RCV005182058] | likely benign | 19 | 4123864 | 4123864 | Human | 1 | name |
| 150516623 | CV1227155 | deletion | NM_030662.4(MAP2K2):c.92+152_92+178del | not provided [RCV001639253] | benign | 19 | 4123606 | 4123632 | Human | | name |
| 152157709 | CV1541836 | deletion | NM_030662.4(MAP2K2):c.706-15_706-14del | RASopathy [RCV002103194] | likely benign | 19 | 4099428 | 4099429 | Human | 1 | name |
| 152111408 | CV1552419 | single nucleotide variant | NM_030662.4(MAP2K2):c.66A>G (p.Pro22=) | Cardiovascular phenotype [RCV004990710]|RASopathy [RCV002134532] | likely benign | 19 | 4123810 | 4123810 | Human | 1 | name |
| 152155962 | CV1561066 | single nucleotide variant | NM_030662.4(MAP2K2):c.30G>A (p.Pro10=) | RASopathy [RCV002102943] | likely benign | 19 | 4123846 | 4123846 | Human | 1 | name |
| 155727004 | CV1822376 | single nucleotide variant | NM_030662.4(MAP2K2):c.69C>T (p.Ser23=) | Cardiovascular phenotype [RCV002364745] | likely benign | 19 | 4123807 | 4123807 | Human | | name |
| 405162034 | CV2906387 | inversion | NM_030662.4(MAP2K2):c.528+19_528+20inv | RASopathy [RCV003540198] | uncertain significance | 19 | 4102356 | 4102357 | Human | | name |
| 405060882 | CV3007988 | single nucleotide variant | NM_030662.4(MAP2K2):c.30G>C (p.Pro10=) | RASopathy [RCV003655930] | likely benign | 19 | 4123846 | 4123846 | Human | 1 | name |
| 405084771 | CV3167278 | microsatellite | NM_030662.4(MAP2K2):c.451-20_451-17del | RASopathy [RCV003851859] | likely benign | 19 | 4102470 | 4102473 | Human | | name |
| 405683301 | CV3387825 | single nucleotide variant | NM_030662.4(MAP2K2):c.54C>T (p.Ile18=) | Cardiovascular phenotype [RCV004517800] | likely benign | 19 | 4123822 | 4123822 | Human | | name |
| 596945295 | CV3547809 | single nucleotide variant | NM_030662.4(MAP2K2):c.84C>A (p.Gly28=) | not provided [RCV004809140] | likely benign | 19 | 4123792 | 4123792 | Human | | name |
| 597729924 | CV3699989 | single nucleotide variant | NM_030662.4(MAP2K2):c.48T>C (p.Pro16=) | Cardiovascular phenotype [RCV004995638] | likely benign | 19 | 4123828 | 4123828 | Human | | name |
| 12840828 | CV377537 | single nucleotide variant | NM_030662.4(MAP2K2):c.42C>T (p.Ile14=) | not provided [RCV000431447]|not specified [RCV001193492] | likely benign | 19 | 4123834 | 4123834 | Human | | name |
| 12888926 | CV403730 | single nucleotide variant | NM_030662.4(MAP2K2):c.39C>T (p.Thr13=) | Cardiovascular phenotype [RCV003168916]|RASopathy [RCV000471846]|not provided [RCV002225631]|not specified [RCV000586167] | likely benign|uncertain significance | 19 | 4123837 | 4123837 | Human | 1 | name |
| 13477613 | CV442542 | single nucleotide variant | NM_030662.4(MAP2K2):c.45C>T (p.Asn15=) | RASopathy [RCV000520444] | likely benign | 19 | 4123831 | 4123831 | Human | 1 | name |
| 8691900 | CV49233 | single nucleotide variant | NM_030662.3(MAP2K2):c.8C>T (p.Ala3Val) | not provided [RCV000126681] | benign | 19 | 4123868 | 4123868 | Human | | name |
| 9832814 | CV49234 | deletion | NM_030662.4(MAP2K2):c.22del (p.Val8fs) | RASopathy [RCV000158044] | uncertain significance | 19 | 4123854 | 4123854 | Human | 1 | name |
| 13626547 | CV533121 | single nucleotide variant | NM_030662.4(MAP2K2):c.96A>G (p.Ala32=) | RASopathy [RCV000654994] | likely benign | 19 | 4117626 | 4117626 | Human | 1 | name |
| 13796794 | CV553045 | microsatellite | NM_030662.4(MAP2K2):c.92+212_92+237del | not provided [RCV000680758] | benign | 19 | 4123547 | 4123572 | Human | | name |
| 14699183 | CV624658 | single nucleotide variant | NM_030662.4(MAP2K2):c.7G>T (p.Ala3Ser) | Cardiofaciocutaneous syndrome 4 [RCV005029451]|not provided [RCV000788439] | uncertain significance | 19 | 4123869 | 4123869 | Human | 1 | name |
| 8611990 | CV65596 | single nucleotide variant | NM_030662.4(MAP2K2):c.33G>A (p.Ala11=) | Cardiovascular phenotype [RCV002453344]|RASopathy [RCV000655007]|not specified [RCV000043640] | benign|likely benign|conflicting interpretations of pathogenicity | 19 | 4123843 | 4123843 | Human | 1 | name |
| 127235102 | CV1084747 | single nucleotide variant | NM_030662.4(MAP2K2):c.282G>A (p.Ser94=) | Cardiovascular phenotype [RCV002438963]|RASopathy [RCV001414356] | likely benign | 19 | 4117440 | 4117440 | Human | 1 | name |
| 127235819 | CV1106530 | single nucleotide variant | NM_030662.4(MAP2K2):c.186C>T (p.Ala62=) | RASopathy [RCV001433194] | likely benign | 19 | 4117536 | 4117536 | Human | 1 | name |
| 150453093 | CV1205606 | deletion | NM_030662.4(MAP2K2):c.303+92_303+128del | not provided [RCV001585507] | likely benign | 19 | 4117291 | 4117327 | Human | | name |
| 151352164 | CV1325121 | single nucleotide variant | NM_030662.4(MAP2K2):c.237C>T (p.Gly79=) | Cardiovascular phenotype [RCV002458621]|Noonan syndrome and Noonan-related syndrome [RCV001813677]|RASopathy [RCV002542453]|not provided [RCV005428429] | likely benign|uncertain significance | 19 | 4117485 | 4117485 | Human | 1 | name |
| 151352165 | CV1325122 | single nucleotide variant | NM_030662.4(MAP2K2):c.102G>C (p.Leu34=) | Noonan syndrome and Noonan-related syndrome [RCV001813678]|RASopathy [RCV005095228] | likely benign|uncertain significance | 19 | 4117620 | 4117620 | Human | 1 | name |
| 152106521 | CV1577629 | single nucleotide variant | NM_030662.4(MAP2K2):c.160C>T (p.Leu54=) | RASopathy [RCV002096243] | likely benign | 19 | 4117562 | 4117562 | Human | 1 | name |
| 152135736 | CV1624583 | single nucleotide variant | NM_030662.4(MAP2K2):c.291C>T (p.Ile97=) | RASopathy [RCV002177393] | likely benign | 19 | 4117431 | 4117431 | Human | 1 | name |
| 152047885 | CV1627457 | single nucleotide variant | NM_030662.4(MAP2K2):c.216C>T (p.Phe72=) | Cardiovascular phenotype [RCV005375053]|RASopathy [RCV002108564] | likely benign | 19 | 4117506 | 4117506 | Human | 1 | name |
| 9832820 | CV179829 | deletion | NM_030662.4(MAP2K2):c.71del (p.Pro24fs) | RASopathy [RCV000158050] | uncertain significance | 19 | 4123805 | 4123805 | Human | 1 | name |
| 9832819 | CV179830 | single nucleotide variant | NM_030662.4(MAP2K2):c.10C>T (p.Arg4Trp) | not provided [RCV000158049] | uncertain significance | 19 | 4123866 | 4123866 | Human | | name |
| 155722314 | CV1831323 | single nucleotide variant | NM_030662.4(MAP2K2):c.171T>C (p.Phe57=) | Cardiovascular phenotype [RCV002399052] | likely benign | 19 | 4117551 | 4117551 | Human | | name |
| 156156603 | CV1931577 | single nucleotide variant | NM_030662.4(MAP2K2):c.279C>G (p.Pro93=) | RASopathy [RCV002664087] | likely benign | 19 | 4117443 | 4117443 | Human | 1 | name |
| 156437000 | CV1936824 | single nucleotide variant | NM_030662.4(MAP2K2):c.168C>G (p.Ala56=) | RASopathy [RCV003106527] | likely benign | 19 | 4117554 | 4117554 | Human | 1 | name |
| 156162543 | CV2070619 | single nucleotide variant | NM_030662.4(MAP2K2):c.17A>G (p.Lys6Arg) | RASopathy [RCV002851265] | uncertain significance | 19 | 4123859 | 4123859 | Human | 1 | name |
| 156027011 | CV2108839 | single nucleotide variant | NM_030662.4(MAP2K2):c.150G>A (p.Gln50=) | RASopathy [RCV002909888] | likely benign | 19 | 4117572 | 4117572 | Human | 1 | name |
| 11092388 | CV231027 | single nucleotide variant | NM_030662.4(MAP2K2):c.174C>T (p.Leu58=) | RASopathy [RCV002517479]|not specified [RCV000218473] | likely benign | 19 | 4117548 | 4117548 | Human | 1 | name |
| 401766350 | CV2732259 | single nucleotide variant | NM_030662.4(MAP2K2):c.232C>T (p.Leu78=) | Cardiovascular phenotype [RCV003301797] | likely benign | 19 | 4117490 | 4117490 | Human | | name |
| 405057280 | CV2964084 | single nucleotide variant | NM_030662.4(MAP2K2):c.255G>A (p.Val85=) | RASopathy [RCV003655643] | likely benign | 19 | 4117467 | 4117467 | Human | 1 | name |
| 405060643 | CV2993673 | single nucleotide variant | NM_030662.4(MAP2K2):c.234G>A (p.Leu78=) | RASopathy [RCV003655911] | likely benign | 19 | 4117488 | 4117488 | Human | 1 | name |
| 405062410 | CV3025207 | single nucleotide variant | NM_030662.4(MAP2K2):c.162G>A (p.Leu54=) | RASopathy [RCV003656052] | likely benign | 19 | 4117560 | 4117560 | Human | 1 | name |
| 405050232 | CV3046382 | single nucleotide variant | NM_030662.4(MAP2K2):c.165A>G (p.Glu55=) | RASopathy [RCV003654578] | likely benign | 19 | 4117557 | 4117557 | Human | 1 | name |
| 402511766 | CV3178302 | single nucleotide variant | NM_030662.4(MAP2K2):c.183A>G (p.Lys61=) | RASopathy [RCV003878919] | likely benign | 19 | 4117539 | 4117539 | Human | 1 | name |
| 405268460 | CV3187046 | single nucleotide variant | NM_030662.4(MAP2K2):c.288C>T (p.Leu96=) | not provided [RCV003887129] | likely benign | 19 | 4117434 | 4117434 | Human | | name |
| 12845697 | CV377711 | single nucleotide variant | NM_030662.4(MAP2K2):c.240G>A (p.Ala80=) | Cardiovascular phenotype [RCV002446659]|MAP2K2-related disorder [RCV003922721]|RASopathy [RCV000523706]|not provided [RCV000590354] | benign|likely benign | 19 | 4117482 | 4117482 | Human | 2 | name , trait , alternate_id |
| 597889340 | CV3804820 | single nucleotide variant | NM_030662.4(MAP2K2):c.237C>G (p.Gly79=) | RASopathy [RCV005151082] | likely benign | 19 | 4117485 | 4117485 | Human | 1 | name |
| 12887979 | CV403261 | single nucleotide variant | NM_030662.4(MAP2K2):c.279C>T (p.Pro93=) | RASopathy [RCV001426020] | likely benign | 19 | 4117443 | 4117443 | Human | 1 | name |
| 13504511 | CV442540 | single nucleotide variant | NM_030662.4(MAP2K2):c.225C>T (p.Ile75=) | Cardiovascular phenotype [RCV002448566]|MAP2K2-related disorder [RCV003960232]|RASopathy [RCV000520281]|not provided [RCV004584737]|not specified [RCV003387865] | benign|likely benign | 19 | 4117497 | 4117497 | Human | 2 | name , trait , alternate_id |
| 13489457 | CV442541 | single nucleotide variant | NM_030662.4(MAP2K2):c.141C>T (p.Asp47=) | Cardiovascular phenotype [RCV002395242]|Noonan syndrome and Noonan-related syndrome [RCV001813495]|RASopathy [RCV000523895]|not provided [RCV001637063] | benign|likely benign | 19 | 4117581 | 4117581 | Human | 1 | name |
| 13481140 | CV442543 | single nucleotide variant | NM_030662.3(MAP2K2):c.14G>A (p.Arg5Lys) | Rasopathy [RCV000521428] | benign | 19 | 4123862 | 4123862 | Human | | name |
| 13466686 | CV468821 | single nucleotide variant | NM_030662.4(MAP2K2):c.207C>T (p.Asp69=) | Cardiovascular phenotype [RCV002420542]|RASopathy [RCV000552205]|not provided [RCV001556214]|not specified [RCV000588692] | likely benign|uncertain significance | 19 | 4117515 | 4117515 | Human | 1 | name |
| 13813739 | CV49235 | single nucleotide variant | NM_030662.4(MAP2K2):c.26T>C (p.Leu9Pro) | Cardiovascular phenotype [RCV002426539]|Noonan syndrome [RCV000824941]|RASopathy [RCV000704590]|not specified [RCV001251263] | uncertain significance | 19 | 4123850 | 4123850 | Human | 2 | name |
| 8609088 | CV49240 | single nucleotide variant | NM_030662.4(MAP2K2):c.192C>T (p.Val64=) | Cardiofaciocutaneous syndrome 4 [RCV000999991]|Cardiovascular phenotype [RCV002408500]|RASopathy [RCV000473659]|not provided [RCV004716914]|not specified [RCV000039473] | benign | 19 | 4117530 | 4117530 | Human | 2 | name |
| 13482806 | CV49257 | single nucleotide variant | NM_030662.4(MAP2K2):c.291C>A (p.Ile97=) | Cardiovascular phenotype [RCV002433490]|Noonan syndrome and Noonan-related syndrome [RCV001813311]|RASopathy [RCV000521884]|not provided [RCV001668150] | benign|likely benign | 19 | 4117431 | 4117431 | Human | 1 | name |
| 13529425 | CV506834 | single nucleotide variant | NM_030662.4(MAP2K2):c.168C>T (p.Ala56=) | RASopathy [RCV002528536]|not specified [RCV000600305] | likely benign | 19 | 4117554 | 4117554 | Human | 1 | name |
| 13525249 | CV507401 | single nucleotide variant | NM_030662.4(MAP2K2):c.258C>T (p.Val86=) | RASopathy [RCV005091663]|not specified [RCV000602906] | likely benign | 19 | 4117464 | 4117464 | Human | 1 | name |
| 8609089 | CV55394 | single nucleotide variant | NM_030662.4(MAP2K2):c.246C>T (p.Asn82=) | Cardiovascular phenotype [RCV002453321]|RASopathy [RCV002054764]|not specified [RCV000039474] | benign|likely benign|conflicting interpretations of pathogenicity | 19 | 4117476 | 4117476 | Human | 1 | name |
| 8609090 | CV55395 | single nucleotide variant | NM_030662.4(MAP2K2):c.258C>A (p.Val86=) | Cardiofaciocutaneous syndrome 4 [RCV003741150]|Cardiovascular phenotype [RCV002453322]|RASopathy [RCV001078949]|not provided [RCV000680292]|not specified [RCV000039475] | pathogenic|likely pathogenic|benign|likely benign | 19 | 4117464 | 4117464 | Human | 2 | name |
| 14732452 | CV648138 | single nucleotide variant | NM_030662.4(MAP2K2):c.195C>T (p.Gly65=) | RASopathy [RCV000801847] | likely benign|uncertain significance | 19 | 4117527 | 4117527 | Human | 1 | name |
| 14703083 | CV653050 | indel | NM_030662.4(MAP2K2):c.706-1_706delinsTT | Cardiofaciocutaneous syndrome 4 [RCV005021230]|RASopathy [RCV000811084]|not provided [RCV004777887]|not specified [RCV000825042] | uncertain significance | 19 | 4099414 | 4099415 | Human | | name |
| 15149361 | CV757039 | single nucleotide variant | NM_030662.4(MAP2K2):c.228A>C (p.Ser76=) | not provided [RCV000923272] | likely benign | 19 | 4117494 | 4117494 | Human | | name |
| 38496846 | CV958644 | single nucleotide variant | NM_030662.4(MAP2K2):c.249C>T (p.Gly83=) | RASopathy [RCV001242818] | likely benign|uncertain significance | 19 | 4117473 | 4117473 | Human | 1 | name |
| 126913064 | CV1038721 | single nucleotide variant | NM_030662.4(MAP2K2):c.52A>T (p.Ile18Phe) | not provided [RCV001357033] | uncertain significance | 19 | 4123824 | 4123824 | Human | | name |
| 126919746 | CV1051330 | single nucleotide variant | NM_030662.4(MAP2K2):c.351C>T (p.Arg117=) | RASopathy [RCV001373409] | likely benign|uncertain significance | 19 | 4110608 | 4110608 | Human | 1 | name |
| 127236605 | CV1084741 | single nucleotide variant | NM_030662.4(MAP2K2):c.912C>A (p.Pro304=) | RASopathy [RCV001396927] | likely benign | 19 | 4099208 | 4099208 | Human | 1 | name |
| 127279930 | CV1084743 | single nucleotide variant | NM_030662.4(MAP2K2):c.786C>T (p.Val262=) | Cardiovascular phenotype [RCV002413971]|RASopathy [RCV001409415] | likely benign | 19 | 4099334 | 4099334 | Human | 1 | name |
| 127247665 | CV1084744 | single nucleotide variant | NM_030662.4(MAP2K2):c.570C>T (p.Ile190=) | RASopathy [RCV001394299] | likely benign | 19 | 4101239 | 4101239 | Human | 1 | name |
| 127249602 | CV1084745 | single nucleotide variant | NM_030662.4(MAP2K2):c.546G>C (p.Ala182=) | Cardiovascular phenotype [RCV002350760]|RASopathy [RCV001399633] | likely benign | 19 | 4101263 | 4101263 | Human | 1 | name |
| 127248037 | CV1084746 | single nucleotide variant | NM_030662.4(MAP2K2):c.447C>T (p.His149=) | RASopathy [RCV001394365] | likely benign | 19 | 4110512 | 4110512 | Human | 1 | name |
| 127277540 | CV1106527 | single nucleotide variant | NM_030662.4(MAP2K2):c.696C>T (p.Ser232=) | RASopathy [RCV001444476]|not provided [RCV003426101] | likely benign | 19 | 4101028 | 4101028 | Human | 1 | name |
| 127278194 | CV1106529 | single nucleotide variant | NM_030662.4(MAP2K2):c.423G>A (p.Gly141=) | Cardiovascular phenotype [RCV002329503]|RASopathy [RCV001444887] | likely benign | 19 | 4110536 | 4110536 | Human | 1 | name |
| 127290049 | CV1148866 | single nucleotide variant | NM_030662.4(MAP2K2):c.903C>G (p.Pro301=) | RASopathy [RCV001495863] | likely benign | 19 | 4099217 | 4099217 | Human | 1 | name |
| 127312045 | CV1148867 | single nucleotide variant | NM_030662.4(MAP2K2):c.885G>A (p.Ser295=) | Cardiovascular phenotype [RCV003284356]|RASopathy [RCV001501794] | likely benign | 19 | 4099235 | 4099235 | Human | 1 | name |
| 127318210 | CV1148868 | single nucleotide variant | NM_030662.4(MAP2K2):c.744G>A (p.Ser248=) | RASopathy [RCV001503600] | likely benign | 19 | 4099376 | 4099376 | Human | 1 | name |
| 127329011 | CV1148869 | single nucleotide variant | NM_030662.4(MAP2K2):c.510G>A (p.Leu170=) | Cardiovascular phenotype [RCV002342100]|RASopathy [RCV001487152] | likely benign | 19 | 4102394 | 4102394 | Human | 1 | name |
| 127337581 | CV1148870 | single nucleotide variant | NM_030662.4(MAP2K2):c.339C>T (p.Asn113=) | Cardiovascular phenotype [RCV002456880]|RASopathy [RCV001492927] | likely benign | 19 | 4110620 | 4110620 | Human | 1 | name |
| 150332204 | CV1163747 | single nucleotide variant | NM_030662.4(MAP2K2):c.528G>A (p.Ala176=) | Cardiofaciocutaneous syndrome 4 [RCV001528135]|RASopathy [RCV001873729] | likely pathogenic|uncertain significance | 19 | 4102376 | 4102376 | Human | 2 | name |
| 150331925 | CV1169831 | single nucleotide variant | NM_030662.4(MAP2K2):c.810C>T (p.Pro270=) | Cardiovascular phenotype [RCV002421181]|RASopathy [RCV002071927]|not provided [RCV001536683] | likely benign | 19 | 4099310 | 4099310 | Human | 1 | name |
| 150428969 | CV1188778 | single nucleotide variant | NM_030662.4(MAP2K2):c.924C>T (p.His308=) | RASopathy [RCV003771721]|not provided [RCV001562972] | likely benign | 19 | 4097339 | 4097339 | Human | 1 | name |
| 150516915 | CV1227354 | deletion | NM_030662.4(MAP2K2):c.984+250_984+251del | not provided [RCV001639455] | benign | 19 | 4097028 | 4097029 | Human | | name |
| 150531317 | CV1299382 | single nucleotide variant | NM_030662.4(MAP2K2):c.74C>A (p.Thr25Asn) | not provided [RCV001757075] | uncertain significance | 19 | 4123802 | 4123802 | Human | | name |
| 150553571 | CV1303580 | deletion | NM_030662.4(MAP2K2):c.206del (p.Asp69fs) | not provided [RCV001769270] | uncertain significance | 19 | 4117516 | 4117516 | Human | | name |
| 151234554 | CV1320322 | single nucleotide variant | NM_030662.4(MAP2K2):c.912C>T (p.Pro304=) | Cardiovascular phenotype [RCV002370325]|RASopathy [RCV002074146]|not provided [RCV001799946]|not specified [RCV003994330] | likely benign | 19 | 4099208 | 4099208 | Human | 1 | name |
| 151352158 | CV1325117 | single nucleotide variant | NM_030662.4(MAP2K2):c.951C>T (p.Ala317=) | Cardiovascular phenotype [RCV004996019]|Noonan syndrome and Noonan-related syndrome [RCV001813673]|RASopathy [RCV002074234] | likely benign|uncertain significance | 19 | 4097312 | 4097312 | Human | 1 | name |
| 151352161 | CV1325119 | single nucleotide variant | NM_030662.4(MAP2K2):c.627G>A (p.Lys209=) | Noonan syndrome and Noonan-related syndrome [RCV001813675] | uncertain significance | 19 | 4101097 | 4101097 | Human | | name |
| 151352167 | CV1325123 | single nucleotide variant | NM_030662.4(MAP2K2):c.85G>T (p.Ala29Ser) | Noonan syndrome and Noonan-related syndrome [RCV001813679]|RASopathy [RCV005095229] | uncertain significance | 19 | 4123791 | 4123791 | Human | 1 | name |
| 151354565 | CV1329698 | single nucleotide variant | NM_030662.4(MAP2K2):c.895A>C (p.Arg299=) | Cardiovascular phenotype [RCV002370343]|not specified [RCV001818063] | likely benign | 19 | 4099225 | 4099225 | Human | | name |
| 8691894 | CV141861 | single nucleotide variant | NM_030662.4(MAP2K2):c.546G>A (p.Ala182=) | Cardiovascular phenotype [RCV002345435]|RASopathy [RCV000226018]|not specified [RCV000126673] | benign|likely benign|conflicting interpretations of pathogenicity | 19 | 4101263 | 4101263 | Human | 1 | name |
| 8691895 | CV141862 | single nucleotide variant | NM_030662.4(MAP2K2):c.690G>A (p.Thr230=) | Cardiofaciocutaneous syndrome 4 [RCV003114276]|Cardiovascular phenotype [RCV002362765]|MAP2K2-related disorder [RCV003975121]|Noonan syndrome and Noonan-related syndrome [RCV001813386]|RASopathy [RCV000232567]|not provided [RCV000589657]|not specified [RCV000126 675] | benign|likely benign | 19 | 4101034 | 4101034 | Human | 2 | name , trait , alternate_id |
| 8691897 | CV141864 | single nucleotide variant | NM_030662.4(MAP2K2):c.825G>A (p.Leu275=) | Cardiovascular phenotype [RCV002426686]|MAP2K2-related disorder [RCV003965051]|RASopathy [RCV000524027]|not provided [RCV000589791]|not specified [RCV000126677] | benign|likely benign | 19 | 4099295 | 4099295 | Human | 2 | name , trait , alternate_id |
| 152120769 | CV1521339 | single nucleotide variant | NM_030662.4(MAP2K2):c.768C>G (p.Ser256=) | RASopathy [RCV002135679]|not provided [RCV004809790] | likely benign | 19 | 4099352 | 4099352 | Human | 1 | name |
| 152078343 | CV1564839 | single nucleotide variant | NM_030662.4(MAP2K2):c.381G>A (p.Ser127=) | RASopathy [RCV002192714] | likely benign | 19 | 4110578 | 4110578 | Human | 1 | name |
| 152103865 | CV1569884 | single nucleotide variant | NM_030662.4(MAP2K2):c.852C>G (p.Val284=) | RASopathy [RCV002195888] | likely benign | 19 | 4099268 | 4099268 | Human | 1 | name |
| 152054059 | CV1574199 | single nucleotide variant | NM_030662.4(MAP2K2):c.876C>T (p.His292=) | RASopathy [RCV002189747] | likely benign | 19 | 4099244 | 4099244 | Human | 1 | name |
| 152128961 | CV1599857 | single nucleotide variant | NM_030662.4(MAP2K2):c.642G>A (p.Gly214=) | RASopathy [RCV002136684] | likely benign | 19 | 4101082 | 4101082 | Human | 1 | name |
| 152160719 | CV1601745 | single nucleotide variant | NM_030662.4(MAP2K2):c.735G>A (p.Ser245=) | Cardiovascular phenotype [RCV002382384]|RASopathy [RCV002180884] | likely benign | 19 | 4099385 | 4099385 | Human | 1 | name |
| 152132909 | CV1621512 | single nucleotide variant | NM_030662.4(MAP2K2):c.597C>T (p.Asn199=) | RASopathy [RCV002218318] | likely benign | 19 | 4101127 | 4101127 | Human | 1 | name |
| 152095475 | CV1653091 | single nucleotide variant | NM_030662.4(MAP2K2):c.807G>T (p.Pro269=) | Cardiovascular phenotype [RCV002409484]|RASopathy [RCV002094778] | likely benign | 19 | 4099313 | 4099313 | Human | 1 | name |
| 152060744 | CV1659734 | single nucleotide variant | NM_030662.4(MAP2K2):c.459C>A (p.Gly153=) | Cardiovascular phenotype [RCV002337247]|RASopathy [RCV002073645] | likely benign | 19 | 4102445 | 4102445 | Human | 1 | name |
| 9690476 | CV176029 | single nucleotide variant | NM_030662.4(MAP2K2):c.639C>T (p.Phe213=) | Cardiovascular phenotype [RCV004992030]|RASopathy [RCV003114306]|not provided [RCV000680624]|not specified [RCV000156156] | likely benign | 19 | 4101085 | 4101085 | Human | 1 | name |
| 9691800 | CV176030 | single nucleotide variant | NM_030662.4(MAP2K2):c.564C>T (p.His188=) | Cardiovascular phenotype [RCV004019813]|not specified [RCV000151008] | likely benign | 19 | 4101245 | 4101245 | Human | | name |
| 9691801 | CV176173 | single nucleotide variant | NM_030662.4(MAP2K2):c.384G>A (p.Pro128=) | Cardiovascular phenotype [RCV004992021]|MAP2K2-related disorder [RCV004745217]|RASopathy [RCV001476321]|not specified [RCV000151010] | likely benign | 19 | 4110575 | 4110575 | Human | 2 | name , trait , alternate_id |
| 155664178 | CV1789786 | single nucleotide variant | NM_030662.4(MAP2K2):c.369C>T (p.His123=) | Cardiovascular phenotype [RCV002348877]|RASopathy [RCV005096354]|not specified [RCV004782923] | likely benign | 19 | 4110590 | 4110590 | Human | 1 | name |
| 155666374 | CV1793105 | single nucleotide variant | NM_030662.4(MAP2K2):c.363C>T (p.Val121=) | Cardiovascular phenotype [RCV002452415] | likely benign | 19 | 4110596 | 4110596 | Human | | name |
| 155669182 | CV1800031 | single nucleotide variant | NM_030662.4(MAP2K2):c.546G>T (p.Ala182=) | Cardiovascular phenotype [RCV002349785] | likely benign | 19 | 4101263 | 4101263 | Human | | name |
| 155666907 | CV1803108 | single nucleotide variant | NM_030662.4(MAP2K2):c.540C>T (p.Gly180=) | Cardiovascular phenotype [RCV002349409] | likely benign | 19 | 4101269 | 4101269 | Human | | name |
| 155728056 | CV1812871 | single nucleotide variant | NM_030662.4(MAP2K2):c.726A>G (p.Thr242=) | Cardiovascular phenotype [RCV002382565] | likely benign | 19 | 4099394 | 4099394 | Human | | name |
| 155714395 | CV1815280 | single nucleotide variant | NM_030662.4(MAP2K2):c.684G>A (p.Val228=) | Cardiovascular phenotype [RCV002362109] | likely benign | 19 | 4101040 | 4101040 | Human | | name |
| 155666566 | CV1819546 | single nucleotide variant | NM_030662.4(MAP2K2):c.741G>A (p.Gln247=) | Cardiovascular phenotype [RCV002384976]|MAP2K2-related disorder [RCV003903684] | likely benign | 19 | 4099379 | 4099379 | Human | 1 | name , trait , alternate_id |
| 155705279 | CV1824118 | single nucleotide variant | NM_030662.4(MAP2K2):c.843G>A (p.Arg281=) | Cardiovascular phenotype [RCV002445940] | likely benign | 19 | 4099277 | 4099277 | Human | | name |
| 155698927 | CV1824494 | single nucleotide variant | NM_030662.4(MAP2K2):c.888T>G (p.Pro296=) | Cardiovascular phenotype [RCV002376009] | likely benign | 19 | 4099232 | 4099232 | Human | | name |
| 155684693 | CV1824975 | single nucleotide variant | NM_030662.4(MAP2K2):c.937C>A (p.Arg313=) | Cardiovascular phenotype [RCV002371744] | likely benign | 19 | 4097326 | 4097326 | Human | | name |
| 156362519 | CV1881371 | single nucleotide variant | NM_030662.4(MAP2K2):c.570C>A (p.Ile190=) | RASopathy [RCV003065719] | likely benign | 19 | 4101239 | 4101239 | Human | 1 | name |
| 156408720 | CV1911739 | single nucleotide variant | NM_030662.4(MAP2K2):c.879C>T (p.Ser293=) | RASopathy [RCV002607325] | likely benign | 19 | 4099241 | 4099241 | Human | 1 | name |
| 156296760 | CV1924160 | single nucleotide variant | NM_030662.4(MAP2K2):c.889C>A (p.Arg297=) | RASopathy [RCV002629050] | likely benign | 19 | 4099231 | 4099231 | Human | 1 | name |
| 156122594 | CV1952802 | single nucleotide variant | NM_030662.4(MAP2K2):c.73A>G (p.Thr25Ala) | RASopathy [RCV002571923] | uncertain significance | 19 | 4123803 | 4123803 | Human | 1 | name |
| 10052855 | CV195430 | single nucleotide variant | NM_030662.4(MAP2K2):c.648C>T (p.Ser216=) | RASopathy [RCV002054134]|not provided [RCV000179542]|not specified [RCV001844072] | likely benign|uncertain significance | 19 | 4101076 | 4101076 | Human | 1 | name |
| 10053081 | CV195756 | single nucleotide variant | NM_030662.4(MAP2K2):c.763C>T (p.Leu255=) | not provided [RCV000179979] | uncertain significance | 19 | 4099357 | 4099357 | Human | | name |
| 156200941 | CV2024541 | single nucleotide variant | NM_030662.4(MAP2K2):c.83G>A (p.Gly28Asp) | RASopathy [RCV002711397] | uncertain significance | 19 | 4123793 | 4123793 | Human | 1 | name |
| 156131376 | CV2084918 | deletion | NM_030662.4(MAP2K2):c.1093-14_1093-11del | RASopathy [RCV002871646] | likely benign | 19 | 4090719 | 4090722 | Human | 1 | name |
| 156101824 | CV2088040 | single nucleotide variant | NM_030662.4(MAP2K2):c.508C>T (p.Leu170=) | RASopathy [RCV002848113] | likely benign | 19 | 4102396 | 4102396 | Human | 1 | name |
| 156152879 | CV2098548 | single nucleotide variant | NM_030662.4(MAP2K2):c.463C>T (p.Leu155=) | RASopathy [RCV002890713] | likely benign | 19 | 4102441 | 4102441 | Human | 1 | name |
| 156153947 | CV2098613 | single nucleotide variant | NM_030662.4(MAP2K2):c.807G>A (p.Pro269=) | RASopathy [RCV002890749] | likely benign | 19 | 4099313 | 4099313 | Human | 1 | name |
| 156056331 | CV2102044 | single nucleotide variant | NM_030662.4(MAP2K2):c.963C>A (p.Leu321=) | RASopathy [RCV002886340] | likely benign | 19 | 4097300 | 4097300 | Human | 1 | name |
| 155947735 | CV2108193 | single nucleotide variant | NM_030662.4(MAP2K2):c.79G>A (p.Glu27Lys) | RASopathy [RCV002904875] | uncertain significance | 19 | 4123797 | 4123797 | Human | 1 | name |
| 156237037 | CV2118470 | single nucleotide variant | NM_030662.4(MAP2K2):c.715T>C (p.Leu239=) | RASopathy [RCV002958731] | likely benign | 19 | 4099405 | 4099405 | Human | 1 | name |
| 156030400 | CV2141978 | single nucleotide variant | NM_030662.4(MAP2K2):c.999G>A (p.Leu333=) | RASopathy [RCV002976579] | likely benign | 19 | 4095435 | 4095435 | Human | 1 | name |
| 156270202 | CV2178946 | single nucleotide variant | NM_030662.4(MAP2K2):c.792G>A (p.Arg264=) | RASopathy [RCV003044426] | likely benign | 19 | 4099328 | 4099328 | Human | 1 | name |
| 156161451 | CV2191854 | single nucleotide variant | NM_030662.4(MAP2K2):c.900C>A (p.Pro300=) | RASopathy [RCV003040725] | likely benign | 19 | 4099220 | 4099220 | Human | 1 | name |
| 329385305 | CV2423101 | single nucleotide variant | NM_030662.4(MAP2K2):c.44A>C (p.Asn15Thr) | Cardiovascular phenotype [RCV003177074]|RASopathy [RCV005101073] | uncertain significance | 19 | 4123832 | 4123832 | Human | 1 | name |
| 329385309 | CV2423103 | single nucleotide variant | NM_030662.4(MAP2K2):c.567G>A (p.Gln189=) | Cardiovascular phenotype [RCV003177076]|RASopathy [RCV003779502] | likely benign | 19 | 4101242 | 4101242 | Human | 1 | name |
| 329385310 | CV2423104 | single nucleotide variant | NM_030662.4(MAP2K2):c.927G>A (p.Gly309=) | Cardiovascular phenotype [RCV003177077] | likely benign | 19 | 4097336 | 4097336 | Human | | name |
| 11552429 | CV257128 | single nucleotide variant | NM_030662.4(MAP2K2):c.804C>T (p.Pro268=) | RASopathy [RCV002058364]|not specified [RCV000254367] | likely benign | 19 | 4099316 | 4099316 | Human | 1 | name |
| 11549189 | CV257132 | single nucleotide variant | NM_030662.4(MAP2K2):c.516A>G (p.Lys172=) | not specified [RCV000250088] | likely benign | 19 | 4102388 | 4102388 | Human | | name |
| 401908244 | CV2815196 | single nucleotide variant | NM_030662.4(MAP2K2):c.70C>G (p.Pro24Ala) | not provided [RCV003423210] | uncertain significance | 19 | 4123806 | 4123806 | Human | | name |
| 401914186 | CV2830589 | single nucleotide variant | NM_030662.4(MAP2K2):c.687C>T (p.Gly229=) | RASopathy [RCV003539491]|not provided [RCV003442327] | uncertain significance | 19 | 4101037 | 4101037 | Human | 1 | name |
| 405158189 | CV2861765 | single nucleotide variant | NM_030662.4(MAP2K2):c.55G>T (p.Ala19Ser) | RASopathy [RCV003539541] | uncertain significance | 19 | 4123821 | 4123821 | Human | 1 | name |
| 405160646 | CV2889582 | single nucleotide variant | NM_030662.4(MAP2K2):c.801C>T (p.Ile267=) | RASopathy [RCV003540084] | likely benign | 19 | 4099319 | 4099319 | Human | 1 | name |
| 405162069 | CV2902742 | single nucleotide variant | NM_030662.4(MAP2K2):c.855C>T (p.Asp285=) | Cardiovascular phenotype [RCV004369316]|RASopathy [RCV003540201] | likely benign | 19 | 4099265 | 4099265 | Human | 1 | name |
| 405163193 | CV2916224 | single nucleotide variant | NM_030662.4(MAP2K2):c.900C>T (p.Pro300=) | RASopathy [RCV003540293] | likely benign | 19 | 4099220 | 4099220 | Human | 1 | name |
| 405165204 | CV2933439 | single nucleotide variant | NM_030662.4(MAP2K2):c.537G>A (p.Arg179=) | RASopathy [RCV003540459] | likely benign | 19 | 4101272 | 4101272 | Human | 1 | name |
| 405060371 | CV2999768 | single nucleotide variant | NM_030662.4(MAP2K2):c.61G>C (p.Gly21Arg) | RASopathy [RCV003655889] | uncertain significance | 19 | 4123815 | 4123815 | Human | 1 | name |
| 405060126 | CV3002011 | single nucleotide variant | NM_030662.4(MAP2K2):c.513G>A (p.Gly171=) | RASopathy [RCV003655868] | likely benign | 19 | 4102391 | 4102391 | Human | 1 | name |
| 405047251 | CV3019887 | single nucleotide variant | NM_030662.4(MAP2K2):c.990T>C (p.Pro330=) | RASopathy [RCV003654468] | likely benign | 19 | 4095444 | 4095444 | Human | 1 | name |
| 405047114 | CV3029815 | single nucleotide variant | NM_030662.4(MAP2K2):c.594C>T (p.Ser198=) | RASopathy [RCV003654456] | uncertain significance | 19 | 4101130 | 4101130 | Human | 1 | name |
| 405047480 | CV3030385 | single nucleotide variant | NM_030662.4(MAP2K2):c.999G>T (p.Leu333=) | RASopathy [RCV003654486] | likely benign | 19 | 4095435 | 4095435 | Human | 1 | name |
| 405050709 | CV3061009 | single nucleotide variant | NM_030662.4(MAP2K2):c.600C>T (p.Ile200=) | RASopathy [RCV003654714] | likely benign | 19 | 4101124 | 4101124 | Human | 1 | name |
| 405049797 | CV3066683 | single nucleotide variant | NM_030662.4(MAP2K2):c.528G>C (p.Ala176=) | RASopathy [RCV003654667]|not specified [RCV004701807] | uncertain significance | 19 | 4102376 | 4102376 | Human | 1 | name |
| 405049813 | CV3066732 | single nucleotide variant | NM_030662.4(MAP2K2):c.630G>A (p.Leu210=) | RASopathy [RCV003654668] | likely benign | 19 | 4101094 | 4101094 | Human | 1 | name |
| 405051723 | CV3069948 | single nucleotide variant | NM_030662.4(MAP2K2):c.543G>A (p.Leu181=) | RASopathy [RCV003654793] | likely benign | 19 | 4101266 | 4101266 | Human | 1 | name |
| 405052723 | CV3076763 | single nucleotide variant | NM_030662.4(MAP2K2):c.591C>G (p.Pro197=) | RASopathy [RCV003654874] | likely benign | 19 | 4101133 | 4101133 | Human | 1 | name |
| 405052370 | CV3079118 | single nucleotide variant | NM_030662.4(MAP2K2):c.660C>T (p.Ile220=) | RASopathy [RCV003654844] | likely benign | 19 | 4101064 | 4101064 | Human | 1 | name |
| 405052773 | CV3079891 | single nucleotide variant | NM_030662.4(MAP2K2):c.363C>G (p.Val121=) | RASopathy [RCV003654878] | likely benign | 19 | 4110596 | 4110596 | Human | 1 | name |
| 405204276 | CV3116923 | single nucleotide variant | NM_030662.4(MAP2K2):c.363C>A (p.Val121=) | RASopathy [RCV003822407] | likely benign | 19 | 4110596 | 4110596 | Human | 1 | name |
| 405112430 | CV3118542 | single nucleotide variant | NM_030662.4(MAP2K2):c.996G>A (p.Lys332=) | RASopathy [RCV003813770] | likely benign | 19 | 4095438 | 4095438 | Human | 1 | name |
| 405210758 | CV3146245 | single nucleotide variant | NM_030662.4(MAP2K2):c.708G>A (p.Pro236=) | RASopathy [RCV003845776] | likely benign | 19 | 4099412 | 4099412 | Human | 1 | name |
| 405092601 | CV3164085 | single nucleotide variant | NM_030662.4(MAP2K2):c.97A>C (p.Asn33His) | RASopathy [RCV003852400] | uncertain significance | 19 | 4117625 | 4117625 | Human | 1 | name |
| 402494836 | CV3183030 | single nucleotide variant | NM_030662.4(MAP2K2):c.58G>A (p.Glu20Lys) | RASopathy [RCV003877338] | uncertain significance | 19 | 4123818 | 4123818 | Human | 1 | name |
| 405683296 | CV3387823 | single nucleotide variant | NM_030662.4(MAP2K2):c.405G>A (p.Gly135=) | Cardiovascular phenotype [RCV004517798]|RASopathy [RCV005100635] | likely benign | 19 | 4110554 | 4110554 | Human | 1 | name |
| 405683297 | CV3387824 | single nucleotide variant | NM_030662.4(MAP2K2):c.498C>G (p.Pro166=) | Cardiovascular phenotype [RCV004517799]|RASopathy [RCV005100636] | likely benign | 19 | 4102406 | 4102406 | Human | 1 | name |
| 405683309 | CV3387827 | single nucleotide variant | NM_030662.4(MAP2K2):c.91G>A (p.Glu31Lys) | Cardiovascular phenotype [RCV004517802] | uncertain significance | 19 | 4123785 | 4123785 | Human | | name |
| 407468985 | CV3446441 | single nucleotide variant | NM_030662.4(MAP2K2):c.336G>C (p.Arg112=) | Cardiovascular phenotype [RCV004636472] | likely benign | 19 | 4110623 | 4110623 | Human | | name |
| 408374089 | CV3514322 | single nucleotide variant | NM_030662.4(MAP2K2):c.642G>T (p.Gly214=) | MAP2K2-related disorder [RCV004745965] | likely benign | 19 | 4101082 | 4101082 | Human | | name , trait , alternate_id |
| 596921484 | CV3535106 | single nucleotide variant | NM_030662.4(MAP2K2):c.47C>G (p.Pro16Arg) | Cardiofaciocutaneous syndrome 4 [RCV005017277]|RASopathy [RCV005105054]|not provided [RCV004784665] | uncertain significance | 19 | 4123829 | 4123829 | Human | 2 | name |
| 12741112 | CV360561 | deletion | NM_030662.4(MAP2K2):c.159del (p.Leu54fs) | Cardiofaciocutaneous syndrome 4 [RCV005027472]|RASopathy [RCV001850984]|not provided [RCV000414117]|not specified [RCV001201247] | uncertain significance | 19 | 4117563 | 4117563 | Human | 2 | name |
| 597729918 | CV3699986 | single nucleotide variant | NM_030662.4(MAP2K2):c.852C>T (p.Val284=) | Cardiovascular phenotype [RCV004995636] | likely benign | 19 | 4099268 | 4099268 | Human | | name |
| 597729920 | CV3699987 | single nucleotide variant | NM_030662.4(MAP2K2):c.798C>T (p.Pro266=) | Cardiovascular phenotype [RCV004995637] | likely benign | 19 | 4099322 | 4099322 | Human | | name |
| 597852677 | CV3737665 | single nucleotide variant | NM_030662.4(MAP2K2):c.77G>A (p.Ser26Asn) | RASopathy [RCV005066438] | uncertain significance | 19 | 4123799 | 4123799 | Human | 1 | name |
| 597899211 | CV3774391 | single nucleotide variant | NM_030662.4(MAP2K2):c.81G>T (p.Glu27Asp) | RASopathy [RCV005111927] | uncertain significance | 19 | 4123795 | 4123795 | Human | 1 | name |
| 597899218 | CV3774392 | single nucleotide variant | NM_030662.4(MAP2K2):c.62G>T (p.Gly21Val) | Cardiovascular phenotype [RCV005365411]|RASopathy [RCV005111928] | uncertain significance | 19 | 4123814 | 4123814 | Human | 1 | name |
| 12843853 | CV377533 | single nucleotide variant | NM_030662.4(MAP2K2):c.327G>A (p.Pro109=) | Cardiovascular phenotype [RCV002323589]|RASopathy [RCV002061426]|not provided [RCV000436974] | likely benign | 19 | 4110632 | 4110632 | Human | 1 | name |
| 12838956 | CV377687 | single nucleotide variant | NM_030662.4(MAP2K2):c.813C>T (p.Asp271=) | Cardiovascular phenotype [RCV002418252]|RASopathy [RCV000519008]|not provided [RCV000427922] | benign|likely benign | 19 | 4099307 | 4099307 | Human | 1 | name |
| 597888682 | CV3787778 | single nucleotide variant | NM_030662.4(MAP2K2):c.735G>T (p.Ser245=) | RASopathy [RCV005125345] | likely benign | 19 | 4099385 | 4099385 | Human | 1 | name |
| 597948709 | CV3801226 | single nucleotide variant | NM_030662.4(MAP2K2):c.612T>A (p.Ser204=) | RASopathy [RCV005135406] | likely benign | 19 | 4101112 | 4101112 | Human | 1 | name |
| 597882513 | CV3803143 | single nucleotide variant | NM_030662.4(MAP2K2):c.672C>T (p.Ala224=) | RASopathy [RCV005149994] | likely benign | 19 | 4101052 | 4101052 | Human | 1 | name |
| 597951709 | CV3815388 | single nucleotide variant | NM_030662.4(MAP2K2):c.68C>T (p.Ser23Phe) | RASopathy [RCV005161338] | uncertain significance | 19 | 4123808 | 4123808 | Human | 1 | name |
| 597886388 | CV3842333 | single nucleotide variant | NM_030662.4(MAP2K2):c.906G>A (p.Gly302=) | RASopathy [RCV005178968] | likely benign | 19 | 4099214 | 4099214 | Human | 1 | name |
| 597933327 | CV3844669 | single nucleotide variant | NM_030662.4(MAP2K2):c.37A>T (p.Thr13Ser) | RASopathy [RCV005186175] | uncertain significance | 19 | 4123839 | 4123839 | Human | 1 | name |
| 597937773 | CV3852676 | single nucleotide variant | NM_030662.4(MAP2K2):c.534C>T (p.Leu178=) | RASopathy [RCV005187075] | likely benign | 19 | 4101275 | 4101275 | Human | 1 | name |
| 597932025 | CV3862448 | single nucleotide variant | NM_030662.4(MAP2K2):c.99C>G (p.Asn33Lys) | RASopathy [RCV005206693] | uncertain significance | 19 | 4117623 | 4117623 | Human | 1 | name |
| 598196845 | CV3988648 | single nucleotide variant | NM_030662.4(MAP2K2):c.954C>T (p.Ile318=) | Cardiovascular phenotype [RCV005375334] | likely benign | 19 | 4097309 | 4097309 | Human | | name |
| 598166179 | CV3988650 | single nucleotide variant | NM_030662.4(MAP2K2):c.828G>A (p.Glu276=) | Cardiovascular phenotype [RCV005369301] | likely benign | 19 | 4099292 | 4099292 | Human | | name |
| 12891678 | CV403254 | single nucleotide variant | NM_030662.4(MAP2K2):c.909C>T (p.Arg303=) | Cardiovascular phenotype [RCV002374862]|RASopathy [RCV001419294] | likely benign | 19 | 4099211 | 4099211 | Human | 1 | name |
| 12882531 | CV403727 | single nucleotide variant | NM_030662.4(MAP2K2):c.783C>T (p.Ala261=) | Cardiovascular phenotype [RCV002411559]|RASopathy [RCV001494223] | likely benign | 19 | 4099337 | 4099337 | Human | 1 | name |
| 13464935 | CV470250 | single nucleotide variant | NM_030662.4(MAP2K2):c.918C>T (p.Ser306=) | Cardiovascular phenotype [RCV003159945]|MAP2K2-related disorder [RCV003900241]|RASopathy [RCV000544637] | likely benign|uncertain significance | 19 | 4099202 | 4099202 | Human | 2 | name , trait , alternate_id |
| 13468930 | CV470924 | single nucleotide variant | NM_030662.4(MAP2K2):c.861A>G (p.Glu287=) | RASopathy [RCV000560481] | likely benign | 19 | 4099259 | 4099259 | Human | 1 | name |
| 13521516 | CV488055 | single nucleotide variant | NM_030662.4(MAP2K2):c.399C>T (p.Phe133=) | Cardiovascular phenotype [RCV002377219]|RASopathy [RCV002065138]|not specified [RCV000589407] | likely benign|uncertain significance | 19 | 4110560 | 4110560 | Human | 1 | name |
| 8609095 | CV49263 | single nucleotide variant | NM_030662.4(MAP2K2):c.405G>C (p.Gly135=) | Cardiofaciocutaneous syndrome 4 [RCV000999815]|Cardiovascular phenotype [RCV002321501]|Noonan syndrome and Noonan-related syndrome [RCV001813312]|RASopathy [RCV000149844]|not provided [RCV001711143]|not specified [RCV000039480] | benign | 19 | 4110554 | 4110554 | Human | 2 | name |
| 8609100 | CV49272 | single nucleotide variant | NM_030662.4(MAP2K2):c.498C>T (p.Pro166=) | Cardiovascular phenotype [RCV002336106]|Noonan syndrome and Noonan-related syndrome [RCV001813313]|RASopathy [RCV000458075]|not provided [RCV000726603]|not specified [RCV000039485] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4102406 | 4102406 | Human | 1 | name |
| 150477559 | CV49280 | single nucleotide variant | NM_030662.4(MAP2K2):c.591C>T (p.Pro197=) | not provided [RCV001672231] | benign | 19 | 4101133 | 4101133 | Human | | name |
| 8609104 | CV49281 | single nucleotide variant | NM_030662.4(MAP2K2):c.603C>T (p.Leu201=) | Cardiovascular phenotype [RCV004018724]|MAP2K2-related disorder [RCV003894846]|Noonan syndrome and Noonan-related syndrome [RCV001813315]|RASopathy [RCV000466681]|not provided [RCV001705635]|not specified [RCV000039489] | benign|likely benign | 19 | 4101121 | 4101121 | Human | 2 | name , trait , alternate_id |
| 150515481 | CV49285 | single nucleotide variant | NM_030662.4(MAP2K2):c.651C>G (p.Gly217=) | Cardiovascular phenotype [RCV002360990]|RASopathy [RCV005057537]|not provided [RCV001638845] | benign|likely benign | 19 | 4101073 | 4101073 | Human | 1 | name |
| 8609105 | CV49286 | single nucleotide variant | NM_030662.4(MAP2K2):c.660C>A (p.Ile220=) | Cardiofaciocutaneous syndrome 4 [RCV000610143]|Cardiovascular phenotype [RCV002371813]|RASopathy [RCV000149846]|not provided [RCV001705636]|not specified [RCV000039490] | benign | 19 | 4101064 | 4101064 | Human | 2 | name |
| 8609109 | CV49295 | single nucleotide variant | NM_030662.4(MAP2K2):c.823C>T (p.Leu275=) | Cardiovascular phenotype [RCV002426540]|MAP2K2-related disorder [RCV003944870]|RASopathy [RCV000520563]|not provided [RCV001705637]|not specified [RCV000039494] | benign|likely benign | 19 | 4099297 | 4099297 | Human | 2 | name , trait , alternate_id |
| 8609111 | CV49297 | single nucleotide variant | NM_030662.4(MAP2K2):c.846C>T (p.Pro282=) | Cardiofaciocutaneous syndrome 4 [RCV001000054]|Cardiovascular phenotype [RCV002444458]|Noonan syndrome and Noonan-related syndrome [RCV001813316]|RASopathy [RCV000197348]|not provided [RCV001705638]|not specified [RCV000039496] | benign|likely benign | 19 | 4099274 | 4099274 | Human | 2 | name |
| 13491491 | CV49303 | single nucleotide variant | NM_030662.4(MAP2K2):c.903C>T (p.Pro301=) | Cardiovascular phenotype [RCV002371814]|RASopathy [RCV000534262]|not provided [RCV001610308]|not specified [RCV001194170] | benign|likely benign | 19 | 4099217 | 4099217 | Human | 1 | name |
| 8609114 | CV49310 | single nucleotide variant | NM_030662.4(MAP2K2):c.981C>T (p.Asn327=) | Cardiovascular phenotype [RCV002371816]|MAP2K2-related disorder [RCV003934877]|RASopathy [RCV001080291]|not provided [RCV000590665]|not specified [RCV000039499] | benign|likely benign | 19 | 4097282 | 4097282 | Human | 2 | name , trait , alternate_id |
| 13518456 | CV494978 | single nucleotide variant | NM_030662.4(MAP2K2):c.32C>G (p.Ala11Gly) | not specified [RCV000597450] | uncertain significance | 19 | 4123844 | 4123844 | Human | | name |
| 13528780 | CV497521 | single nucleotide variant | NM_030662.4(MAP2K2):c.834C>A (p.Ile278=) | not specified [RCV000605554] | likely benign | 19 | 4099286 | 4099286 | Human | | name |
| 13537195 | CV506828 | single nucleotide variant | NM_030662.4(MAP2K2):c.894G>A (p.Pro298=) | Cardiovascular phenotype [RCV002448902]|MAP2K2-related disorder [RCV003892378]|RASopathy [RCV002066693]|not provided [RCV005427163]|not specified [RCV000610061] | likely benign | 19 | 4099226 | 4099226 | Human | 2 | name , trait , alternate_id |
| 13538184 | CV506831 | single nucleotide variant | NM_030662.4(MAP2K2):c.456C>T (p.Gly152=) | Cardiovascular phenotype [RCV003302944]|RASopathy [RCV001054943]|not provided [RCV003884662]|not specified [RCV000611453] | benign|likely benign|uncertain significance | 19 | 4102448 | 4102448 | Human | 1 | name |
| 13536725 | CV507397 | single nucleotide variant | NM_030662.4(MAP2K2):c.351C>G (p.Arg117=) | Cardiovascular phenotype [RCV002457954]|Noonan syndrome and Noonan-related syndrome [RCV001813526]|RASopathy [RCV005091733]|not provided [RCV001719079] | likely benign|uncertain significance | 19 | 4110608 | 4110608 | Human | 1 | name |
| 13626613 | CV533110 | single nucleotide variant | NM_030662.4(MAP2K2):c.390C>T (p.Ile130=) | Cardiovascular phenotype [RCV002369767]|RASopathy [RCV000655014]|not specified [RCV001193490] | likely benign | 19 | 4110569 | 4110569 | Human | 1 | name |
| 13626550 | CV533548 | single nucleotide variant | NM_030662.4(MAP2K2):c.477G>A (p.Leu159=) | Cardiovascular phenotype [RCV003303081]|RASopathy [RCV002534223]|not specified [RCV001797772] | likely benign | 19 | 4102427 | 4102427 | Human | 1 | name |
| 13626541 | CV533554 | single nucleotide variant | NM_030662.4(MAP2K2):c.402C>T (p.Tyr134=) | Cardiovascular phenotype [RCV002358898]|MAP2K2-related disorder [RCV003945685]|RASopathy [RCV000654985] | likely benign | 19 | 4110557 | 4110557 | Human | 2 | name , trait , alternate_id |
| 13796746 | CV553031 | deletion | NM_030662.4(MAP2K2):c.1046+91_1046+92del | not provided [RCV000680732] | likely benign | 19 | 4095296 | 4095297 | Human | | name |
| 8609096 | CV55400 | single nucleotide variant | NM_030662.4(MAP2K2):c.420C>T (p.Asp140=) | Cardiovascular phenotype [RCV002326746]|Noonan syndrome and Noonan-related syndrome [RCV001813365]|RASopathy [RCV000521680]|not provided [RCV000587230]|not specified [RCV000039481] | benign|likely benign | 19 | 4110539 | 4110539 | Human | 1 | name |
| 8609099 | CV55402 | single nucleotide variant | NM_030662.4(MAP2K2):c.453C>T (p.Asp151=) | Cardiofaciocutaneous syndrome 4 [RCV001001539]|Cardiovascular phenotype [RCV002326747]|RASopathy [RCV000149845]|not provided [RCV000509111]|not specified [RCV000039484] | benign|not provided | 19 | 4102451 | 4102451 | Human | 2 | name |
| 8609101 | CV55403 | single nucleotide variant | NM_030662.4(MAP2K2):c.49A>G (p.Thr17Ala) | not provided [RCV001564919]|not specified [RCV000039486] | likely benign|uncertain significance | 19 | 4123827 | 4123827 | Human | | name |
| 8609102 | CV55404 | single nucleotide variant | NM_030662.4(MAP2K2):c.525C>T (p.Ile175=) | Cardiovascular phenotype [RCV002336140]|Noonan syndrome and Noonan-related syndrome [RCV001813366]|RASopathy [RCV000126671]|not specified [RCV000039487] | benign|likely benign|conflicting interpretations of pathogenicity | 19 | 4102379 | 4102379 | Human | 1 | name |
| 8609106 | CV55405 | single nucleotide variant | NM_030662.4(MAP2K2):c.678C>T (p.Ser226=) | Cardiovascular phenotype [RCV002362632]|RASopathy [RCV000654987]|not provided [RCV003237418]|not specified [RCV000039491] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4101046 | 4101046 | Human | 1 | name |
| 8609113 | CV55408 | single nucleotide variant | NM_030662.4(MAP2K2):c.939G>T (p.Arg313=) | Cardiovascular phenotype [RCV003162346]|RASopathy [RCV000862266]|not specified [RCV000039498] | likely benign | 19 | 4097324 | 4097324 | Human | 1 | name |
| 14396243 | CV612027 | single nucleotide variant | NM_030662.4(MAP2K2):c.46C>A (p.Pro16Thr) | Cardiofaciocutaneous syndrome 4 [RCV005021149]|Noonan syndrome [RCV000761005]|RASopathy [RCV002533858] | uncertain significance | 19 | 4123830 | 4123830 | Human | 3 | name |
| 14689796 | CV621634 | single nucleotide variant | NM_030662.4(MAP2K2):c.699C>T (p.Tyr233=) | Cardiovascular phenotype [RCV004027317]|RASopathy [RCV002536864]|not specified [RCV000780393] | likely benign|uncertain significance | 19 | 4101025 | 4101025 | Human | 1 | name |
| 14689807 | CV621635 | single nucleotide variant | NM_030662.4(MAP2K2):c.531T>C (p.Val177=) | Cardiovascular phenotype [RCV004994003]|RASopathy [RCV003655209]|not specified [RCV000780397] | likely benign|uncertain significance | 19 | 4101278 | 4101278 | Human | 1 | name |
| 14689799 | CV621636 | single nucleotide variant | NM_030662.4(MAP2K2):c.357G>A (p.Leu119=) | RASopathy [RCV003768453]|not specified [RCV000780394] | likely benign|uncertain significance | 19 | 4110602 | 4110602 | Human | 1 | name |
| 8611994 | CV65600 | single nucleotide variant | NM_030662.4(MAP2K2):c.474G>A (p.Val158=) | Cardiovascular phenotype [RCV002336167]|RASopathy [RCV002054865]|not provided [RCV000680359]|not specified [RCV000043644] | likely benign | 19 | 4102430 | 4102430 | Human | 1 | name |
| 8611995 | CV65601 | single nucleotide variant | NM_030662.4(MAP2K2):c.621G>A (p.Glu207=) | Cardiovascular phenotype [RCV003298088]|MAP2K2-related disorder [RCV003894883]|RASopathy [RCV001412978]|not provided [RCV004703198]|not specified [RCV000043645] | benign|likely benign|conflicting interpretations of pathogenicity | 19 | 4101103 | 4101103 | Human | 2 | name , trait , alternate_id |
| 15149389 | CV689062 | single nucleotide variant | NM_030662.4(MAP2K2):c.681C>T (p.Phe227=) | RASopathy [RCV000866848] | likely benign | 19 | 4101043 | 4101043 | Human | 1 | name |
| 15152732 | CV689063 | single nucleotide variant | NM_030662.4(MAP2K2):c.429C>T (p.Ile143=) | Cardiovascular phenotype [RCV002332801]|RASopathy [RCV001416962] | likely benign | 19 | 4110530 | 4110530 | Human | 1 | name |
| 15107953 | CV694425 | single nucleotide variant | NM_030662.4(MAP2K2):c.778C>T (p.Leu260=) | RASopathy [RCV005092597] | likely benign | 19 | 4099342 | 4099342 | Human | 1 | name |
| 15116940 | CV694426 | single nucleotide variant | NM_030662.4(MAP2K2):c.534C>G (p.Leu178=) | RASopathy [RCV000873415]|not specified [RCV001251360] | benign|likely benign | 19 | 4101275 | 4101275 | Human | 1 | name |
| 15203306 | CV757038 | single nucleotide variant | NM_030662.4(MAP2K2):c.315T>G (p.Leu105=) | RASopathy [RCV001430524]|not provided [RCV003424468] | likely benign | 19 | 4110644 | 4110644 | Human | 1 | name |
| 34896170 | CV917295 | single nucleotide variant | NM_030662.4(MAP2K2):c.990T>A (p.Pro330=) | not specified [RCV001193491] | likely benign | 19 | 4095444 | 4095444 | Human | | name |
| 34896167 | CV917296 | single nucleotide variant | NM_030662.4(MAP2K2):c.987A>G (p.Pro329=) | not specified [RCV001193487] | uncertain significance | 19 | 4095447 | 4095447 | Human | | name |
| 42723989 | CV984001 | single nucleotide variant | NM_030662.4(MAP2K2):c.750C>T (p.Ile250=) | not specified [RCV001290623] | likely benign | 19 | 4099370 | 4099370 | Human | | name |
| 126753733 | CV998618 | single nucleotide variant | NM_030662.4(MAP2K2):c.34C>A (p.Leu12Ile) | RASopathy [RCV001307458] | uncertain significance | 19 | 4123842 | 4123842 | Human | 1 | name |
| 150528988 | CV1288599 | single nucleotide variant | NM_030662.4(MAP2K2):c.260C>A (p.Thr87Asn) | not provided [RCV001727067] | uncertain significance | 19 | 4117462 | 4117462 | Human | | name |
| 150553566 | CV1303575 | single nucleotide variant | NM_030662.4(MAP2K2):c.250G>A (p.Gly84Arg) | not provided [RCV001769265] | uncertain significance | 19 | 4117472 | 4117472 | Human | | name |
| 151352162 | CV1325120 | single nucleotide variant | NM_030662.4(MAP2K2):c.284G>A (p.Gly95Asp) | Noonan syndrome and Noonan-related syndrome [RCV001813676] | uncertain significance | 19 | 4117438 | 4117438 | Human | | name |
| 151767790 | CV1348760 | deletion | NM_030662.4(MAP2K2):c.639del (p.Phe213fs) | RASopathy [RCV001896035] | uncertain significance | 19 | 4101085 | 4101085 | Human | 1 | name |
| 151764785 | CV1362398 | duplication | NM_030662.4(MAP2K2):c.608dup (p.Asn203fs) | RASopathy [RCV001970588] | uncertain significance | 19 | 4101115 | 4101116 | Human | 1 | name |
| 151804578 | CV1362940 | single nucleotide variant | NM_030662.4(MAP2K2):c.238G>A (p.Ala80Thr) | RASopathy [RCV002028406]|not provided [RCV002225958] | likely benign|uncertain significance | 19 | 4117484 | 4117484 | Human | 1 | name |
| 151849091 | CV1402951 | single nucleotide variant | NM_030662.4(MAP2K2):c.292A>G (p.Met98Val) | Cardiovascular phenotype [RCV004041478]|RASopathy [RCV001882357] | uncertain significance | 19 | 4117430 | 4117430 | Human | 1 | name |
| 151727421 | CV1412690 | single nucleotide variant | NM_030662.4(MAP2K2):c.214T>G (p.Phe72Val) | RASopathy [RCV001945701] | uncertain significance | 19 | 4117508 | 4117508 | Human | 1 | name |
| 8691898 | CV141865 | single nucleotide variant | NM_030662.4(MAP2K2):c.1005C>T (p.Asn335=) | Cardiovascular phenotype [RCV002408633]|Noonan syndrome and Noonan-related syndrome [RCV001813387]|RASopathy [RCV003654206]|not specified [RCV000126679] | benign|likely benign|uncertain significance | 19 | 4095429 | 4095429 | Human | 1 | name |
| 151884741 | CV1424995 | single nucleotide variant | NM_030662.4(MAP2K2):c.1074G>C (p.Ala358=) | Cardiovascular phenotype [RCV002422994]|RASopathy [RCV001887210]|not provided [RCV005242123] | likely benign | 19 | 4094471 | 4094471 | Human | 1 | name |
| 152159032 | CV1529174 | single nucleotide variant | NM_030662.4(MAP2K2):c.1101C>G (p.Thr367=) | RASopathy [RCV002159303] | likely benign | 19 | 4090700 | 4090700 | Human | 1 | name |
| 152052814 | CV1607296 | single nucleotide variant | NM_030662.4(MAP2K2):c.1053C>T (p.Ile351=) | RASopathy [RCV002109190] | likely benign | 19 | 4094492 | 4094492 | Human | 1 | name |
| 152100044 | CV1610765 | single nucleotide variant | NM_030662.4(MAP2K2):c.1116C>T (p.Ser372=) | RASopathy [RCV002133158] | likely benign | 19 | 4090685 | 4090685 | Human | 1 | name |
| 152039718 | CV1643991 | single nucleotide variant | NM_030662.4(MAP2K2):c.1159C>T (p.Leu387=) | RASopathy [RCV002125906] | likely benign | 19 | 4090642 | 4090642 | Human | 1 | name |
| 9691802 | CV176174 | single nucleotide variant | NM_030662.4(MAP2K2):c.169T>A (p.Phe57Ile) | not specified [RCV000151011] | uncertain significance | 19 | 4117553 | 4117553 | Human | | name |
| 155697513 | CV1790350 | single nucleotide variant | NM_030662.4(MAP2K2):c.1162C>A (p.Arg388=) | Cardiovascular phenotype [RCV002375740] | likely benign | 19 | 4090639 | 4090639 | Human | | name |
| 155681641 | CV1795614 | single nucleotide variant | NM_030662.4(MAP2K2):c.1011G>A (p.Val337=) | Cardiovascular phenotype [RCV002456918] | likely benign | 19 | 4095423 | 4095423 | Human | | name |
| 9832812 | CV179827 | single nucleotide variant | NM_030662.4(MAP2K2):c.190G>T (p.Val64Phe) | RASopathy [RCV003539802]|not provided [RCV000158040] | likely pathogenic | 19 | 4117532 | 4117532 | Human | 1 | name |
| 9832810 | CV179828 | single nucleotide variant | NM_030662.4(MAP2K2):c.169T>C (p.Phe57Leu) | Cardiofaciocutaneous syndrome 4 [RCV004796053]|RASopathy [RCV003447507]|not provided [RCV000158037] | pathogenic|likely pathogenic | 19 | 4117553 | 4117553 | Human | 2 | name |
| 155667883 | CV1799804 | single nucleotide variant | NM_030662.4(MAP2K2):c.1017C>T (p.Thr339=) | Cardiofaciocutaneous syndrome 4 [RCV005025801]|Cardiovascular phenotype [RCV002349558] | likely benign|uncertain significance | 19 | 4095417 | 4095417 | Human | 1 | name |
| 155672574 | CV1809182 | single nucleotide variant | NM_030662.4(MAP2K2):c.118A>C (p.Lys40Gln) | Cardiovascular phenotype [RCV002351333] | uncertain significance | 19 | 4117604 | 4117604 | Human | | name |
| 155694815 | CV1844484 | single nucleotide variant | NM_030662.4(MAP2K2):c.1089C>G (p.Leu363=) | Cardiovascular phenotype [RCV002443532] | likely benign | 19 | 4094456 | 4094456 | Human | | name |
| 155686822 | CV1852715 | single nucleotide variant | NM_030662.4(MAP2K2):c.1116C>G (p.Ser372=) | Cardiovascular phenotype [RCV002441654] | likely benign | 19 | 4090685 | 4090685 | Human | | name |
| 156155306 | CV1931394 | single nucleotide variant | NM_030662.4(MAP2K2):c.193G>A (p.Gly65Ser) | RASopathy [RCV002664043] | uncertain significance | 19 | 4117529 | 4117529 | Human | 1 | name |
| 156208217 | CV1932192 | single nucleotide variant | NM_030662.4(MAP2K2):c.256G>A (p.Val86Ile) | RASopathy [RCV002643893] | uncertain significance | 19 | 4117466 | 4117466 | Human | 1 | name |
| 156159810 | CV1977743 | single nucleotide variant | NM_030662.4(MAP2K2):c.245A>G (p.Asn82Ser) | RASopathy [RCV002594425] | uncertain significance | 19 | 4117477 | 4117477 | Human | 1 | name |
| 156415770 | CV1987503 | single nucleotide variant | NM_030662.4(MAP2K2):c.178C>T (p.Gln60Ter) | RASopathy [RCV002609826] | uncertain significance | 19 | 4117544 | 4117544 | Human | 1 | name |
| 156029444 | CV2036792 | single nucleotide variant | NM_030662.4(MAP2K2):c.1165C>T (p.Leu389=) | RASopathy [RCV002781048] | likely benign | 19 | 4090636 | 4090636 | Human | 1 | name |
| 156079487 | CV2053786 | single nucleotide variant | NM_030662.4(MAP2K2):c.238G>T (p.Ala80Ser) | RASopathy [RCV002823806] | uncertain significance | 19 | 4117484 | 4117484 | Human | 1 | name |
| 156100819 | CV2107387 | single nucleotide variant | NM_030662.4(MAP2K2):c.158G>A (p.Arg53Gln) | RASopathy [RCV002927045]|not provided [RCV004779379] | likely pathogenic|uncertain significance | 19 | 4117564 | 4117564 | Human | 1 | name |
| 156025263 | CV2112414 | single nucleotide variant | NM_030662.4(MAP2K2):c.1188G>A (p.Thr396=) | RASopathy [RCV002909807] | likely benign | 19 | 4090613 | 4090613 | Human | 1 | name |
| 155992108 | CV2147640 | single nucleotide variant | NM_030662.4(MAP2K2):c.209A>G (p.Asp70Gly) | RASopathy [RCV003016875] | uncertain significance | 19 | 4117513 | 4117513 | Human | 1 | name |
| 156330555 | CV2224284 | single nucleotide variant | NM_030662.4(MAP2K2):c.191T>C (p.Val64Ala) | Cardiovascular phenotype [RCV004096105] | uncertain significance | 19 | 4117531 | 4117531 | Human | | name |
| 8560417 | CV23311 | single nucleotide variant | NM_030662.4(MAP2K2):c.170T>G (p.Phe57Cys) | Cardio-facio-cutaneous syndrome [RCV000208756]|Cardiofaciocutaneous syndrome 4 [RCV000008761]|RASopathy [RCV005252030]|not provided [RCV000158038] | pathogenic|not provided | 19 | 4117552 | 4117552 | Human | 3 | name |
| 8560418 | CV23312 | single nucleotide variant | NM_030662.4(MAP2K2):c.169T>G (p.Phe57Val) | Cardio-facio-cutaneous syndrome [RCV000521375]|Cardiofaciocutaneous syndrome 4 [RCV000008762] | pathogenic|likely pathogenic | 19 | 4117553 | 4117553 | Human | 2 | name |
| 243052568 | CV2417931 | single nucleotide variant | NM_030662.4(MAP2K2):c.167C>A (p.Ala56Asp) | Cardiofaciocutaneous syndrome 4 [RCV003152996] | likely pathogenic | 19 | 4117555 | 4117555 | Human | 1 | name |
| 11552194 | CV257127 | single nucleotide variant | NM_030662.4(MAP2K2):c.1074G>A (p.Ala358=) | Cardiovascular phenotype [RCV002418088]|RASopathy [RCV000470994]|not specified [RCV000254049] | benign|likely benign | 19 | 4094471 | 4094471 | Human | 1 | name |
| 11633349 | CV264851 | single nucleotide variant | NM_030662.4(MAP2K2):c.183A>C (p.Lys61Asn) | Cardiofaciocutaneous syndrome 4 [RCV001775109]|RASopathy [RCV001855055]|not provided [RCV000330980] | pathogenic|likely pathogenic | 19 | 4117539 | 4117539 | Human | 2 | name |
| 329951992 | CV2668740 | single nucleotide variant | NM_030662.4(MAP2K2):c.208G>A (p.Asp70Asn) | RASopathy [RCV003655412]|not specified [RCV003230821] | uncertain significance | 19 | 4117514 | 4117514 | Human | 1 | name |
| 401932132 | CV2801605 | single nucleotide variant | NM_030662.4(MAP2K2):c.277C>A (p.Pro93Thr) | MAP2K2-related disorder [RCV003408493] | uncertain significance | 19 | 4117445 | 4117445 | Human | | name , trait , alternate_id |
| 401905431 | CV2831461 | duplication | NM_030662.4(MAP2K2):c.903dup (p.Gly302fs) | Cardiofaciocutaneous syndrome 4 [RCV003444453]|RASopathy [RCV003539492] | uncertain significance | 19 | 4099216 | 4099217 | Human | 2 | name |
| 405160483 | CV2882452 | single nucleotide variant | NM_030662.4(MAP2K2):c.1158C>T (p.Thr386=) | RASopathy [RCV003540068] | likely benign | 19 | 4090643 | 4090643 | Human | 1 | name |
| 405160841 | CV2883025 | single nucleotide variant | NM_030662.4(MAP2K2):c.205G>C (p.Asp69His) | Cardiovascular phenotype [RCV004992647]|RASopathy [RCV003540100] | uncertain significance | 19 | 4117517 | 4117517 | Human | 1 | name |
| 405160739 | CV2886450 | deletion | NM_030662.4(MAP2K2):c.903del (p.Arg303fs) | RASopathy [RCV003540092] | uncertain significance | 19 | 4099217 | 4099217 | Human | 1 | name |
| 405165495 | CV2911420 | single nucleotide variant | NM_030662.4(MAP2K2):c.110T>A (p.Leu37Gln) | Cardiovascular phenotype [RCV004369442]|RASopathy [RCV003540370] | uncertain significance | 19 | 4117612 | 4117612 | Human | 1 | name |
| 405162982 | CV2915856 | single nucleotide variant | NM_030662.4(MAP2K2):c.188A>C (p.Lys63Thr) | RASopathy [RCV003540276] | uncertain significance | 19 | 4117534 | 4117534 | Human | 1 | name |
| 405054499 | CV2946649 | single nucleotide variant | NM_030662.4(MAP2K2):c.157C>T (p.Arg53Trp) | RASopathy [RCV003655450] | uncertain significance | 19 | 4117565 | 4117565 | Human | 1 | name |
| 405057856 | CV2970060 | single nucleotide variant | NM_030662.4(MAP2K2):c.166G>A (p.Ala56Thr) | RASopathy [RCV003655714] | uncertain significance | 19 | 4117556 | 4117556 | Human | 1 | name |
| 405059666 | CV2998579 | duplication | NM_030662.4(MAP2K2):c.567dup (p.Ile190fs) | RASopathy [RCV003655856] | uncertain significance | 19 | 4101241 | 4101242 | Human | 1 | name |
| 405050186 | CV3039020 | single nucleotide variant | NM_030662.4(MAP2K2):c.270G>T (p.Gln90His) | RASopathy [RCV003654540] | uncertain significance | 19 | 4117452 | 4117452 | Human | 1 | name |
| 405048872 | CV3043710 | single nucleotide variant | NM_030662.4(MAP2K2):c.1050C>T (p.Leu350=) | Cardiovascular phenotype [RCV004634333]|RASopathy [RCV003654595] | likely benign | 19 | 4094495 | 4094495 | Human | 1 | name |
| 405051759 | CV3066103 | single nucleotide variant | NM_030662.4(MAP2K2):c.1041T>C (p.Asn347=) | RASopathy [RCV003654796] | likely benign | 19 | 4095393 | 4095393 | Human | 1 | name |
| 405094062 | CV3134691 | single nucleotide variant | NM_030662.4(MAP2K2):c.1197C>G (p.Ala399=) | RASopathy [RCV003835037]|not provided [RCV004585069] | likely benign | 19 | 4090604 | 4090604 | Human | 1 | name |
| 405156954 | CV3152551 | single nucleotide variant | NM_030662.4(MAP2K2):c.185C>T (p.Ala62Val) | RASopathy [RCV003840478] | uncertain significance | 19 | 4117537 | 4117537 | Human | 1 | name |
| 407425478 | CV3411272 | single nucleotide variant | NM_030662.4(MAP2K2):c.260C>T (p.Thr87Ile) | RASopathy [RCV005102002]|not provided [RCV004588963] | uncertain significance | 19 | 4117462 | 4117462 | Human | 1 | name |
| 408378686 | CV3505283 | single nucleotide variant | NM_030662.4(MAP2K2):c.211G>A (p.Asp71Asn) | MAP2K2-related disorder [RCV004727990] | uncertain significance | 19 | 4117511 | 4117511 | Human | | name , trait , alternate_id |
| 408374770 | CV3507281 | single nucleotide variant | NM_030662.4(MAP2K2):c.1191C>A (p.Arg397=) | MAP2K2-related disorder [RCV004747465] | likely benign | 19 | 4090610 | 4090610 | Human | | name , trait , alternate_id |
| 408390219 | CV3519259 | single nucleotide variant | NM_030662.4(MAP2K2):c.146A>C (p.Gln49Pro) | not provided [RCV004762568] | uncertain significance | 19 | 4117576 | 4117576 | Human | | name |
| 596923380 | CV3530364 | single nucleotide variant | NM_030662.4(MAP2K2):c.209A>T (p.Asp70Val) | not provided [RCV004776963] | uncertain significance | 19 | 4117513 | 4117513 | Human | | name |
| 12741062 | CV360427 | single nucleotide variant | NM_030662.4(MAP2K2):c.216C>G (p.Phe72Leu) | not specified [RCV000413956] | uncertain significance | 19 | 4117506 | 4117506 | Human | | name |
| 12740744 | CV360436 | single nucleotide variant | NM_030662.4(MAP2K2):c.247G>A (p.Gly83Ser) | Cardiofaciocutaneous syndrome 4 [RCV002502442]|RASopathy [RCV001850988]|not provided [RCV002223837]|not specified [RCV000412991] | uncertain significance | 19 | 4117475 | 4117475 | Human | 2 | name |
| 12835226 | CV363057 | single nucleotide variant | NM_030662.4(MAP2K2):c.179A>C (p.Gln60Pro) | Melanoma [RCV000421323] | likely pathogenic | 19 | 4117543 | 4117543 | Human | 1 | name |
| 12841116 | CV363058 | single nucleotide variant | NM_030662.4(MAP2K2):c.136C>T (p.Leu46Phe) | Melanoma [RCV000432005] | likely pathogenic | 19 | 4117586 | 4117586 | Human | 1 | name |
| 12847769 | CV363059 | single nucleotide variant | NM_030662.4(MAP2K2):c.103G>A (p.Val35Met) | Melanoma [RCV000444084] | likely pathogenic | 19 | 4117619 | 4117619 | Human | 1 | name |
| 12834325 | CV363328 | single nucleotide variant | NM_030662.4(MAP2K2):c.171T>G (p.Phe57Leu) | Gastric adenocarcinoma [RCV000438529]|Malignant melanoma of skin [RCV000417753]|Pancreatic adenocarcinoma [RCV000428429]|Squamous cell carcinoma of the head and neck [RCV000429600] | likely pathogenic | 19 | 4117551 | 4117551 | Human | 3 | name |
| 597729911 | CV3699984 | single nucleotide variant | NM_030662.4(MAP2K2):c.1164G>A (p.Arg388=) | Cardiovascular phenotype [RCV004995634] | likely benign | 19 | 4090637 | 4090637 | Human | | name |
| 597662549 | CV3709759 | single nucleotide variant | NM_030662.4(MAP2K2):c.251G>T (p.Gly84Val) | Cardiofaciocutaneous syndrome 4 [RCV005028652] | uncertain significance | 19 | 4117471 | 4117471 | Human | 1 | name |
| 597750981 | CV3709760 | single nucleotide variant | NM_030662.4(MAP2K2):c.176C>G (p.Thr59Ser) | Cardiofaciocutaneous syndrome 4 [RCV005015761] | uncertain significance | 19 | 4117546 | 4117546 | Human | 1 | name |
| 597849022 | CV3762290 | single nucleotide variant | NM_030662.4(MAP2K2):c.151A>C (p.Lys51Gln) | not specified [RCV005087710] | uncertain significance | 19 | 4117571 | 4117571 | Human | | name |
| 597899194 | CV3774388 | single nucleotide variant | NM_030662.4(MAP2K2):c.286C>G (p.Leu96Val) | RASopathy [RCV005111924] | uncertain significance | 19 | 4117436 | 4117436 | Human | 1 | name |
| 597899200 | CV3774389 | single nucleotide variant | NM_030662.4(MAP2K2):c.283G>C (p.Gly95Arg) | RASopathy [RCV005111925] | uncertain significance | 19 | 4117439 | 4117439 | Human | 1 | name |
| 597899204 | CV3774390 | single nucleotide variant | NM_030662.4(MAP2K2):c.142G>C (p.Glu48Gln) | RASopathy [RCV005111926] | uncertain significance | 19 | 4117580 | 4117580 | Human | 1 | name |
| 597878793 | CV3783163 | single nucleotide variant | NM_030662.4(MAP2K2):c.1074G>T (p.Ala358=) | RASopathy [RCV005123865] | likely benign | 19 | 4094471 | 4094471 | Human | 1 | name |
| 597951679 | CV3798395 | single nucleotide variant | NM_030662.4(MAP2K2):c.1068G>A (p.Glu356=) | RASopathy [RCV005136175] | likely benign | 19 | 4094477 | 4094477 | Human | 1 | name |
| 597929396 | CV3862866 | single nucleotide variant | NM_030662.4(MAP2K2):c.207C>A (p.Asp69Glu) | RASopathy [RCV005206400] | uncertain significance | 19 | 4117515 | 4117515 | Human | 1 | name |
| 598127643 | CV3888267 | single nucleotide variant | NM_030662.4(MAP2K2):c.280T>C (p.Ser94Pro) | not provided [RCV005242953] | uncertain significance | 19 | 4117442 | 4117442 | Human | | name |
| 12899800 | CV410619 | single nucleotide variant | NM_030662.4(MAP2K2):c.143A>G (p.Glu48Gly) | RASopathy [RCV005090926]|not provided [RCV000480980] | uncertain significance | 19 | 4117579 | 4117579 | Human | 1 | name |
| 13210994 | CV424697 | single nucleotide variant | NM_030662.4(MAP2K2):c.191T>G (p.Val64Gly) | Cardiofaciocutaneous syndrome 4 [RCV000496536] | likely pathogenic | 19 | 4117531 | 4117531 | Human | 1 | name |
| 13520331 | CV487815 | single nucleotide variant | NM_030662.4(MAP2K2):c.170T>A (p.Phe57Tyr) | not provided [RCV000587607] | uncertain significance | 19 | 4117552 | 4117552 | Human | | name |
| 13519944 | CV488001 | single nucleotide variant | NM_030662.4(MAP2K2):c.1176C>T (p.Pro392=) | Cardiovascular phenotype [RCV003160002]|Noonan syndrome and Noonan-related syndrome [RCV001813513]|RASopathy [RCV001486600]|not provided [RCV001706681]|not specified [RCV000604668] | likely benign|uncertain significance | 19 | 4090625 | 4090625 | Human | 1 | name |
| 13520251 | CV488049 | single nucleotide variant | NM_030662.4(MAP2K2):c.1197C>T (p.Ala399=) | Cardiovascular phenotype [RCV002341507]|RASopathy [RCV001442973]|not specified [RCV000608972] | likely benign|uncertain significance | 19 | 4090604 | 4090604 | Human | 1 | name |
| 9832811 | CV49239 | single nucleotide variant | NM_030662.4(MAP2K2):c.181A>G (p.Lys61Glu) | Cardiofaciocutaneous syndrome 1 [RCV000200295]|Cardiofaciocutaneous syndrome 4 [RCV001781338]|RASopathy [RCV001205317]|not provided [RCV000158039] | pathogenic|likely pathogenic | 19 | 4117541 | 4117541 | Human | 3 | name |
| 9832813 | CV49241 | single nucleotide variant | NM_030662.4(MAP2K2):c.253G>T (p.Val85Leu) | not provided [RCV000158041] | uncertain significance | 19 | 4117469 | 4117469 | Human | | name |
| 12740751 | CV49242 | single nucleotide variant | NM_030662.4(MAP2K2):c.274A>G (p.Arg92Gly) | Cardiovascular phenotype [RCV003162290]|Neurofibromatosis-Noonan syndrome [RCV000824945]|RASopathy [RCV001063339]|not provided [RCV003153319]|not specified [RCV000413006] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4117448 | 4117448 | Human | 2 | name |
| 9689127 | CV49256 | single nucleotide variant | NM_030662.4(MAP2K2):c.281C>T (p.Ser94Leu) | Cardiofaciocutaneous syndrome 4 [RCV003129758]|Cardiovascular phenotype [RCV004991982]|RASopathy [RCV000521587]|not provided [RCV000767152]|not specified [RCV000154558] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4117441 | 4117441 | Human | 2 | name |
| 11637436 | CV49258 | single nucleotide variant | NM_030662.4(MAP2K2):c.291C>G (p.Ile97Met) | RASopathy [RCV002513331]|not provided [RCV000285952]|not specified [RCV003488354] | likely benign|uncertain significance | 19 | 4117431 | 4117431 | Human | 1 | name |
| 8609087 | CV49316 | single nucleotide variant | NM_030662.4(MAP2K2):c.1194C>T (p.Thr398=) | Cardiovascular phenotype [RCV002336107]|RASopathy [RCV000205301]|not provided [RCV000590246]|not specified [RCV000039472] | benign|likely benign | 19 | 4090607 | 4090607 | Human | 1 | name |
| 13526091 | CV497522 | single nucleotide variant | NM_030662.4(MAP2K2):c.183A>T (p.Lys61Asn) | Noonan syndrome 1 [RCV003451363]|Noonan syndrome with multiple lentigines [RCV000824943]|not provided [RCV004722970]|not specified [RCV000603653] | likely pathogenic|uncertain significance | 19 | 4117539 | 4117539 | Human | 2 | name |
| 13540084 | CV506826 | single nucleotide variant | NM_030662.4(MAP2K2):c.1167G>A (p.Leu389=) | Cardiovascular phenotype [RCV002331061]|RASopathy [RCV005091678]|not specified [RCV000614207] | likely benign | 19 | 4090634 | 4090634 | Human | 1 | name |
| 13535332 | CV507820 | single nucleotide variant | NM_030662.4(MAP2K2):c.1092A>G (p.Thr364=) | not specified [RCV000602266] | likely benign | 19 | 4094453 | 4094453 | Human | | name |
| 13626505 | CV533051 | single nucleotide variant | NM_030662.4(MAP2K2):c.217G>A (p.Glu73Lys) | Cardiofaciocutaneous syndrome 4 [RCV002485483]|Cardiovascular phenotype [RCV002424552]|RASopathy [RCV000654927] | uncertain significance | 19 | 4117505 | 4117505 | Human | 2 | name |
| 13796556 | CV553043 | single nucleotide variant | NM_030662.4(MAP2K2):c.198A>T (p.Glu66Asp) | not provided [RCV000680643] | uncertain significance | 19 | 4117524 | 4117524 | Human | | name |
| 8609084 | CV55391 | single nucleotide variant | NM_030662.4(MAP2K2):c.1020C>T (p.Pro340=) | Cardiovascular phenotype [RCV002381315]|MAP2K2-related disorder [RCV003944927]|Noonan syndrome and Noonan-related syndrome [RCV001813364]|RASopathy [RCV000233235]|not provided [RCV003415776]|not specified [RCV000039469] | benign|likely benign | 19 | 4095414 | 4095414 | Human | 2 | name , trait , alternate_id |
| 8609085 | CV55392 | single nucleotide variant | NM_030662.4(MAP2K2):c.1065G>A (p.Ala355=) | Cardiovascular phenotype [RCV002408525]|RASopathy [RCV001088940]|not provided [RCV000680295]|not specified [RCV000039470] | benign|likely benign|conflicting interpretations of pathogenicity | 19 | 4094480 | 4094480 | Human | 1 | name |
| 8609092 | CV55397 | single nucleotide variant | NM_030662.4(MAP2K2):c.289A>T (p.Ile97Phe) | RASopathy [RCV000545526]|not provided [RCV000767153]|not specified [RCV000039477] | uncertain significance | 19 | 4117433 | 4117433 | Human | 1 | name |
| 13809442 | CV574980 | single nucleotide variant | NM_030662.4(MAP2K2):c.171T>A (p.Phe57Leu) | RASopathy [RCV000702132] | pathogenic|uncertain significance | 19 | 4117551 | 4117551 | Human | 1 | name |
| 14689804 | CV621633 | single nucleotide variant | NM_030662.4(MAP2K2):c.1092A>C (p.Thr364=) | Cardiofaciocutaneous syndrome 4 [RCV005021168]|Noonan syndrome and Noonan-related syndrome [RCV001813551]|RASopathy [RCV001856185]|not specified [RCV000780396] | uncertain significance | 19 | 4094453 | 4094453 | Human | 2 | name |
| 14702884 | CV653985 | single nucleotide variant | NM_030662.4(MAP2K2):c.149A>G (p.Gln50Arg) | Noonan syndrome [RCV000824942] | likely benign | 19 | 4117573 | 4117573 | Human | 1 | name |
| 8611993 | CV65599 | single nucleotide variant | NM_030662.4(MAP2K2):c.1140C>T (p.Ala380=) | Cardiovascular phenotype [RCV002460041]|MAP2K2-related disorder [RCV003944960]|Noonan syndrome and Noonan-related syndrome [RCV001813371]|RASopathy [RCV000521790]|not specified [RCV000043643] | benign|likely benign|conflicting interpretations of pathogenicity | 19 | 4090661 | 4090661 | Human | 2 | name , trait , alternate_id |
| 15133361 | CV684819 | single nucleotide variant | NM_030662.4(MAP2K2):c.1191C>T (p.Arg397=) | Cardiovascular phenotype [RCV002336765]|RASopathy [RCV000863950]|not provided [RCV001593076]|not specified [RCV001193489] | likely benign | 19 | 4090610 | 4090610 | Human | 1 | name |
| 34896168 | CV917294 | single nucleotide variant | NM_030662.4(MAP2K2):c.1080G>A (p.Leu360=) | RASopathy [RCV005094026]|not specified [RCV001193488] | likely benign | 19 | 4094465 | 4094465 | Human | 1 | name |
| 38473525 | CV950802 | single nucleotide variant | NM_030662.4(MAP2K2):c.239C>T (p.Ala80Val) | RASopathy [RCV001231849] | uncertain significance | 19 | 4117483 | 4117483 | Human | 1 | name |
| 42723988 | CV984000 | single nucleotide variant | NM_030662.4(MAP2K2):c.1182A>G (p.Thr394=) | Cardiovascular phenotype [RCV002327627]|RASopathy [RCV001422838]|not provided [RCV001587321]|not specified [RCV001290622] | likely benign | 19 | 4090619 | 4090619 | Human | 1 | name |
| 126749237 | CV998617 | single nucleotide variant | NM_030662.4(MAP2K2):c.154A>C (p.Lys52Gln) | RASopathy [RCV001306589]|not specified [RCV004699293] | likely pathogenic|likely benign|uncertain significance | 19 | 4117568 | 4117568 | Human | 1 | name |
| 126733318 | CV1021896 | single nucleotide variant | NM_030662.4(MAP2K2):c.300G>T (p.Arg100Ser) | Cardiofaciocutaneous syndrome 4 [RCV001334285] | uncertain significance | 19 | 4117422 | 4117422 | Human | 1 | name |
| 126760887 | CV1034319 | deletion | NM_030662.4(MAP2K2):c.1185del (p.Thr396fs) | RASopathy [RCV001340534] | uncertain significance | 19 | 4090616 | 4090616 | Human | 1 | name |
| 126743754 | CV1034320 | single nucleotide variant | NM_030662.4(MAP2K2):c.794A>T (p.Tyr265Phe) | RASopathy [RCV001351187] | uncertain significance | 19 | 4099326 | 4099326 | Human | 1 | name |
| 126748659 | CV1034321 | single nucleotide variant | NM_030662.4(MAP2K2):c.604G>T (p.Val202Leu) | RASopathy [RCV001337694] | uncertain significance | 19 | 4101120 | 4101120 | Human | 1 | name |
| 126733187 | CV1034322 | single nucleotide variant | NM_030662.4(MAP2K2):c.515A>G (p.Lys172Arg) | RASopathy [RCV001349733] | uncertain significance | 19 | 4102389 | 4102389 | Human | 1 | name |
| 126733608 | CV1034323 | single nucleotide variant | NM_030662.4(MAP2K2):c.358C>G (p.Gln120Glu) | RASopathy [RCV001349809] | uncertain significance | 19 | 4110601 | 4110601 | Human | 1 | name |
| 127283927 | CV1084742 | single nucleotide variant | NM_030662.4(MAP2K2):c.813C>G (p.Asp271Glu) | Cardiovascular phenotype [RCV002420923]|RASopathy [RCV001412095]|not specified [RCV001806170] | likely benign|uncertain significance | 19 | 4099307 | 4099307 | Human | 1 | name |
| 150413126 | CV1178385 | single nucleotide variant | NM_030662.4(MAP2K2):c.974T>C (p.Ile325Thr) | not provided [RCV001547701] | uncertain significance | 19 | 4097289 | 4097289 | Human | | name |
| 150435327 | CV1244388 | single nucleotide variant | NM_030662.4(MAP2K2):c.928A>G (p.Met310Val) | RASopathy [RCV002539609]|not provided [RCV001665379] | uncertain significance | 19 | 4097335 | 4097335 | Human | 1 | name |
| 150528986 | CV1288598 | single nucleotide variant | NM_030662.4(MAP2K2):c.764T>C (p.Leu255Pro) | not provided [RCV001727066] | likely benign|uncertain significance | 19 | 4099356 | 4099356 | Human | | name |
| 150555859 | CV1305351 | single nucleotide variant | NM_030662.4(MAP2K2):c.479A>G (p.Lys160Arg) | not provided [RCV001773284] | uncertain significance | 19 | 4102425 | 4102425 | Human | | name |
| 151236110 | CV1319541 | single nucleotide variant | NM_030662.4(MAP2K2):c.908G>T (p.Arg303Leu) | not provided [RCV001797486] | uncertain significance | 19 | 4099212 | 4099212 | Human | | name |
| 151351631 | CV1321878 | single nucleotide variant | NM_030662.4(MAP2K2):c.743C>T (p.Ser248Leu) | Cardiofaciocutaneous syndrome 4 [RCV005014672]|RASopathy [RCV002541377]|not provided [RCV001806548] | uncertain significance | 19 | 4099377 | 4099377 | Human | 2 | name |
| 151352157 | CV1325116 | single nucleotide variant | NM_030662.4(MAP2K2):c.969C>G (p.Asp323Glu) | Cardiofaciocutaneous syndrome 4 [RCV002482343]|Cardiovascular phenotype [RCV002386574]|Noonan syndrome and Noonan-related syndrome [RCV001813672]|RASopathy [RCV005095227] | uncertain significance | 19 | 4097294 | 4097294 | Human | 2 | name |
| 151352160 | CV1325118 | single nucleotide variant | NM_030662.4(MAP2K2):c.907C>T (p.Arg303Cys) | Cardiofaciocutaneous syndrome 4 [RCV003992562]|Noonan syndrome and Noonan-related syndrome [RCV001813674]|RASopathy [RCV001869617] | uncertain significance | 19 | 4099213 | 4099213 | Human | 2 | name |
| 151771010 | CV1340184 | single nucleotide variant | NM_030662.4(MAP2K2):c.703G>T (p.Ala235Ser) | RASopathy [RCV001874448] | uncertain significance | 19 | 4101021 | 4101021 | Human | 1 | name |
| 151845726 | CV1341842 | single nucleotide variant | NM_030662.4(MAP2K2):c.908G>A (p.Arg303His) | Cardiovascular phenotype [RCV002370436]|RASopathy [RCV001922086] | uncertain significance | 19 | 4099212 | 4099212 | Human | 1 | name |
| 151784711 | CV1344727 | single nucleotide variant | NM_030662.4(MAP2K2):c.919G>A (p.Gly307Ser) | RASopathy [RCV001989454] | uncertain significance | 19 | 4099201 | 4099201 | Human | 1 | name |
| 151804462 | CV1362883 | single nucleotide variant | NM_030662.4(MAP2K2):c.395G>T (p.Gly132Val) | RASopathy [RCV002028395] | likely pathogenic | 19 | 4110564 | 4110564 | Human | 1 | name |
| 151838309 | CV1382730 | single nucleotide variant | NM_030662.4(MAP2K2):c.349C>T (p.Arg117Cys) | RASopathy [RCV002031522] | uncertain significance | 19 | 4110610 | 4110610 | Human | 1 | name |
| 151714679 | CV1388662 | single nucleotide variant | NM_030662.4(MAP2K2):c.836T>C (p.Phe279Ser) | RASopathy [RCV002002697] | uncertain significance | 19 | 4099284 | 4099284 | Human | 1 | name |
| 151711414 | CV1395059 | single nucleotide variant | NM_030662.4(MAP2K2):c.457G>A (p.Gly153Ser) | Cardiofaciocutaneous syndrome 4 [RCV005025556]|Cardiovascular phenotype [RCV004631879]|RASopathy [RCV001964375] | uncertain significance | 19 | 4102447 | 4102447 | Human | 2 | name |
| 151859344 | CV1403527 | single nucleotide variant | NM_030662.4(MAP2K2):c.388A>G (p.Ile130Val) | Cardiovascular phenotype [RCV004043833]|RASopathy [RCV001979923] | uncertain significance | 19 | 4110571 | 4110571 | Human | 1 | name |
| 151775332 | CV1424250 | single nucleotide variant | NM_030662.4(MAP2K2):c.872C>T (p.Pro291Leu) | Cardiovascular phenotype [RCV003303622]|RASopathy [RCV002025754] | uncertain significance | 19 | 4099248 | 4099248 | Human | 1 | name |
| 151709996 | CV1433497 | single nucleotide variant | NM_030662.4(MAP2K2):c.499G>A (p.Glu167Lys) | RASopathy [RCV002001757] | uncertain significance | 19 | 4102405 | 4102405 | Human | 1 | name |
| 151823137 | CV1466231 | single nucleotide variant | NM_030662.4(MAP2K2):c.940C>A (p.Pro314Thr) | RASopathy [RCV001879409] | uncertain significance | 19 | 4097323 | 4097323 | Human | 1 | name |
| 151873796 | CV1470269 | single nucleotide variant | NM_030662.4(MAP2K2):c.521G>C (p.Ser174Thr) | RASopathy [RCV001885605] | uncertain significance | 19 | 4102383 | 4102383 | Human | 1 | name |
| 151713949 | CV1476882 | single nucleotide variant | NM_030662.4(MAP2K2):c.554G>A (p.Arg185Gln) | RASopathy [RCV001908582]|not provided [RCV004719191] | uncertain significance | 19 | 4101255 | 4101255 | Human | 1 | name |
| 151834141 | CV1489025 | single nucleotide variant | NM_030662.4(MAP2K2):c.527C>T (p.Ala176Val) | Cardiovascular phenotype [RCV003299065]|RASopathy [RCV001902105] | uncertain significance | 19 | 4102377 | 4102377 | Human | 1 | name |
| 151766087 | CV1496085 | single nucleotide variant | NM_030662.4(MAP2K2):c.558G>T (p.Glu186Asp) | RASopathy [RCV001873987] | uncertain significance | 19 | 4101251 | 4101251 | Human | 1 | name |
| 151734930 | CV1502460 | single nucleotide variant | NM_030662.4(MAP2K2):c.370G>A (p.Glu124Lys) | RASopathy [RCV001911281] | uncertain significance | 19 | 4110589 | 4110589 | Human | 1 | name |
| 151759279 | CV1503693 | single nucleotide variant | NM_030662.4(MAP2K2):c.775G>C (p.Glu259Gln) | RASopathy [RCV002007666] | uncertain significance | 19 | 4099345 | 4099345 | Human | 1 | name |
| 151773663 | CV1504828 | single nucleotide variant | NM_030662.4(MAP2K2):c.611C>G (p.Ser204Cys) | RASopathy [RCV002009087] | uncertain significance | 19 | 4101113 | 4101113 | Human | 1 | name |
| 151888652 | CV1512934 | single nucleotide variant | NM_030662.4(MAP2K2):c.842G>C (p.Arg281Pro) | RASopathy [RCV001888011] | uncertain significance | 19 | 4099278 | 4099278 | Human | 1 | name |
| 152037316 | CV1669099 | single nucleotide variant | NM_030662.4(MAP2K2):c.538G>T (p.Gly180Cys) | RASopathy [RCV003655347]|not provided [RCV002224151] | uncertain significance | 19 | 4101271 | 4101271 | Human | 1 | name |
| 152037875 | CV1669185 | single nucleotide variant | NM_030662.4(MAP2K2):c.991C>T (p.Pro331Ser) | not provided [RCV002224237] | uncertain significance | 19 | 4095443 | 4095443 | Human | | name |
| 152038719 | CV1669317 | single nucleotide variant | NM_030662.4(MAP2K2):c.449T>C (p.Met150Thr) | RASopathy [RCV003774654]|not provided [RCV002224369]|not specified [RCV003403731] | uncertain significance | 19 | 4110510 | 4110510 | Human | 1 | name |
| 9689097 | CV176028 | single nucleotide variant | NM_030662.4(MAP2K2):c.806C>G (p.Pro269Arg) | Cardiofaciocutaneous syndrome 4 [RCV005025235]|Cardiovascular phenotype [RCV003162628]|MAP2K2-related disorder [RCV003416007]|RASopathy [RCV001172272]|not provided [RCV000681198]|not specified [RCV000154524] | likely benign|uncertain significance | 19 | 4099314 | 4099314 | Human | 2 | name , trait , alternate_id |
| 9689088 | CV176031 | single nucleotide variant | NM_030662.4(MAP2K2):c.401A>G (p.Tyr134Cys) | Cardio-facio-cutaneous syndrome [RCV000208747]|Noonan syndrome 1 [RCV003453160]|Noonan syndrome [RCV000844676]|RASopathy [RCV000154507]|not provided [RCV000412815] | pathogenic|likely pathogenic|not provided | 19 | 4110558 | 4110558 | Human | 4 | name |
| 9689061 | CV176169 | single nucleotide variant | NM_030662.4(MAP2K2):c.985C>T (p.Pro329Ser) | Cardiovascular phenotype [RCV004019851]|RASopathy [RCV005089745]|not specified [RCV000154480] | uncertain significance | 19 | 4095449 | 4095449 | Human | 1 | name |
| 9689079 | CV176170 | single nucleotide variant | NM_030662.4(MAP2K2):c.658A>G (p.Ile220Val) | not specified [RCV000154498] | likely benign | 19 | 4101066 | 4101066 | Human | | name |
| 9691001 | CV176171 | single nucleotide variant | NM_030662.4(MAP2K2):c.578G>A (p.Arg193Gln) | Cardiovascular phenotype [RCV003162645]|MAP2K2-related disorder [RCV003407584]|RASopathy [RCV000686315]|not specified [RCV000156700] | uncertain significance | 19 | 4101231 | 4101231 | Human | 2 | name , trait , alternate_id |
| 155745678 | CV1771583 | single nucleotide variant | NM_030662.4(MAP2K2):c.547T>C (p.Tyr183His) | RASopathy [RCV002303364] | uncertain significance | 19 | 4101262 | 4101262 | Human | 1 | name |
| 155750070 | CV1772944 | single nucleotide variant | NM_030662.4(MAP2K2):c.419A>C (p.Asp140Ala) | RASopathy [RCV002305319] | uncertain significance | 19 | 4110540 | 4110540 | Human | 1 | name |
| 155677963 | CV1776144 | single nucleotide variant | NM_030662.4(MAP2K2):c.872C>G (p.Pro291Arg) | Cardiovascular phenotype [RCV002373088]|RASopathy [RCV002299965] | uncertain significance | 19 | 4099248 | 4099248 | Human | 1 | name |
| 155740846 | CV1777050 | single nucleotide variant | NM_030662.4(MAP2K2):c.976G>T (p.Val326Leu) | RASopathy [RCV002302373] | uncertain significance | 19 | 4097287 | 4097287 | Human | 1 | name |
| 155671978 | CV1796617 | single nucleotide variant | NM_030662.4(MAP2K2):c.377A>G (p.Asn126Ser) | Cardiovascular phenotype [RCV002351129] | uncertain significance | 19 | 4110582 | 4110582 | Human | | name |
| 155686866 | CV1796722 | single nucleotide variant | NM_030662.4(MAP2K2):c.391G>T (p.Val131Leu) | Cardiofaciocutaneous syndrome 4 [RCV005019179]|Cardiovascular phenotype [RCV002373177]|RASopathy [RCV003655362] | uncertain significance | 19 | 4110568 | 4110568 | Human | 2 | name |
| 155741115 | CV1797552 | single nucleotide variant | NM_030662.4(MAP2K2):c.415A>G (p.Ser139Gly) | Cardiovascular phenotype [RCV002333297] | uncertain significance | 19 | 4110544 | 4110544 | Human | | name |
| 9832805 | CV179821 | single nucleotide variant | NM_030662.4(MAP2K2):c.971A>G (p.Tyr324Cys) | Cardiofaciocutaneous syndrome 4 [RCV003325190]|RASopathy [RCV001850203]|not provided [RCV000158032] | uncertain significance | 19 | 4097292 | 4097292 | Human | 2 | name |
| 9832796 | CV179822 | single nucleotide variant | NM_030662.4(MAP2K2):c.913G>A (p.Val305Ile) | Cardiofaciocutaneous syndrome 4 [RCV005025240]|RASopathy [RCV001296102]|not provided [RCV000158017] | likely benign|uncertain significance | 19 | 4099207 | 4099207 | Human | 2 | name |
| 9832800 | CV179823 | single nucleotide variant | NM_030662.4(MAP2K2):c.806C>T (p.Pro269Leu) | Cardiofaciocutaneous syndrome 4 [RCV005394542]|RASopathy [RCV001857558]|not provided [RCV000588108] | uncertain significance | 19 | 4099314 | 4099314 | Human | 2 | name |
| 9832817 | CV179824 | single nucleotide variant | NM_030662.4(MAP2K2):c.787G>A (p.Gly263Arg) | RASopathy [RCV005055639]|not provided [RCV000158047]|not specified [RCV002247552] | likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4099333 | 4099333 | Human | 1 | name |
| 9832798 | CV179825 | single nucleotide variant | NM_030662.4(MAP2K2):c.535C>T (p.Arg179Trp) | Cardiofaciocutaneous syndrome 4 [RCV002484967]|MAP2K2-related disorder [RCV003895069]|RASopathy [RCV000519027]|not provided [RCV000158023] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4101274 | 4101274 | Human | 2 | name , trait , alternate_id |
| 9832816 | CV179826 | single nucleotide variant | NM_030662.4(MAP2K2):c.313C>G (p.Leu105Val) | not provided [RCV000158046] | uncertain significance | 19 | 4110646 | 4110646 | Human | | name |
| 155737378 | CV1801909 | single nucleotide variant | NM_030662.4(MAP2K2):c.484G>A (p.Ala162Thr) | Cardiovascular phenotype [RCV002330803] | uncertain significance | 19 | 4102420 | 4102420 | Human | | name |
| 155708647 | CV1819306 | single nucleotide variant | NM_030662.4(MAP2K2):c.712C>T (p.Arg238Trp) | Cardiofaciocutaneous syndrome 4 [RCV003741308]|Cardiovascular phenotype [RCV002378338] | uncertain significance | 19 | 4099408 | 4099408 | Human | 1 | name |
| 155700136 | CV1821016 | single nucleotide variant | NM_030662.4(MAP2K2):c.899C>A (p.Pro300His) | Cardiovascular phenotype [RCV002376303]|RASopathy [RCV003103548] | uncertain significance | 19 | 4099221 | 4099221 | Human | 1 | name |
| 155804236 | CV1866669 | single nucleotide variant | NM_030662.4(MAP2K2):c.520A>G (p.Ser174Gly) | not provided [RCV002481217] | uncertain significance | 19 | 4102384 | 4102384 | Human | | name |
| 155944032 | CV1878954 | single nucleotide variant | NM_030662.4(MAP2K2):c.758T>C (p.Met253Thr) | Cardiofaciocutaneous syndrome 4 [RCV005019599]|RASopathy [RCV003073730] | uncertain significance | 19 | 4099362 | 4099362 | Human | 2 | name |
| 156271009 | CV1915308 | single nucleotide variant | NM_030662.4(MAP2K2):c.403G>A (p.Gly135Arg) | RASopathy [RCV002628094]|not provided [RCV003329461] | uncertain significance | 19 | 4110556 | 4110556 | Human | 1 | name |
| 156302760 | CV1916199 | single nucleotide variant | NM_030662.4(MAP2K2):c.871C>G (p.Pro291Ala) | Cardiofaciocutaneous syndrome 4 [RCV005233094]|RASopathy [RCV002599253] | uncertain significance | 19 | 4099249 | 4099249 | Human | 2 | name |
| 156295904 | CV1924113 | single nucleotide variant | NM_030662.4(MAP2K2):c.904G>A (p.Gly302Arg) | RASopathy [RCV002629014] | uncertain significance | 19 | 4099216 | 4099216 | Human | 1 | name |
| 155944751 | CV1935549 | single nucleotide variant | NM_030662.4(MAP2K2):c.674A>C (p.Asn225Thr) | Cardiovascular phenotype [RCV003308138]|not provided [RCV002511296] | uncertain significance | 19 | 4101050 | 4101050 | Human | | name |
| 156438945 | CV1943867 | single nucleotide variant | NM_030662.4(MAP2K2):c.901C>G (p.Pro301Ala) | RASopathy [RCV003108895] | uncertain significance | 19 | 4099219 | 4099219 | Human | 1 | name |
| 156257831 | CV2000174 | single nucleotide variant | NM_030662.4(MAP2K2):c.350G>A (p.Arg117His) | RASopathy [RCV002627662] | uncertain significance | 19 | 4110609 | 4110609 | Human | 1 | name |
| 156297485 | CV2017136 | single nucleotide variant | NM_030662.4(MAP2K2):c.334C>T (p.Arg112Trp) | RASopathy [RCV002715909] | likely pathogenic | 19 | 4110625 | 4110625 | Human | 1 | name |
| 156275449 | CV2023472 | single nucleotide variant | NM_030662.4(MAP2K2):c.685G>A (p.Gly229Ser) | RASopathy [RCV002746784] | uncertain significance | 19 | 4101039 | 4101039 | Human | 1 | name |
| 155951314 | CV2026240 | single nucleotide variant | NM_030662.4(MAP2K2):c.518T>C (p.Val173Ala) | RASopathy [RCV002730695] | uncertain significance | 19 | 4102386 | 4102386 | Human | 1 | name |
| 156024990 | CV2037187 | single nucleotide variant | NM_030662.4(MAP2K2):c.925G>A (p.Gly309Arg) | Cardiofaciocutaneous syndrome 4 [RCV005019401]|RASopathy [RCV002795770] | likely benign|uncertain significance | 19 | 4097338 | 4097338 | Human | 2 | name |
| 156321293 | CV2057107 | single nucleotide variant | NM_030662.4(MAP2K2):c.745G>T (p.Asp249Tyr) | RASopathy [RCV002810089] | uncertain significance | 19 | 4099375 | 4099375 | Human | 1 | name |
| 156014916 | CV2061552 | single nucleotide variant | NM_030662.4(MAP2K2):c.565C>G (p.Gln189Glu) | RASopathy [RCV002820324] | uncertain significance | 19 | 4101244 | 4101244 | Human | 1 | name |
| 156171108 | CV2075566 | single nucleotide variant | NM_030662.4(MAP2K2):c.602T>C (p.Leu201Pro) | RASopathy [RCV002851532] | uncertain significance | 19 | 4101122 | 4101122 | Human | 1 | name |
| 155963213 | CV2140829 | single nucleotide variant | NM_030662.4(MAP2K2):c.551T>C (p.Leu184Pro) | RASopathy [RCV003015574] | uncertain significance | 19 | 4101258 | 4101258 | Human | 1 | name |
| 156024285 | CV2175079 | single nucleotide variant | NM_030662.4(MAP2K2):c.767C>G (p.Ser256Cys) | RASopathy [RCV003035885] | uncertain significance | 19 | 4099353 | 4099353 | Human | 1 | name |
| 156138740 | CV2186737 | single nucleotide variant | NM_030662.4(MAP2K2):c.454G>T (p.Gly152Cys) | RASopathy [RCV003056100] | uncertain significance | 19 | 4102450 | 4102450 | Human | 1 | name |
| 156261772 | CV2191062 | single nucleotide variant | NM_030662.4(MAP2K2):c.542T>C (p.Leu181Ser) | Cardiovascular phenotype [RCV004070093]|RASopathy [RCV003044143] | uncertain significance | 19 | 4101267 | 4101267 | Human | 1 | name |
| 156128571 | CV2220050 | single nucleotide variant | NM_030662.4(MAP2K2):c.727C>A (p.His243Asn) | Cardiovascular phenotype [RCV004093927] | uncertain significance | 19 | 4099393 | 4099393 | Human | | name |
| 156124150 | CV2227314 | single nucleotide variant | NM_030662.4(MAP2K2):c.897G>C (p.Arg299Ser) | Cardiovascular phenotype [RCV004091861] | uncertain significance | 19 | 4099223 | 4099223 | Human | | name |
| 11091886 | CV231026 | single nucleotide variant | NM_030662.4(MAP2K2):c.326C>T (p.Pro109Leu) | Cardiofaciocutaneous syndrome 4 [RCV005016572]|Noonan syndrome 1 [RCV003454599]|RASopathy [RCV002517564]|not provided [RCV000680337]|not specified [RCV000217864] | uncertain significance | 19 | 4110633 | 4110633 | Human | 3 | name |
| 8572472 | CV23313 | single nucleotide variant | NM_030662.4(MAP2K2):c.400T>C (p.Tyr134His) | Cardio-facio-cutaneous syndrome [RCV000008763]|Cardiofaciocutaneous syndrome 4 [RCV000043675]|MAP2K2-related disorder [RCV003390660]|Noonan syndrome 1 [RCV003450621]|Noonan syndrome and Noonan-related syndrome [RCV001813182]|RASopathy [RCV000521479]|not provided [RCV000158022] | pathogenic|likely pathogenic | 19 | 4110559 | 4110559 | Human | 5 | name , trait , alternate_id |
| 8560419 | CV23314 | single nucleotide variant | NM_030662.4(MAP2K2):c.383C>A (p.Pro128Gln) | Cardio-facio-cutaneous syndrome [RCV000208770]|Cardiofaciocutaneous syndrome 4 [RCV000008764]|RASopathy [RCV004760323]|not provided [RCV000158021] | pathogenic|not provided | 19 | 4110576 | 4110576 | Human | 3 | name |
| 243052992 | CV2416248 | single nucleotide variant | NM_030662.4(MAP2K2):c.317A>C (p.Glu106Ala) | not provided [RCV003149309] | uncertain significance | 19 | 4110642 | 4110642 | Human | | name |
| 329385302 | CV2423100 | single nucleotide variant | NM_030662.4(MAP2K2):c.743C>G (p.Ser248Trp) | Cardiovascular phenotype [RCV003177073] | uncertain significance | 19 | 4099377 | 4099377 | Human | | name |
| 329351057 | CV2477887 | single nucleotide variant | NM_030662.4(MAP2K2):c.360G>T (p.Gln120His) | not provided [RCV003224000] | uncertain significance | 19 | 4110599 | 4110599 | Human | | name |
| 329847148 | CV2534307 | single nucleotide variant | NM_030662.4(MAP2K2):c.455G>A (p.Gly152Asp) | not provided [RCV003228516] | uncertain significance | 19 | 4102449 | 4102449 | Human | | name |
| 11641744 | CV264952 | single nucleotide variant | NM_030662.4(MAP2K2):c.937C>T (p.Arg313Trp) | Cardiofaciocutaneous syndrome 4 [RCV000656742]|Cardiovascular phenotype [RCV002374449]|RASopathy [RCV001859537]|not provided [RCV000360631] | uncertain significance | 19 | 4097326 | 4097326 | Human | 2 | name |
| 11639162 | CV265085 | single nucleotide variant | NM_030662.4(MAP2K2):c.536G>A (p.Arg179Gln) | Cardiofaciocutaneous syndrome 4 [RCV005016664]|Cardiovascular phenotype [RCV004021071]|MAP2K2-related disorder [RCV003417878]|RASopathy [RCV001348032]|not provided [RCV000315212] | likely benign|uncertain significance | 19 | 4101273 | 4101273 | Human | 2 | name , trait , alternate_id |
| 329848154 | CV2667773 | single nucleotide variant | NM_030662.4(MAP2K2):c.653A>T (p.Gln218Leu) | RASopathy [RCV003539480]|not provided [RCV003229340] | uncertain significance | 19 | 4101071 | 4101071 | Human | 1 | name |
| 11639022 | CV268100 | single nucleotide variant | NM_030662.4(MAP2K2):c.904G>C (p.Gly302Arg) | not provided [RCV000313977] | uncertain significance | 19 | 4099216 | 4099216 | Human | | name |
| 11638789 | CV269358 | single nucleotide variant | NM_030662.4(MAP2K2):c.890G>A (p.Arg297Gln) | Cardiofaciocutaneous syndrome 4 [RCV000764204]|RASopathy [RCV000690698]|not provided [RCV000680326] | conflicting interpretations of pathogenicity|uncertain significance | 19 | 4099230 | 4099230 | Human | 2 | name |
| 401732902 | CV2736779 | single nucleotide variant | NM_030662.4(MAP2K2):c.757A>T (p.Met253Leu) | not provided [RCV003313541] | uncertain significance | 19 | 4099363 | 4099363 | Human | | name |
| 401720214 | CV2737197 | single nucleotide variant | NM_030662.4(MAP2K2):c.829G>A (p.Ala277Thr) | not provided [RCV003314136] | uncertain significance | 19 | 4099291 | 4099291 | Human | | name |
| 401864131 | CV2773439 | single nucleotide variant | NM_030662.4(MAP2K2):c.932A>G (p.Asp311Gly) | Cardiovascular phenotype [RCV004354076] | uncertain significance | 19 | 4097331 | 4097331 | Human | | name |
| 401920215 | CV2796536 | single nucleotide variant | NM_030662.4(MAP2K2):c.356T>C (p.Leu119Pro) | MAP2K2-related disorder [RCV003402572] | uncertain significance | 19 | 4110603 | 4110603 | Human | | name , trait , alternate_id |
| 405158906 | CV2876640 | single nucleotide variant | NM_030662.4(MAP2K2):c.727C>G (p.His243Asp) | RASopathy [RCV003539695] | uncertain significance | 19 | 4099393 | 4099393 | Human | 1 | name |
| 405161863 | CV2899716 | single nucleotide variant | NM_030662.4(MAP2K2):c.386A>C (p.Tyr129Ser) | RASopathy [RCV003540185] | uncertain significance | 19 | 4110573 | 4110573 | Human | 1 | name |
| 405163374 | CV2913863 | single nucleotide variant | NM_030662.4(MAP2K2):c.924C>G (p.His308Gln) | RASopathy [RCV003540306] | uncertain significance | 19 | 4097339 | 4097339 | Human | 1 | name |
| 405164356 | CV2928281 | single nucleotide variant | NM_030662.4(MAP2K2):c.386A>G (p.Tyr129Cys) | RASopathy [RCV003540386] | uncertain significance | 19 | 4110573 | 4110573 | Human | 1 | name |
| 405164485 | CV2931439 | single nucleotide variant | NM_030662.4(MAP2K2):c.548A>G (p.Tyr183Cys) | RASopathy [RCV003540397] | uncertain significance | 19 | 4101261 | 4101261 | Human | 1 | name |
| 405164695 | CV2931980 | single nucleotide variant | NM_030662.4(MAP2K2):c.655C>G (p.Leu219Val) | RASopathy [RCV003540415] | uncertain significance | 19 | 4101069 | 4101069 | Human | 1 | name |
| 405164890 | CV2932638 | single nucleotide variant | NM_030662.4(MAP2K2):c.713G>A (p.Arg238Gln) | RASopathy [RCV003540430] | uncertain significance | 19 | 4099407 | 4099407 | Human | 1 | name |
| 405054451 | CV2936646 | single nucleotide variant | NM_030662.4(MAP2K2):c.806C>A (p.Pro269Gln) | RASopathy [RCV003655446] | uncertain significance | 19 | 4099314 | 4099314 | Human | 1 | name |
| 405059918 | CV2971606 | single nucleotide variant | NM_030662.4(MAP2K2):c.956T>C (p.Phe319Ser) | RASopathy [RCV003655662] | uncertain significance | 19 | 4097307 | 4097307 | Human | 1 | name |
| 405058731 | CV2978947 | single nucleotide variant | NM_030662.4(MAP2K2):c.694T>A (p.Ser232Thr) | RASopathy [RCV003655787] | uncertain significance | 19 | 4101030 | 4101030 | Human | 1 | name |
| 405059488 | CV2994597 | single nucleotide variant | NM_030662.4(MAP2K2):c.886C>T (p.Pro296Ser) | RASopathy [RCV003655843] | uncertain significance | 19 | 4099234 | 4099234 | Human | 1 | name |
| 405061585 | CV3009670 | single nucleotide variant | NM_030662.4(MAP2K2):c.674A>T (p.Asn225Ile) | RASopathy [RCV003655986] | uncertain significance | 19 | 4101050 | 4101050 | Human | 1 | name |
| 405049548 | CV3046085 | single nucleotide variant | NM_030662.4(MAP2K2):c.532C>G (p.Leu178Val) | RASopathy [RCV003654648] | uncertain significance | 19 | 4101277 | 4101277 | Human | 1 | name |
| 405048788 | CV3050079 | single nucleotide variant | NM_030662.4(MAP2K2):c.854A>T (p.Asp285Val) | RASopathy [RCV003654589] | uncertain significance | 19 | 4099266 | 4099266 | Human | 1 | name |
| 405049726 | CV3056331 | single nucleotide variant | NM_030662.4(MAP2K2):c.626A>G (p.Lys209Arg) | RASopathy [RCV003654662] | uncertain significance | 19 | 4101098 | 4101098 | Human | 1 | name |
| 405050463 | CV3060587 | single nucleotide variant | NM_030662.4(MAP2K2):c.791G>A (p.Arg264Lys) | RASopathy [RCV003654696] | uncertain significance | 19 | 4099329 | 4099329 | Human | 1 | name |
| 405050622 | CV3067824 | single nucleotide variant | NM_030662.4(MAP2K2):c.874C>T (p.His292Tyr) | Cardiofaciocutaneous syndrome 4 [RCV005030239]|RASopathy [RCV003654708] | uncertain significance | 19 | 4099246 | 4099246 | Human | 2 | name |
| 405052443 | CV3076231 | single nucleotide variant | NM_030662.4(MAP2K2):c.305T>C (p.Leu102Pro) | RASopathy [RCV003654850] | uncertain significance | 19 | 4110654 | 4110654 | Human | 1 | name |
| 405057065 | CV3081379 | single nucleotide variant | NM_030662.4(MAP2K2):c.650G>C (p.Gly217Ala) | Cardiofaciocutaneous syndrome 4 [RCV003741142] | uncertain significance | 19 | 4101074 | 4101074 | Human | 1 | name |
| 405007998 | CV3117524 | single nucleotide variant | NM_030662.4(MAP2K2):c.946A>G (p.Met316Val) | Cardiofaciocutaneous syndrome 4 [RCV005030288]|RASopathy [RCV003828579] | uncertain significance | 19 | 4097317 | 4097317 | Human | 2 | name |
| 405214330 | CV3143115 | single nucleotide variant | NM_030662.4(MAP2K2):c.572T>C (p.Met191Thr) | RASopathy [RCV003846278] | uncertain significance | 19 | 4101237 | 4101237 | Human | 1 | name |
| 405216781 | CV3143436 | single nucleotide variant | NM_030662.4(MAP2K2):c.539G>A (p.Gly180Asp) | RASopathy [RCV003846600] | uncertain significance | 19 | 4101270 | 4101270 | Human | 1 | name |
| 405188072 | CV3156583 | single nucleotide variant | NM_030662.4(MAP2K2):c.739C>T (p.Gln247Ter) | RASopathy [RCV003859461] | uncertain significance | 19 | 4099381 | 4099381 | Human | 1 | name |
| 405254830 | CV3175559 | single nucleotide variant | NM_030662.4(MAP2K2):c.917G>T (p.Ser306Ile) | RASopathy [RCV003871826] | uncertain significance | 19 | 4099203 | 4099203 | Human | 1 | name |
| 405291121 | CV3222078 | single nucleotide variant | NM_030662.4(MAP2K2):c.404G>T (p.Gly135Val) | Cardiofaciocutaneous syndrome 4 [RCV003984897]|RASopathy [RCV005103149] | likely pathogenic|uncertain significance | 19 | 4110555 | 4110555 | Human | 2 | name |
| 405683291 | CV3387822 | single nucleotide variant | NM_030662.4(MAP2K2):c.346A>G (p.Ile116Val) | Cardiovascular phenotype [RCV004517797]|RASopathy [RCV005100634] | uncertain significance | 19 | 4110613 | 4110613 | Human | 1 | name |
| 405683305 | CV3387826 | single nucleotide variant | NM_030662.4(MAP2K2):c.794A>G (p.Tyr265Cys) | Cardiofaciocutaneous syndrome 4 [RCV005023557]|Cardiovascular phenotype [RCV004517801] | uncertain significance | 19 | 4099326 | 4099326 | Human | 1 | name |
| 407493703 | CV3446442 | single nucleotide variant | NM_030662.4(MAP2K2):c.857G>A (p.Gly286Glu) | Cardiovascular phenotype [RCV004642807]|RASopathy [RCV005102280] | uncertain significance | 19 | 4099263 | 4099263 | Human | 1 | name |
| 408380621 | CV3523608 | single nucleotide variant | NM_030662.4(MAP2K2):c.368A>C (p.His123Pro) | not provided [RCV004766006] | likely pathogenic | 19 | 4110591 | 4110591 | Human | | name |
| 408388940 | CV3529152 | single nucleotide variant | NM_030662.4(MAP2K2):c.734C>T (p.Ser245Leu) | not provided [RCV004773974] | uncertain significance | 19 | 4099386 | 4099386 | Human | | name |
| 12740807 | CV360426 | single nucleotide variant | NM_030662.4(MAP2K2):c.834C>G (p.Ile278Met) | RASopathy [RCV000458371]|not specified [RCV000413176] | uncertain significance | 19 | 4099286 | 4099286 | Human | 1 | name |
| 12740994 | CV360428 | single nucleotide variant | NM_030662.4(MAP2K2):c.541T>A (p.Leu181Met) | not specified [RCV000413749] | uncertain significance | 19 | 4101268 | 4101268 | Human | | name |
| 12740664 | CV360554 | single nucleotide variant | NM_030662.4(MAP2K2):c.826G>C (p.Glu276Gln) | Cardiovascular phenotype [RCV005372303]|RASopathy [RCV001861423]|not specified [RCV000412732] | uncertain significance | 19 | 4099294 | 4099294 | Human | 1 | name |
| 12839847 | CV363055 | single nucleotide variant | NM_030662.4(MAP2K2):c.376A>G (p.Asn126Asp) | Cardio-facio-cutaneous syndrome [RCV000824947]|Cardiofaciocutaneous syndrome 4 [RCV000995803]|RASopathy [RCV001851015] | pathogenic|likely pathogenic | 19 | 4110583 | 4110583 | Human | 3 | name |
| 12844722 | CV363056 | single nucleotide variant | NM_030662.4(MAP2K2):c.373T>A (p.Cys125Ser) | Melanoma [RCV000438500] | likely pathogenic | 19 | 4110586 | 4110586 | Human | 1 | name |
| 597729914 | CV3699985 | single nucleotide variant | NM_030662.4(MAP2K2):c.836T>G (p.Phe279Cys) | Cardiovascular phenotype [RCV004995635] | uncertain significance | 19 | 4099284 | 4099284 | Human | | name |
| 597729927 | CV3699990 | single nucleotide variant | NM_030662.4(MAP2K2):c.646A>G (p.Ser216Gly) | Cardiovascular phenotype [RCV004995639] | uncertain significance | 19 | 4101078 | 4101078 | Human | | name |
| 597750969 | CV3709751 | single nucleotide variant | NM_030662.4(MAP2K2):c.695C>T (p.Ser232Phe) | Cardiofaciocutaneous syndrome 4 [RCV005015759] | uncertain significance | 19 | 4101029 | 4101029 | Human | 1 | name |
| 597662509 | CV3709752 | single nucleotide variant | NM_030662.4(MAP2K2):c.674A>G (p.Asn225Ser) | Cardiofaciocutaneous syndrome 4 [RCV005028646]|RASopathy [RCV005063228] | uncertain significance | 19 | 4101050 | 4101050 | Human | 2 | name |
| 597662515 | CV3709753 | single nucleotide variant | NM_030662.4(MAP2K2):c.590C>T (p.Pro197Leu) | Cardiofaciocutaneous syndrome 4 [RCV005028647]|RASopathy [RCV005112716] | uncertain significance | 19 | 4101134 | 4101134 | Human | 2 | name |
| 597662522 | CV3709754 | single nucleotide variant | NM_030662.4(MAP2K2):c.500A>G (p.Glu167Gly) | Cardiofaciocutaneous syndrome 4 [RCV005028648] | uncertain significance | 19 | 4102404 | 4102404 | Human | 1 | name |
| 597662529 | CV3709755 | single nucleotide variant | NM_030662.4(MAP2K2):c.491G>A (p.Arg164Lys) | Cardiofaciocutaneous syndrome 4 [RCV005028649] | uncertain significance | 19 | 4102413 | 4102413 | Human | 1 | name |
| 597750974 | CV3709756 | single nucleotide variant | NM_030662.4(MAP2K2):c.464T>C (p.Leu155Pro) | Cardiofaciocutaneous syndrome 4 [RCV005015760] | uncertain significance | 19 | 4102440 | 4102440 | Human | 1 | name |
| 597653792 | CV3731356 | single nucleotide variant | NM_030662.4(MAP2K2):c.792G>T (p.Arg264Ser) | not provided [RCV005001536] | uncertain significance | 19 | 4099328 | 4099328 | Human | | name |
| 597833716 | CV3735068 | single nucleotide variant | NM_030662.4(MAP2K2):c.329C>T (p.Ala110Val) | not provided [RCV005054801] | uncertain significance | 19 | 4110630 | 4110630 | Human | | name |
| 597834362 | CV3735840 | single nucleotide variant | NM_030662.4(MAP2K2):c.833T>C (p.Ile278Thr) | not provided [RCV005063703] | uncertain significance | 19 | 4099287 | 4099287 | Human | | name |
| 597956160 | CV3754548 | single nucleotide variant | NM_030662.4(MAP2K2):c.413A>G (p.Tyr138Cys) | RASopathy [RCV005080398] | uncertain significance | 19 | 4110546 | 4110546 | Human | 1 | name |
| 597956375 | CV3754620 | single nucleotide variant | NM_030662.4(MAP2K2):c.488A>G (p.Lys163Arg) | RASopathy [RCV005080470] | uncertain significance | 19 | 4102416 | 4102416 | Human | 1 | name |
| 597836954 | CV3761416 | single nucleotide variant | NM_030662.4(MAP2K2):c.823C>G (p.Leu275Val) | RASopathy [RCV005085787] | uncertain significance | 19 | 4099297 | 4099297 | Human | 1 | name |
| 12847667 | CV376562 | single nucleotide variant | NM_030662.4(MAP2K2):c.475C>G (p.Leu159Val) | not provided [RCV000443892] | uncertain significance | 19 | 4102429 | 4102429 | Human | | name |
| 597905364 | CV3772909 | single nucleotide variant | NM_030662.4(MAP2K2):c.624C>G (p.Ile208Met) | RASopathy [RCV005112974] | uncertain significance | 19 | 4101100 | 4101100 | Human | 1 | name |
| 597885812 | CV3774379 | single nucleotide variant | NM_030662.4(MAP2K2):c.926G>A (p.Gly309Glu) | RASopathy [RCV005109933] | uncertain significance | 19 | 4097337 | 4097337 | Human | 1 | name |
| 597885818 | CV3774380 | single nucleotide variant | NM_030662.4(MAP2K2):c.797C>G (p.Pro266Arg) | RASopathy [RCV005109934] | uncertain significance | 19 | 4099323 | 4099323 | Human | 1 | name |
| 597885825 | CV3774381 | single nucleotide variant | NM_030662.4(MAP2K2):c.664T>C (p.Ser222Pro) | RASopathy [RCV005109935] | uncertain significance | 19 | 4101060 | 4101060 | Human | 1 | name |
| 597885831 | CV3774382 | single nucleotide variant | NM_030662.4(MAP2K2):c.649G>C (p.Gly217Arg) | RASopathy [RCV005109936] | uncertain significance | 19 | 4101075 | 4101075 | Human | 1 | name |
| 597885836 | CV3774383 | single nucleotide variant | NM_030662.4(MAP2K2):c.595A>C (p.Asn199His) | RASopathy [RCV005109937] | uncertain significance | 19 | 4101129 | 4101129 | Human | 1 | name |
| 597885843 | CV3774384 | single nucleotide variant | NM_030662.4(MAP2K2):c.511G>A (p.Gly171Arg) | RASopathy [RCV005109938] | uncertain significance | 19 | 4102393 | 4102393 | Human | 1 | name |
| 597885849 | CV3774385 | single nucleotide variant | NM_030662.4(MAP2K2):c.497C>T (p.Pro166Leu) | RASopathy [RCV005109939] | uncertain significance | 19 | 4102407 | 4102407 | Human | 1 | name |
| 597885855 | CV3774386 | single nucleotide variant | NM_030662.4(MAP2K2):c.447C>G (p.His149Gln) | RASopathy [RCV005109940] | uncertain significance | 19 | 4110512 | 4110512 | Human | 1 | name |
| 597899188 | CV3774387 | single nucleotide variant | NM_030662.4(MAP2K2):c.390C>G (p.Ile130Met) | RASopathy [RCV005111923] | uncertain significance | 19 | 4110569 | 4110569 | Human | 1 | name |
| 597954749 | CV3796069 | single nucleotide variant | NM_030662.4(MAP2K2):c.338A>G (p.Asn113Ser) | RASopathy [RCV005136886] | uncertain significance | 19 | 4110621 | 4110621 | Human | 1 | name |
| 597857650 | CV3822278 | single nucleotide variant | NM_030662.4(MAP2K2):c.853G>C (p.Asp285His) | RASopathy [RCV005174576] | uncertain significance | 19 | 4099267 | 4099267 | Human | 1 | name |
| 597844349 | CV3827447 | single nucleotide variant | NM_030662.4(MAP2K2):c.539G>T (p.Gly180Val) | RASopathy [RCV005172718] | uncertain significance | 19 | 4101270 | 4101270 | Human | 1 | name |
| 597883196 | CV3834144 | single nucleotide variant | NM_030662.4(MAP2K2):c.496C>T (p.Pro166Ser) | RASopathy [RCV005178463] | uncertain significance | 19 | 4102408 | 4102408 | Human | 1 | name |
| 597891263 | CV3856555 | single nucleotide variant | NM_030662.4(MAP2K2):c.448A>G (p.Met150Val) | RASopathy [RCV005200620] | uncertain significance | 19 | 4110511 | 4110511 | Human | 1 | name |
| 597935434 | CV3863678 | single nucleotide variant | NM_030662.4(MAP2K2):c.700A>G (p.Met234Val) | not provided [RCV005207491] | uncertain significance | 19 | 4101024 | 4101024 | Human | | name |
| 8568157 | CV39126 | single nucleotide variant | NM_030662.4(MAP2K2):c.395G>A (p.Gly132Asp) | Cardiofaciocutaneous syndrome 4 [RCV000023088]|Cardiovascular phenotype [RCV005372225]|RASopathy [RCV000149835]|not provided [RCV000413893] | pathogenic|likely pathogenic | 19 | 4110564 | 4110564 | Human | 2 | name |
| 598196846 | CV3988649 | single nucleotide variant | NM_030662.4(MAP2K2):c.560A>G (p.Lys187Arg) | Cardiovascular phenotype [RCV005375335] | uncertain significance | 19 | 4101249 | 4101249 | Human | | name |
| 12881208 | CV403729 | single nucleotide variant | NM_030662.4(MAP2K2):c.325C>G (p.Pro109Ala) | Noonan syndrome [RCV000824946]|RASopathy [RCV000457414]|not provided [RCV005414499] | likely benign|uncertain significance | 19 | 4110634 | 4110634 | Human | 2 | name |
| 12901367 | CV410613 | single nucleotide variant | NM_030662.4(MAP2K2):c.952A>G (p.Ile318Val) | Cardiovascular phenotype [RCV003278838]|RASopathy [RCV003539906]|not provided [RCV000484509] | likely benign|uncertain significance | 19 | 4097311 | 4097311 | Human | 1 | name |
| 12900451 | CV410616 | single nucleotide variant | NM_030662.4(MAP2K2):c.814G>A (p.Ala272Thr) | Cardiofaciocutaneous syndrome 4 [RCV003129871]|Cardiovascular phenotype [RCV002420244]|RASopathy [RCV002526970]|not provided [RCV000680366]|not specified [RCV000482431] | likely benign|uncertain significance | 19 | 4099306 | 4099306 | Human | 2 | name |
| 12901148 | CV410617 | single nucleotide variant | NM_030662.4(MAP2K2):c.454G>A (p.Gly152Ser) | RASopathy [RCV005056058]|not provided [RCV000484028] | uncertain significance | 19 | 4102450 | 4102450 | Human | 1 | name |
| 12905545 | CV413490 | single nucleotide variant | NM_030662.4(MAP2K2):c.682G>A (p.Val228Met) | RASopathy [RCV003766733]|not provided [RCV000487640] | uncertain significance | 19 | 4101042 | 4101042 | Human | 1 | name |
| 13211886 | CV426315 | single nucleotide variant | NM_030662.4(MAP2K2):c.331A>T (p.Ile111Phe) | Cardiofaciocutaneous syndrome 4 [RCV005018837]|RASopathy [RCV002527158]|not provided [RCV000498041] | uncertain significance | 19 | 4110628 | 4110628 | Human | 2 | name |
| 13504513 | CV442539 | single nucleotide variant | NM_030662.4(MAP2K2):c.847G>T (p.Val283Leu) | Cardiofaciocutaneous syndrome 4 [RCV005018888]|RASopathy [RCV000520355] | likely benign|uncertain significance | 19 | 4099273 | 4099273 | Human | 2 | name |
| 13520572 | CV487813 | single nucleotide variant | NM_030662.4(MAP2K2):c.627G>C (p.Lys209Asn) | RASopathy [RCV001860145]|not provided [RCV000587985] | uncertain significance | 19 | 4101097 | 4101097 | Human | 1 | name |
| 13519781 | CV488053 | single nucleotide variant | NM_030662.4(MAP2K2):c.847G>A (p.Val283Met) | Cardiofaciocutaneous syndrome 4 [RCV005027696]|RASopathy [RCV001295722]|not specified [RCV003994033] | likely benign|uncertain significance | 19 | 4099273 | 4099273 | Human | 2 | name |
| 13536049 | CV49260 | single nucleotide variant | NM_030662.4(MAP2K2):c.320T>A (p.Ile107Asn) | RASopathy [RCV001059467]|not provided [RCV004799753]|not specified [RCV000608440] | uncertain significance | 19 | 4110639 | 4110639 | Human | 1 | name |
| 156329415 | CV49261 | single nucleotide variant | NM_030662.4(MAP2K2):c.335G>A (p.Arg112Gln) | Cardiofaciocutaneous syndrome 4 [RCV005019475]|RASopathy [RCV002938281] | likely pathogenic|uncertain significance | 19 | 4110624 | 4110624 | Human | 2 | name |
| 9688987 | CV49262 | single nucleotide variant | NM_030662.4(MAP2K2):c.383C>G (p.Pro128Arg) | not specified [RCV000154387] | uncertain significance | 19 | 4110576 | 4110576 | Human | | name |
| 150431138 | CV49271 | single nucleotide variant | NM_030662.4(MAP2K2):c.485C>T (p.Ala162Val) | RASopathy [RCV001866196]|not provided [RCV001580898] | uncertain significance | 19 | 4102419 | 4102419 | Human | 1 | name |
| 155742448 | CV49273 | single nucleotide variant | NM_030662.4(MAP2K2):c.526G>A (p.Ala176Thr) | Cardiovascular phenotype [RCV002344386]|RASopathy [RCV003096675] | uncertain significance | 19 | 4102378 | 4102378 | Human | 1 | name |
| 156028275 | CV49277 | single nucleotide variant | NM_030662.4(MAP2K2):c.545C>T (p.Ala182Val) | RASopathy [RCV002909945] | uncertain significance | 19 | 4101264 | 4101264 | Human | 1 | name |
| 26917375 | CV49282 | single nucleotide variant | NM_030662.4(MAP2K2):c.604G>A (p.Val202Met) | Cardiofaciocutaneous syndrome 4 [RCV003129759]|Cardiovascular phenotype [RCV004018725]|RASopathy [RCV001042609]|not specified [RCV001582507] | uncertain significance | 19 | 4101120 | 4101120 | Human | 2 | name |
| 9689112 | CV49283 | single nucleotide variant | NM_030662.4(MAP2K2):c.619G>A (p.Glu207Lys) | Cardio-facio-cutaneous syndrome [RCV000524055]|Noonan syndrome [RCV000844675]|RASopathy [RCV000158024]|not provided [RCV000254662] | pathogenic|likely pathogenic | 19 | 4101105 | 4101105 | Human | 3 | name |
| 155713905 | CV49284 | single nucleotide variant | NM_030662.4(MAP2K2):c.649G>A (p.Gly217Ser) | Cardiovascular phenotype [RCV002362026]|RASopathy [RCV005096950] | uncertain significance | 19 | 4101075 | 4101075 | Human | 1 | name |
| 156416388 | CV49287 | single nucleotide variant | NM_030662.4(MAP2K2):c.691C>T (p.Arg231Cys) | RASopathy [RCV002610151] | uncertain significance | 19 | 4101033 | 4101033 | Human | 1 | name |
| 9832799 | CV49288 | single nucleotide variant | NM_030662.4(MAP2K2):c.692G>T (p.Arg231Leu) | Cardiofaciocutaneous syndrome 4 [RCV001849290]|Noonan syndrome and Noonan-related syndrome [RCV000788004]|Noonan syndrome with multiple lentigines [RCV000824948]|RASopathy [RCV000466246]|not provided [RCV000158025] | likely pathogenic|uncertain significance | 19 | 4101032 | 4101032 | Human | 3 | name |
| 9832801 | CV49294 | single nucleotide variant | NM_030662.4(MAP2K2):c.818A>G (p.Lys273Arg) | Cardiofaciocutaneous syndrome 4 [RCV000990136]|MAP2K2-related disorder [RCV003952390]|RASopathy [RCV000522446]|not provided [RCV000158027]|not specified [RCV000781517] | likely pathogenic|likely benign|uncertain significance | 19 | 4099302 | 4099302 | Human | 2 | name , trait , alternate_id |
| 8609110 | CV49296 | single nucleotide variant | NM_030662.4(MAP2K2):c.844C>T (p.Pro282Ser) | Cardiovascular phenotype [RCV003343604]|MAP2K2-related disorder [RCV003944871]|Noonan syndrome [RCV000824950]|RASopathy [RCV000522371]|not provided [RCV000680293]|not specified [RCV000039495] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4099276 | 4099276 | Human | 3 | name , trait , alternate_id |
| 9832802 | CV49298 | single nucleotide variant | NM_030662.4(MAP2K2):c.853G>A (p.Asp285Asn) | Noonan syndrome [RCV001261064]|RASopathy [RCV001480813]|not provided [RCV000680294]|not specified [RCV000158029] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4099267 | 4099267 | Human | 2 | name |
| 9832818 | CV49299 | single nucleotide variant | NM_030662.4(MAP2K2):c.856G>A (p.Gly286Arg) | Cardiofaciocutaneous syndrome 4 [RCV005394191]|Cardiovascular phenotype [RCV004018726]|RASopathy [RCV000654943]|not provided [RCV000158048] | conflicting interpretations of pathogenicity|uncertain significance | 19 | 4099264 | 4099264 | Human | 2 | name |
| 9832803 | CV49300 | single nucleotide variant | NM_030662.4(MAP2K2):c.884C>T (p.Ser295Leu) | Cardiofaciocutaneous syndrome 4 [RCV005016318]|Cardiovascular phenotype [RCV005372226]|RASopathy [RCV001852682]|not provided [RCV000158030] | likely benign|uncertain significance | 19 | 4099236 | 4099236 | Human | 2 | name |
| 13520727 | CV49301 | single nucleotide variant | NM_030662.4(MAP2K2):c.889C>T (p.Arg297Trp) | RASopathy [RCV001243507]|not provided [RCV000588230] | likely benign|uncertain significance | 19 | 4099231 | 4099231 | Human | 1 | name |
| 9689073 | CV49302 | single nucleotide variant | NM_030662.4(MAP2K2):c.893C>T (p.Pro298Leu) | Cardiovascular phenotype [RCV005364906]|Hypertrophic cardiomyopathy [RCV000852749]|Noonan syndrome and Noonan-related syndrome [RCV001813317]|RASopathy [RCV000227476]|not provided [RCV000586661]|not specified [RCV000154492] | benign|likely benign | 19 | 4099227 | 4099227 | Human | 3 | name |
| 9832804 | CV49309 | single nucleotide variant | NM_030662.4(MAP2K2):c.938G>A (p.Arg313Gln) | Cardiofaciocutaneous syndrome 4 [RCV002482944]|Cardiovascular phenotype [RCV002371815]|Noonan syndrome [RCV000761056]|Noonan syndrome and Noonan-related syndrome [RCV001813318]|RASopathy [RCV001062526]|not provided [RCV000767154]|not specified [RCV000158031] | uncertain significance | 19 | 4097325 | 4097325 | Human | 3 | name |
| 13612232 | CV514098 | single nucleotide variant | NM_030662.4(MAP2K2):c.514A>G (p.Lys172Glu) | MAP2K2-related disorder [RCV003420086]|Migraine [RCV000626968]|RASopathy [RCV002529800] | uncertain significance | 19 | 4102390 | 4102390 | Human | 17 | name , trait , alternate_id |
| 13626536 | CV533045 | single nucleotide variant | NM_030662.4(MAP2K2):c.692G>A (p.Arg231His) | Cardiofaciocutaneous syndrome 4 [RCV005019090]|MAP2K2-related disorder [RCV004745538]|Noonan syndrome and Noonan-related syndrome [RCV000788005]|RASopathy [RCV000654976]|not provided [RCV001797120] | uncertain significance | 19 | 4101032 | 4101032 | Human | 2 | name , trait , alternate_id |
| 13626503 | CV533539 | single nucleotide variant | NM_030662.4(MAP2K2):c.865G>A (p.Gly289Arg) | Cardiovascular phenotype [RCV003278976]|RASopathy [RCV000654923] | uncertain significance | 19 | 4099255 | 4099255 | Human | 1 | name |
| 13626533 | CV533550 | single nucleotide variant | NM_030662.4(MAP2K2):c.453C>G (p.Asp151Glu) | RASopathy [RCV000654973]|not provided [RCV001507910] | uncertain significance | 19 | 4102451 | 4102451 | Human | 1 | name |
| 13797764 | CV553036 | single nucleotide variant | NM_030662.4(MAP2K2):c.605T>G (p.Val202Gly) | not provided [RCV000681413] | uncertain significance | 19 | 4101119 | 4101119 | Human | | name |
| 8609094 | CV55399 | single nucleotide variant | NM_030662.4(MAP2K2):c.391G>A (p.Val131Met) | RASopathy [RCV003764692]|not specified [RCV000039479] | uncertain significance | 19 | 4110568 | 4110568 | Human | 1 | name |
| 8609108 | CV55407 | single nucleotide variant | NM_030662.4(MAP2K2):c.784G>A (p.Val262Ile) | RASopathy [RCV000519690]|not specified [RCV000039493] | benign|likely benign|uncertain significance | 19 | 4099336 | 4099336 | Human | 1 | name |
| 13813587 | CV570803 | single nucleotide variant | NM_030662.4(MAP2K2):c.842G>A (p.Arg281Gln) | Cardiofaciocutaneous syndrome 4 [RCV005021062]|RASopathy [RCV000690261]|not provided [RCV001815372] | uncertain significance | 19 | 4099278 | 4099278 | Human | 2 | name |
| 13820059 | CV570804 | single nucleotide variant | NM_030662.4(MAP2K2):c.380C>T (p.Ser127Leu) | RASopathy [RCV000694725]|not provided [RCV001756198] | uncertain significance | 19 | 4110579 | 4110579 | Human | 1 | name |
| 13817013 | CV574979 | single nucleotide variant | NM_030662.4(MAP2K2):c.491G>T (p.Arg164Met) | Cardiofaciocutaneous syndrome 4 [RCV005021066]|RASopathy [RCV000692716]|not specified [RCV001264512] | uncertain significance | 19 | 4102413 | 4102413 | Human | 2 | name |
| 13831746 | CV582243 | single nucleotide variant | NM_030662.4(MAP2K2):c.707C>T (p.Pro236Leu) | Cardiovascular phenotype [RCV003338769]|RASopathy [RCV003540854]|not provided [RCV000722428] | uncertain significance | 19 | 4099413 | 4099413 | Human | 1 | name |
| 14396245 | CV612026 | single nucleotide variant | NM_030662.4(MAP2K2):c.523A>G (p.Ile175Val) | Noonan syndrome [RCV000761014] | uncertain significance | 19 | 4102381 | 4102381 | Human | 1 | name |
| 14689802 | CV621637 | single nucleotide variant | NM_030662.4(MAP2K2):c.352G>A (p.Glu118Lys) | MAP2K2-related disorder [RCV003396358]|not specified [RCV000780395] | uncertain significance | 19 | 4110607 | 4110607 | Human | 1 | name , trait , alternate_id |
| 14702630 | CV648137 | single nucleotide variant | NM_030662.4(MAP2K2):c.376A>C (p.Asn126His) | RASopathy [RCV000807052] | uncertain significance | 19 | 4110583 | 4110583 | Human | 1 | name |
| 14745386 | CV653829 | single nucleotide variant | NM_030662.4(MAP2K2):c.383C>T (p.Pro128Leu) | Castleman-Kojima disease [RCV000824698]|MAP2K2-related disorder [RCV003908112]|not provided [RCV003313157] | pathogenic | 19 | 4110576 | 4110576 | Human | 2 | name , trait , alternate_id |
| 14702889 | CV653983 | single nucleotide variant | NM_030662.4(MAP2K2):c.811G>A (p.Asp271Asn) | Cardio-facio-cutaneous syndrome [RCV000824949]|Cardiofaciocutaneous syndrome 4 [RCV005029515]|RASopathy [RCV002536037]|not provided [RCV001772146] | likely benign|uncertain significance | 19 | 4099309 | 4099309 | Human | 3 | name |
| 26885720 | CV847719 | single nucleotide variant | NM_030662.4(MAP2K2):c.689C>T (p.Thr230Met) | RASopathy [RCV001065619] | uncertain significance | 19 | 4101035 | 4101035 | Human | 1 | name |
| 26891650 | CV847720 | single nucleotide variant | NM_030662.4(MAP2K2):c.682G>C (p.Val228Leu) | MAP2K2-related disorder [RCV003983827]|RASopathy [RCV001046546] | uncertain significance | 19 | 4101042 | 4101042 | Human | 2 | name , trait , alternate_id |
| 26900220 | CV847721 | single nucleotide variant | NM_030662.4(MAP2K2):c.643G>T (p.Val215Leu) | Cardiovascular phenotype [RCV002365783]|Noonan syndrome [RCV001261063]|RASopathy [RCV001071204] | likely benign|uncertain significance | 19 | 4101081 | 4101081 | Human | 2 | name |
| 26908909 | CV847722 | single nucleotide variant | NM_030662.4(MAP2K2):c.553C>T (p.Arg185Ter) | Cardiofaciocutaneous syndrome 4 [RCV005021350]|RASopathy [RCV001038407] | uncertain significance | 19 | 4101256 | 4101256 | Human | 2 | name |
| 26913883 | CV847723 | single nucleotide variant | NM_030662.4(MAP2K2):c.433A>G (p.Ile145Val) | Cardiofaciocutaneous syndrome 4 [RCV005021382]|RASopathy [RCV001054554] | uncertain significance | 19 | 4110526 | 4110526 | Human | 2 | name |
| 26909260 | CV847724 | single nucleotide variant | NM_030662.4(MAP2K2):c.335G>T (p.Arg112Leu) | Cardiofaciocutaneous syndrome 4 [RCV003741245]|RASopathy [RCV001038482] | likely pathogenic | 19 | 4110624 | 4110624 | Human | 2 | name |
| 34891273 | CV906038 | single nucleotide variant | NM_030662.4(MAP2K2):c.841C>T (p.Arg281Trp) | Cardiovascular phenotype [RCV002445415]|RASopathy [RCV001873656]|not specified [RCV001174923] | likely benign|uncertain significance | 19 | 4099279 | 4099279 | Human | 1 | name |
| 38460709 | CV919868 | single nucleotide variant | NM_030662.4(MAP2K2):c.661G>A (p.Asp221Asn) | Cardiofaciocutaneous syndrome 4 [RCV001196823]|RASopathy [RCV002560226] | uncertain significance | 19 | 4101063 | 4101063 | Human | 2 | name |
| 38478005 | CV928974 | single nucleotide variant | NM_030662.4(MAP2K2):c.556G>C (p.Glu186Gln) | RASopathy [RCV001216409]|not provided [RCV004783920] | uncertain significance | 19 | 4101253 | 4101253 | Human | 1 | name |
| 38456974 | CV950799 | single nucleotide variant | NM_030662.4(MAP2K2):c.986C>T (p.Pro329Leu) | Cardiovascular phenotype [RCV002379873]|RASopathy [RCV001228528] | uncertain significance | 19 | 4095448 | 4095448 | Human | 1 | name |
| 38456978 | CV950800 | single nucleotide variant | NM_030662.4(MAP2K2):c.577C>T (p.Arg193Ter) | Cardiovascular phenotype [RCV002356972]|RASopathy [RCV001228529] | uncertain significance | 19 | 4101232 | 4101232 | Human | 1 | name |
| 38488449 | CV950801 | single nucleotide variant | NM_030662.4(MAP2K2):c.333C>G (p.Ile111Met) | RASopathy [RCV001238021]|not provided [RCV004762014] | uncertain significance | 19 | 4110626 | 4110626 | Human | 1 | name |
| 40813858 | CV969695 | single nucleotide variant | NM_030662.4(MAP2K2):c.640G>A (p.Gly214Arg) | MAP2K2-related disorder [RCV003405468]|Noonan syndrome [RCV001261062]|RASopathy [RCV001880002]|not provided [RCV004778033] | likely benign|uncertain significance | 19 | 4101084 | 4101084 | Human | 3 | name , trait , alternate_id |
| 126732998 | CV998616 | single nucleotide variant | NM_030662.4(MAP2K2):c.740A>C (p.Gln247Pro) | Cardiovascular phenotype [RCV002384368]|RASopathy [RCV001304190] | uncertain significance | 19 | 4099380 | 4099380 | Human | 1 | name |
| 126746331 | CV1015383 | single nucleotide variant | NM_030662.4(MAP2K2):c.1195G>A (p.Ala399Thr) | RASopathy [RCV002546258]|not specified [RCV001328431] | uncertain significance | 19 | 4090606 | 4090606 | Human | 1 | name |
| 126733312 | CV1021895 | single nucleotide variant | NM_030662.4(MAP2K2):c.1042A>G (p.Lys348Glu) | Cardiofaciocutaneous syndrome 4 [RCV001334283]|RASopathy [RCV001865804] | uncertain significance | 19 | 4095392 | 4095392 | Human | 2 | name |
| 150556279 | CV1296840 | single nucleotide variant | NM_030662.4(MAP2K2):c.1151G>A (p.Cys384Tyr) | RASopathy [RCV003539403]|not provided [RCV001774130] | uncertain significance | 19 | 4090650 | 4090650 | Human | 1 | name |
| 151352156 | CV1325115 | single nucleotide variant | NM_030662.4(MAP2K2):c.1106T>C (p.Ile369Thr) | Noonan syndrome and Noonan-related syndrome [RCV001813671]|not provided [RCV004699481] | uncertain significance | 19 | 4090695 | 4090695 | Human | | name |
| 151798259 | CV1337084 | single nucleotide variant | NM_030662.4(MAP2K2):c.1100C>A (p.Thr367Asn) | RASopathy [RCV002047740] | uncertain significance | 19 | 4090701 | 4090701 | Human | 1 | name |
| 151758875 | CV1342995 | single nucleotide variant | NM_030662.4(MAP2K2):c.1010T>G (p.Val337Gly) | Cardiovascular phenotype [RCV004641897]|RASopathy [RCV002024134] | uncertain significance | 19 | 4095424 | 4095424 | Human | 1 | name |
| 151821792 | CV1355022 | single nucleotide variant | NM_030662.4(MAP2K2):c.1138G>A (p.Ala380Thr) | RASopathy [RCV001934214] | uncertain significance | 19 | 4090663 | 4090663 | Human | 1 | name |
| 151880195 | CV1359994 | single nucleotide variant | NM_030662.4(MAP2K2):c.1141G>A (p.Gly381Ser) | RASopathy [RCV002036760]|not provided [RCV003481257] | uncertain significance | 19 | 4090660 | 4090660 | Human | 1 | name |
| 151793476 | CV1423086 | single nucleotide variant | NM_030662.4(MAP2K2):c.1019C>G (p.Pro340Arg) | RASopathy [RCV001917041] | uncertain significance | 19 | 4095415 | 4095415 | Human | 1 | name |
| 151749393 | CV1430326 | single nucleotide variant | NM_030662.4(MAP2K2):c.1157C>T (p.Thr386Ile) | RASopathy [RCV002006704] | uncertain significance | 19 | 4090644 | 4090644 | Human | 1 | name |
| 151774619 | CV1450215 | single nucleotide variant | NM_030662.4(MAP2K2):c.1109A>T (p.Lys370Met) | RASopathy [RCV001915310] | uncertain significance | 19 | 4090692 | 4090692 | Human | 1 | name |
| 151839696 | CV1487658 | single nucleotide variant | NM_030662.4(MAP2K2):c.1022A>C (p.Asp341Ala) | Cardiovascular phenotype [RCV004043549]|RASopathy [RCV001935956] | uncertain significance | 19 | 4095412 | 4095412 | Human | 1 | name |
| 151734118 | CV1494394 | single nucleotide variant | NM_030662.4(MAP2K2):c.1087C>T (p.Leu363Phe) | RASopathy [RCV001946356] | uncertain significance | 19 | 4094458 | 4094458 | Human | 1 | name |
| 151855550 | CV1506749 | single nucleotide variant | NM_030662.4(MAP2K2):c.1021G>A (p.Asp341Asn) | Cardiovascular phenotype [RCV002407055]|RASopathy [RCV001937904] | uncertain significance | 19 | 4095413 | 4095413 | Human | 1 | name |
| 155645676 | CV1709030 | single nucleotide variant | NM_030662.4(MAP2K2):c.1192A>C (p.Thr398Pro) | not provided [RCV002291906] | uncertain significance | 19 | 4090609 | 4090609 | Human | | name |
| 155699160 | CV1778817 | single nucleotide variant | NM_030662.4(MAP2K2):c.1026C>A (p.Phe342Leu) | RASopathy [RCV002299840] | uncertain significance | 19 | 4095408 | 4095408 | Human | 1 | name |
| 9832809 | CV179818 | single nucleotide variant | NM_030662.4(MAP2K2):c.1189C>T (p.Arg397Cys) | RASopathy [RCV001056752]|not provided [RCV000158036] | conflicting interpretations of pathogenicity|uncertain significance | 19 | 4090612 | 4090612 | Human | 1 | name |
| 9832808 | CV179819 | single nucleotide variant | NM_030662.4(MAP2K2):c.1180A>T (p.Thr394Ser) | RASopathy [RCV003654214]|not provided [RCV000158035] | uncertain significance | 19 | 4090621 | 4090621 | Human | 1 | name |
| 9832806 | CV179820 | single nucleotide variant | NM_030662.4(MAP2K2):c.1085T>C (p.Met362Thr) | RASopathy [RCV000796637]|not provided [RCV001721006] | likely benign|uncertain significance | 19 | 4094460 | 4094460 | Human | 1 | name |
| 155664285 | CV1855165 | single nucleotide variant | NM_030662.4(MAP2K2):c.1117G>A (p.Glu373Lys) | Cardiovascular phenotype [RCV002435121]|RASopathy [RCV003539461]|not specified [RCV004801215] | uncertain significance | 19 | 4090684 | 4090684 | Human | 1 | name |
| 156385003 | CV1883648 | single nucleotide variant | NM_030662.4(MAP2K2):c.1170C>G (p.Asn390Lys) | Cardiovascular phenotype [RCV004992492]|RASopathy [RCV003093600] | uncertain significance | 19 | 4090631 | 4090631 | Human | 1 | name |
| 156186575 | CV1933848 | single nucleotide variant | NM_030662.4(MAP2K2):c.1112G>T (p.Arg371Leu) | RASopathy [RCV002625219] | uncertain significance | 19 | 4090689 | 4090689 | Human | 1 | name |
| 156324564 | CV1975558 | single nucleotide variant | NM_030662.4(MAP2K2):c.1007G>A (p.Gly336Asp) | RASopathy [RCV002630573] | uncertain significance | 19 | 4095427 | 4095427 | Human | 1 | name |
| 156298689 | CV2017195 | single nucleotide variant | NM_030662.4(MAP2K2):c.1073C>T (p.Ala358Val) | RASopathy [RCV002715957] | uncertain significance | 19 | 4094472 | 4094472 | Human | 1 | name |
| 156148154 | CV2026693 | single nucleotide variant | NM_030662.4(MAP2K2):c.1117G>C (p.Glu373Gln) | RASopathy [RCV002741137] | uncertain significance | 19 | 4090684 | 4090684 | Human | 1 | name |
| 156204733 | CV2134925 | single nucleotide variant | NM_030662.4(MAP2K2):c.1051A>C (p.Ile351Leu) | RASopathy [RCV002985354] | uncertain significance | 19 | 4094494 | 4094494 | Human | 1 | name |
| 155942430 | CV2143052 | single nucleotide variant | NM_030662.4(MAP2K2):c.1196C>T (p.Ala399Val) | RASopathy [RCV002994141] | uncertain significance | 19 | 4090605 | 4090605 | Human | 1 | name |
| 11636456 | CV265075 | single nucleotide variant | NM_030662.4(MAP2K2):c.1187C>T (p.Thr396Met) | Cardiofaciocutaneous syndrome 4 [RCV000764203]|Noonan syndrome [RCV000824953]|RASopathy [RCV001030088]|not provided [RCV000588572]|not specified [RCV000269273] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4090614 | 4090614 | Human | 3 | name |
| 11641046 | CV269674 | single nucleotide variant | NM_030662.4(MAP2K2):c.1064C>T (p.Ala355Val) | Cardiovascular phenotype [RCV002411153]|RASopathy [RCV003539874]|not provided [RCV000725661]|not specified [RCV000349966] | uncertain significance | 19 | 4094481 | 4094481 | Human | 1 | name |
| 401752557 | CV2707049 | single nucleotide variant | NM_030662.4(MAP2K2):c.1198G>T (p.Val400Leu) | Cardiofaciocutaneous syndrome 4 [RCV004723252]|Cardiovascular phenotype [RCV004321635] | likely benign|uncertain significance | 19 | 4090603 | 4090603 | Human | 1 | name |
| 401854880 | CV2753349 | single nucleotide variant | NM_030662.4(MAP2K2):c.1063G>C (p.Ala355Pro) | Cardiovascular phenotype [RCV003338978] | uncertain significance | 19 | 4094482 | 4094482 | Human | | name |
| 401877062 | CV2793334 | single nucleotide variant | NM_030662.4(MAP2K2):c.1120G>A (p.Val374Met) | Cardiovascular phenotype [RCV004362147] | uncertain significance | 19 | 4090681 | 4090681 | Human | | name |
| 401908283 | CV2801325 | single nucleotide variant | NM_030662.4(MAP2K2):c.1043A>G (p.Lys348Arg) | MAP2K2-related disorder [RCV003397566]|RASopathy [RCV003655425]|not provided [RCV005235714] | uncertain significance | 19 | 4095391 | 4095391 | Human | 2 | name , trait , alternate_id |
| 405157045 | CV2864785 | single nucleotide variant | NM_030662.4(MAP2K2):c.1130T>C (p.Val377Ala) | RASopathy [RCV003539526] | uncertain significance | 19 | 4090671 | 4090671 | Human | 1 | name |
| 405165098 | CV2923923 | single nucleotide variant | NM_030662.4(MAP2K2):c.1123G>T (p.Glu375Ter) | RASopathy [RCV003540449] | uncertain significance | 19 | 4090678 | 4090678 | Human | 1 | name |
| 405058030 | CV2983948 | single nucleotide variant | NM_030662.4(MAP2K2):c.1105A>C (p.Ile369Leu) | RASopathy [RCV003655730] | uncertain significance | 19 | 4090696 | 4090696 | Human | 1 | name |
| 405060787 | CV3004095 | single nucleotide variant | NM_030662.4(MAP2K2):c.1150T>C (p.Cys384Arg) | Cardiovascular phenotype [RCV004371788]|RASopathy [RCV003655923] | uncertain significance | 19 | 4090651 | 4090651 | Human | 1 | name |
| 405047765 | CV3021062 | single nucleotide variant | NM_030662.4(MAP2K2):c.1190G>T (p.Arg397Leu) | RASopathy [RCV003654507] | uncertain significance | 19 | 4090611 | 4090611 | Human | 1 | name |
| 405048506 | CV3043091 | single nucleotide variant | NM_030662.4(MAP2K2):c.1178G>T (p.Gly393Val) | RASopathy [RCV003654568] | uncertain significance | 19 | 4090623 | 4090623 | Human | 1 | name |
| 405050442 | CV3060401 | single nucleotide variant | NM_030662.4(MAP2K2):c.1157C>A (p.Thr386Asn) | RASopathy [RCV003654694] | uncertain significance | 19 | 4090644 | 4090644 | Human | 1 | name |
| 405051384 | CV3062249 | single nucleotide variant | NM_030662.4(MAP2K2):c.1031A>G (p.Glu344Gly) | RASopathy [RCV003654767] | uncertain significance | 19 | 4095403 | 4095403 | Human | 1 | name |
| 405052321 | CV3073541 | single nucleotide variant | NM_030662.4(MAP2K2):c.1181C>T (p.Thr394Ile) | RASopathy [RCV003654840] | uncertain significance | 19 | 4090620 | 4090620 | Human | 1 | name |
| 405168574 | CV3122333 | single nucleotide variant | NM_030662.4(MAP2K2):c.1085T>G (p.Met362Arg) | RASopathy [RCV003818922] | uncertain significance | 19 | 4094460 | 4094460 | Human | 1 | name |
| 405016737 | CV3139057 | single nucleotide variant | NM_030662.4(MAP2K2):c.1193C>G (p.Thr398Ser) | RASopathy [RCV003829394] | uncertain significance | 19 | 4090608 | 4090608 | Human | 1 | name |
| 402475168 | CV3172707 | single nucleotide variant | NM_030662.4(MAP2K2):c.1090A>G (p.Thr364Ala) | RASopathy [RCV003875125] | uncertain significance | 19 | 4094455 | 4094455 | Human | 1 | name |
| 408380690 | CV3523630 | single nucleotide variant | NM_030662.4(MAP2K2):c.1001C>G (p.Pro334Arg) | not provided [RCV004766028] | uncertain significance | 19 | 4095433 | 4095433 | Human | | name |
| 12740820 | CV360399 | single nucleotide variant | NM_030662.4(MAP2K2):c.1039A>G (p.Asn347Asp) | Cardiovascular phenotype [RCV003168601]|not specified [RCV000413213] | uncertain significance | 19 | 4095395 | 4095395 | Human | | name |
| 12740736 | CV360552 | single nucleotide variant | NM_030662.4(MAP2K2):c.1036G>A (p.Val346Ile) | Cardiofaciocutaneous syndrome 4 [RCV005027473]|Cardiovascular phenotype [RCV004022164]|RASopathy [RCV001861414]|not provided [RCV001718806]|not specified [RCV000412966] | uncertain significance | 19 | 4095398 | 4095398 | Human | 2 | name |
| 597662504 | CV3709748 | single nucleotide variant | NM_030662.4(MAP2K2):c.1086G>A (p.Met362Ile) | Cardiofaciocutaneous syndrome 4 [RCV005028645]|RASopathy [RCV005112715] | uncertain significance | 19 | 4094459 | 4094459 | Human | 2 | name |
| 597885792 | CV3774376 | single nucleotide variant | NM_030662.4(MAP2K2):c.1079T>C (p.Leu360Pro) | RASopathy [RCV005109930] | uncertain significance | 19 | 4094466 | 4094466 | Human | 1 | name |
| 597885798 | CV3774377 | single nucleotide variant | NM_030662.4(MAP2K2):c.1025T>G (p.Phe342Cys) | RASopathy [RCV005109931] | uncertain significance | 19 | 4095409 | 4095409 | Human | 1 | name |
| 597885805 | CV3774378 | single nucleotide variant | NM_030662.4(MAP2K2):c.1018C>T (p.Pro340Ser) | RASopathy [RCV005109932] | uncertain significance | 19 | 4095416 | 4095416 | Human | 1 | name |
| 597933194 | CV3810672 | single nucleotide variant | NM_030662.4(MAP2K2):c.1072G>A (p.Ala358Thr) | RASopathy [RCV005157381] | uncertain significance | 19 | 4094473 | 4094473 | Human | 1 | name |
| 598175019 | CV3890952 | single nucleotide variant | NM_030662.4(MAP2K2):c.1049T>G (p.Leu350Arg) | not provided [RCV005251805] | uncertain significance | 19 | 4094496 | 4094496 | Human | | name |
| 598196840 | CV3988647 | single nucleotide variant | NM_030662.4(MAP2K2):c.1139C>T (p.Ala380Val) | Cardiovascular phenotype [RCV005375333] | uncertain significance | 19 | 4090662 | 4090662 | Human | | name |
| 617154383 | CV4022603 | single nucleotide variant | NM_030662.4(MAP2K2):c.1021G>T (p.Asp341Tyr) | not provided [RCV005429960] | uncertain significance | 19 | 4095413 | 4095413 | Human | | name |
| 9832807 | CV49312 | single nucleotide variant | NM_030662.4(MAP2K2):c.1112G>A (p.Arg371Gln) | Cardiofaciocutaneous syndrome 4 [RCV005016319]|RASopathy [RCV000546588]|not provided [RCV000158034]|not specified [RCV000781515] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4090689 | 4090689 | Human | 2 | name |
| 9689090 | CV49313 | single nucleotide variant | NM_030662.4(MAP2K2):c.1162C>T (p.Arg388Trp) | Cardiofaciocutaneous syndrome 4 [RCV001334284]|Cardiovascular phenotype [RCV002354182]|Noonan syndrome [RCV000824952]|RASopathy [RCV000200611]|not provided [RCV000680296]|not specified [RCV000154509] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4090639 | 4090639 | Human | 3 | name |
| 14746592 | CV49314 | single nucleotide variant | NM_030662.4(MAP2K2):c.1190G>A (p.Arg397His) | Cardiofaciocutaneous syndrome 4 [RCV005016320]|Cardiovascular phenotype [RCV004639124]|RASopathy [RCV000813491] | uncertain significance | 19 | 4090611 | 4090611 | Human | 2 | name |
| 14691377 | CV49317 | single nucleotide variant | NM_030662.4(MAP2K2):c.1198G>A (p.Val400Met) | Noonan syndrome and Noonan-related syndrome [RCV001813319]|RASopathy [RCV000866602]|not provided [RCV001610309]|not specified [RCV000781516] | benign|likely benign | 19 | 4090603 | 4090603 | Human | 1 | name |
| 13536148 | CV497519 | single nucleotide variant | NM_030662.4(MAP2K2):c.1061C>T (p.Pro354Leu) | Cardiovascular phenotype [RCV003278941]|not provided [RCV002223228]|not specified [RCV000608579] | uncertain significance | 19 | 4094484 | 4094484 | Human | | name |
| 13796774 | CV553026 | insertion | NM_030662.4(MAP2K2):c.1047-140_1047-139insG | not provided [RCV000680747] | benign | 19 | 4094637 | 4094638 | Human | | name |
| 13818543 | CV574978 | single nucleotide variant | NM_030662.4(MAP2K2):c.1111C>T (p.Arg371Trp) | Cardiofaciocutaneous syndrome 4 [RCV005027863]|Cardiovascular phenotype [RCV004025165]|RASopathy [RCV000693780]|not provided [RCV001200613] | uncertain significance | 19 | 4090690 | 4090690 | Human | 2 | name |
| 14737146 | CV648136 | single nucleotide variant | NM_030662.4(MAP2K2):c.1006G>A (p.Gly336Ser) | Cardiofaciocutaneous syndrome 4 [RCV005021217]|RASopathy [RCV000803908] | uncertain significance | 19 | 4095428 | 4095428 | Human | 2 | name |
| 14702892 | CV653982 | single nucleotide variant | NM_030662.4(MAP2K2):c.1109A>G (p.Lys370Arg) | Noonan syndrome [RCV000824951] | uncertain significance | 19 | 4090692 | 4090692 | Human | 1 | name |
| 26912431 | CV847718 | single nucleotide variant | NM_030662.4(MAP2K2):c.1177G>A (p.Gly393Ser) | RASopathy [RCV001039331]|not specified [RCV001193485] | uncertain significance | 19 | 4090624 | 4090624 | Human | 1 | name |
| 126728674 | CV985654 | single nucleotide variant | NM_030662.4(MAP2K2):c.1019C>T (p.Pro340Leu) | RASopathy [RCV005094355]|not specified [RCV001293480] | uncertain significance | 19 | 4095415 | 4095415 | Human | 1 | name |
| 126757236 | CV998614 | single nucleotide variant | NM_030662.4(MAP2K2):c.1184C>G (p.Pro395Arg) | RASopathy [RCV001298822] | uncertain significance | 19 | 4090617 | 4090617 | Human | 1 | name |
| 126767164 | CV998615 | single nucleotide variant | NM_030662.4(MAP2K2):c.1163G>A (p.Arg388Gln) | Cardiofaciocutaneous syndrome 4 [RCV005014367]|RASopathy [RCV001302177]|not provided [RCV004692447] | uncertain significance | 19 | 4090638 | 4090638 | Human | 2 | name |
| 156211435 | CV2028430 | microsatellite | NM_030662.4(MAP2K2):c.151AAG[1] (p.Lys52del) | RASopathy [RCV002711778] | uncertain significance | 19 | 4117566 | 4117568 | Human | | name |
| 12899956 | CV410614 | indel | NM_030662.4(MAP2K2):c.919+10_919+12delinsAAG | not provided [RCV000481333]|not specified [RCV001174840] | likely benign|uncertain significance | 19 | 4099189 | 4099191 | Human | | name |
| 13626525 | CV533115 | microsatellite | NM_030662.4(MAP2K2):c.288CAT[1] (p.Ile97del) | Cardiofaciocutaneous syndrome 4 [RCV002245069]|RASopathy [RCV000654959] | uncertain significance | 19 | 4117429 | 4117431 | Human | | name |
| 151879054 | CV1419200 | microsatellite | NM_030662.4(MAP2K2):c.973_974del (p.Ile325fs) | Cardiofaciocutaneous syndrome 4 [RCV005016879]|RASopathy [RCV001982275] | uncertain significance | 19 | 4097289 | 4097290 | Human | | name |
| 156143179 | CV2163924 | deletion | NM_030662.4(MAP2K2):c.760_761del (p.Gly254fs) | RASopathy [RCV003022595] | uncertain significance | 19 | 4099359 | 4099360 | Human | 1 | name |
| 156270169 | CV2178945 | deletion | NM_030662.4(MAP2K2):c.794_824del (p.Tyr265fs) | RASopathy [RCV003044425] | uncertain significance | 19 | 4099296 | 4099326 | Human | 1 | name |
| 12912055 | CV248722 | deletion | NM_030662.4(MAP2K2):c.210_212del (p.Asp71del) | Smith-Magenis Syndrome-like [RCV000490823] | pathogenic | 19 | 4117510 | 4117512 | Human | 1 | name |
| 597864278 | CV3767017 | deletion | NM_030662.4(MAP2K2):c.655_658del (p.Leu219fs) | RASopathy [RCV005106539] | uncertain significance | 19 | 4101066 | 4101069 | Human | 1 | name |
| 597865208 | CV3861181 | deletion | NM_030662.4(MAP2K2):c.485_492del (p.Ala162fs) | RASopathy [RCV005196529] | uncertain significance | 19 | 4102412 | 4102419 | Human | 1 | name |
| 13518208 | CV494977 | microsatellite | NM_030662.4(MAP2K2):c.860AAG[1] (p.Glu288del) | Cardiovascular phenotype [RCV004024874]|RASopathy [RCV001215485]|not provided [RCV001538822]|not specified [RCV000597122] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 19 | 4099255 | 4099257 | Human | | name |
| 12901778 | CV410615 | insertion | NM_030662.4(MAP2K2):c.899_900insT (p.Gly302fs) | not provided [RCV000485520] | uncertain significance | 19 | 4099220 | 4099221 | Human | | name |
| 156330212 | CV2180931 | deletion | NM_030662.4(MAP2K2):c.1043_1046del (p.Lys348fs) | RASopathy [RCV003047164] | uncertain significance | 19 | 4095388 | 4095391 | Human | 1 | name |
| 9832815 | CV49236 | indel | NM_030662.4(MAP2K2):c.83_84delinsAA (p.Gly28Glu) | RASopathy [RCV001852681]|not provided [RCV000158045] | uncertain significance | 19 | 4123792 | 4123793 | Human | | name |
| 13626522 | CV533117 | indel | NM_030662.4(MAP2K2):c.191_192delinsCT (p.Val64Ala) | Cardiovascular phenotype [RCV004025944]|RASopathy [RCV000654954] | uncertain significance | 19 | 4117530 | 4117531 | Human | | name |
| 405056516 | CV2951637 | indel | NM_030662.4(MAP2K2):c.659_660delinsCA (p.Ile220Thr) | RASopathy [RCV003655584] | uncertain significance | 19 | 4101064 | 4101065 | Human | | name |
| 405060669 | CV3000635 | indel | NM_030662.4(MAP2K2):c.536_537delinsTT (p.Arg179Leu) | RASopathy [RCV003655913] | uncertain significance | 19 | 4101272 | 4101273 | Human | | name |
| 14702886 | CV653984 | deletion | NM_030662.4(MAP2K2):c.187_192del (p.Lys63_Val64del) | Cardio-facio-cutaneous syndrome [RCV000824944] | likely pathogenic | 19 | 4117530 | 4117535 | Human | 1 | name |
| 150436874 | CV1249770 | microsatellite | NM_030662.4(MAP2K2):c.92+229_92+230insCCCTCGGGGGAGGACGGGGCAGGGGA | not provided [RCV001665684] | benign | 19 | 4123554 | 4123555 | Human | | name |